Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

A
A. Fernandez Romero, Jose

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Jose A. Fernandez Romero
Favorite
Aare, Mounika

Florida A &M University
(M0930-04-19) Genetically Engineered PD-L1 Targeted Exosomes for Immunotherapy of Doxorubicin Resistant Triple Negative Breast Cancers
Mounika Aare
Favorite
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Mounika Aare
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Mounika Aare
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Mounika Aare
Favorite
Abbruscato, Thomas

Texas Tech University Health Sciences Center
(M0930-04-21) Evaluation of the Blood-Brain Barrier Protective Effects of Metformin after Mixed Exposures to Cigarette Smoke, e-Cigarette Vapor, and Stroke Conditions
Thomas Abbruscato
Favorite
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Thomas Abbruscato
Favorite
Abdelhakk, Hala

University of Texas at Austin
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Hala Abdelhakk
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Hala Abdelhakk
Favorite
Abdelrahman, Muna

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Muna Abdelrahman
Favorite
Abe, Koji

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Koji Abe
Favorite
AboJasser, Esraa

Biotage LLC
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Esraa AboJasser
Favorite
Abos, Alexandra

Sanofi
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Alexandra Abos
Favorite
AboulFotouh, Khaled

University of Texas at Austin
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Khaled AboulFotouh
Favorite
Abou-Taleb, Basant

Pharos University in Alexandria
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Basant Abou-Taleb
Favorite
Abraham, Edidiong

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Edidiong Abraham
Favorite
Abreu, Raquel

Hovione
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Raquel Abreu
Favorite
Acevedo, Waldo

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Waldo Acevedo
Favorite
Acker, Timothy

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Timothy Acker
Favorite
Adamcakova-Dodd, Andrea

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Andrea Adamcakova-Dodd
Favorite
Adams, Ian

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Ian Adams
Favorite
Adams, Joseph

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Joseph Adams
Favorite
Adden, Roland

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Roland Adden
Favorite
Adediran, Emmanuel

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Emmanuel Adediran
Favorite
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Emmanuel Adediran
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Emmanuel Adediran
Favorite
Adeseha, Henry

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Henry Adeseha
Favorite
Adesina, Simeon

Howard University
(M1530-01-03) Targeted Cell-Penetrating Peptide-Drug Conjugates for the Treatment of Pancreatic Cancer
Simeon Adesina
Favorite
(T0930-04-19) Gemcitabine/Doxorubicin-Combination Polymer-Drug Conjugate Synthesized by SPAAC Click Chemistry: Characterization and Evaluation in OVCAR-3 Ovarian Cancer Cells
Simeon Adesina
Favorite
(W1030-05-25) Targeted Peptide Dual Drug Conjugate for the Treatment of Glioblastoma
Simeon Adesina
Favorite
Adiwidjaja, Jeffry

Simulations Plus, Inc.
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Jeffry Adiwidjaja
Favorite
Affagard, Herve

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Herve Affagard
Favorite
Afridi, Hajra

Lonza
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Hajra Afridi
Favorite
Agatovure, Kess

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Kess Agatovure
Favorite
Aghazadeh-Habashi, Ali

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Ali Aghazadeh-Habashi
Favorite
Agrahari, Vibhuti

University of Oklahoma Health Sciences Center
(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation
Vibhuti Agrahari
Favorite
Agrawal, Arun

US Food and Drug Administration
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Arun Agrawal
Favorite
Ahmad, Aziz

University of Minnesota
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Aziz Ahmad
Favorite
Ahmad, Rizwan

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Rizwan Ahmad
Favorite
Ahmed, A.H. Rezwanuddin

City College of New York
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
A.H. Rezwanuddin Ahmed
Favorite
Ahmed, M. Rizwan

University College Cork
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
M. Rizwan Ahmed
Favorite
Ahmed, Nada

Texas A&M University
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Nada Ahmed
Favorite
Ai, Keisuke

Freund Corporation
(M1130-10-57) Evaluation of Lubricant Distribution in Tablets Using All-in-One Excipients
Keisuke Ai
Favorite
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Keisuke Ai
Favorite
Ainampudi, Swetha

St. Joseph's University
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Swetha Ainampudi
Favorite
Akhter, Farhana

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Farhana Akhter
Favorite
Akhzamehr, Arnavaz

Nova Southeastern University
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Arnavaz Akhzamehr
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Arnavaz Akhzamehr
Favorite
Akkineni, Snehitha

Mercer University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Snehitha Akkineni
Favorite
Ako-Adounvo, Ann-Marie

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Ann-Marie Ako-Adounvo
Favorite
Akshintala, Venkata S.

Johns Hopkins Hospital, Baltimore
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Venkata S. Akshintala
Favorite
Akter, Ferdoushi

Merck
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Ferdoushi Akter
Favorite
Akter, Khondker

Texas Tech University Health Sciences Center
(M0930-04-21) Evaluation of the Blood-Brain Barrier Protective Effects of Metformin after Mixed Exposures to Cigarette Smoke, e-Cigarette Vapor, and Stroke Conditions
Khondker Akter
Favorite
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Khondker Akter
Favorite
Akther, Thamina

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Thamina Akther
Favorite
Al Shawakri, Esraa

University of Mississippi
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Esraa Al Shawakri
Favorite
Aladwani, Ghali

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Ghali Aladwani
Favorite
Alajlouni, Ruba

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Ruba Alajlouni
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Ruba Alajlouni
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Ruba Alajlouni
Favorite
Alavi, Sonia

University of Illinois Chicago
(T0930-01-06) Combatting Pseudomonas aeruginosa Biofilms: A Strategy with Glutathione-Conjugated Hydrogels for Disruption and Biofouling Mitigation
Sonia Alavi
Favorite
Albee, Karen

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Karen Albee
Favorite
Alelyunas, Yun

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Yun Alelyunas
Favorite
Al-Ghabeish, Manar

US Food and Drug Administration
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Manar Al-Ghabeish
Favorite
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Manar Al-Ghabeish
Favorite
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Manar Al-Ghabeish
Favorite
Al-Hilal, Taslim

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Taslim Al-Hilal
Favorite
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
Taslim Al-Hilal
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Taslim Al-Hilal
Favorite
Ali, Mariame

Irma Lerma Rangel College of Pharmacy
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Mariame Ali
Favorite
Ali, Md Haider

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Md Haider Ali
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Md Haider Ali
Favorite
Alimi, Ariss

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Ariss Alimi
Favorite
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Ariss Alimi
Favorite
Ali, Muhammad

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Muhammad Ali
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Muhammad Ali
Favorite
Ali, Rizwan

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Rizwan Ali
Favorite
Ali, Syed Nafis Shadman

North South University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Syed Nafis Shadman Ali
Favorite
Aljassimi, Raghad

University of Utah
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Raghad Aljassimi
Favorite
Alkhamis, Khouloud

Jordan Univerisity of Science and Technology
(T1430-01-01) Preparation of a Modified Release Dosage Form of Diltiazem Hydrochloride Using Cation Exchange Resins
Khouloud Alkhamis
Favorite
Allamreddy, Swetha Reddy

University of Alabama
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Swetha Reddy Allamreddy
Favorite
Al-Maghrabi, Passant

Copenhagen University
(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity
Passant Al-Maghrabi
Favorite
Almutairi, Mashan

University of Mississippi
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Mashan Almutairi
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Mashan Almutairi
Favorite
Alnatour, Mohammad

University of Iowa
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Mohammad Alnatour
Favorite
Al-Natour, Mohammad

University of Iowa
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Mohammad Al-Natour
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Mohammad Al-Natour
Favorite
Al-Nimry, Suhair

Jordan University of Science and Technology
(T1430-01-01) Preparation of a Modified Release Dosage Form of Diltiazem Hydrochloride Using Cation Exchange Resins
Suhair Al-Nimry
Favorite
Alomori, Sundus

University of Mississippi
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Sundus Alomori
Favorite
Alshahrouri, Bayan

Temple University
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Bayan Alshahrouri
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Bayan Alshahrouri
Favorite
AlShammari, Nouf

University of Mississippi
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Nouf AlShammari
Favorite
Al-Smadi, Khadeejeh

University of Queensland
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Khadeejeh Al-Smadi
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Khadeejeh Al-Smadi
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Khadeejeh Al-Smadi
Favorite
Alston, Amy

CSL Vifor
(T1430-02-07) Exploring the Potential Influence of Physicochemical Characteristics on Biodistribution of Iron-Carbohydrate Nanoparticles Using a Chicken Embryo Model
Amy Alston
Favorite
Alsunbul, Maha

Prince Bint Abdulrahman University
(T1130-01-01) Active Targeting to the Hepatocytes: How Important is Tailoring the Liposomes and Physicochemical Properties and Surface Modification in Targeting the Hepatocytes?
Maha Alsunbul
Favorite
Alsuwayyid, Faisal

Purdue University
(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer
Faisal Alsuwayyid
Favorite
Al-Taani, Bashar

Zarqa University
(T1430-05-30) Preparation and Characterization of Nanoemulsion Formulation for Andrographolide to Improve its Oral Bioavailability Characteristics
Bashar Al-Taani
Favorite
Altannak, Naser

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Naser Altannak
Favorite
Altenor, Angelo

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Angelo Altenor
Favorite
Aluri, Jagadeesh

Eisai Inc.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Jagadeesh Aluri
Favorite
Ambhore, Nilesh

North Dakota State University
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Nilesh Ambhore
Favorite
Ambhore, Shubhashri

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Shubhashri Ambhore
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Shubhashri Ambhore
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Shubhashri Ambhore
Favorite
Ambudkar, Vaibhav

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Vaibhav Ambudkar
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Vaibhav Ambudkar
Favorite
Aminpour, Peyman

Thermo Fisher Scientific
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Peyman Aminpour
Favorite
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Peyman Aminpour
Favorite
Ananthaswamy, Neeti

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Neeti Ananthaswamy
Favorite
An, Christina

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Christina An
Favorite
Anderson, Carl A.

Duquesne University
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Carl A. Anderson
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Carl A. Anderson
Favorite
Anderson, Maria

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Maria Anderson
Favorite
Andreassen, Alex

International Flavors and Fragrances
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Alex Andreassen
Favorite
Andreo, Gabriella

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Gabriella Andreo
Favorite
Andres, Mark

Thermo Fisher Scientific
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Mark Andres
Favorite
Andrews, Gavin

Queen's University Belfast
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Gavin Andrews
Favorite
Andrianopoulou, Angeliki

University of Illinois Chicago
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Angeliki Andrianopoulou
Favorite
Anekalla, Tirupathi

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Tirupathi Anekalla
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Tirupathi Anekalla
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Tirupathi Anekalla
Favorite
Ang, Rosalind

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Rosalind Ang
Favorite
Angsantikul, Pavimol

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Pavimol Angsantikul
Favorite
Anjani, Qonita

Queen's University Belfast
(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide
Qonita Anjani
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Qonita Anjani
Favorite
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Qonita Anjani
Favorite
Anjum, Md Meraj

University of Iowa
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Md Meraj Anjum
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Md Meraj Anjum
Favorite
Anketell, Dilanjan

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Dilanjan Anketell
Favorite
Annaji, Manjusha

US Food and Drug Administration
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Manjusha Annaji
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Manjusha Annaji
Favorite
Annereau, Maxime

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Maxime Annereau
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Maxime Annereau
Favorite
Anstatt, Ryan

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Ryan Anstatt
Favorite
Arbieva, Zarema

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Zarema Arbieva
Favorite
Arghittu, Sabrina

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Sabrina Arghittu
Favorite
Argikar, Upendra

Bill & Melinda Gates Medical Research Institute
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Upendra Argikar
Favorite
Arnold, Jaden

University of Utah
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jaden Arnold
Favorite
Arnold, Robert

Auburn University
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Robert Arnold
Favorite
Arnous, Anis

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Anis Arnous
Favorite
Arora, Kapildev

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Kapildev Arora
Favorite
Arora, Meenakshi

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Meenakshi Arora
Favorite
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Meenakshi Arora
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Meenakshi Arora
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Meenakshi Arora
Favorite
Arroyo-Maya, Izlia Jazheel

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Izlia Jazheel Arroyo-Maya
Favorite
Arte, Kinnari Santosh

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Kinnari Santosh Arte
Favorite
(M1130-05-28) Understanding the Impact of L-leucine on Stability and Inhalation Potential of Dry Powder Protein Formulations
Kinnari Santosh Arte
Favorite
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Kinnari Santosh Arte
Favorite
Arte, Tanisha

Mercer University
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Tanisha Arte
Favorite
Arte, Tanisha Manoj

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Tanisha Manoj Arte
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Tanisha Manoj Arte
Favorite
Asenso, James

University of Alabama
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
James Asenso
Favorite
Ashkarran, Aliakbar

Michigan State University
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Aliakbar Ashkarran
Favorite
Ashour, Eman

University of Mississippi
(M1230-05-29) Employing Hot Melt Extrusion and Vacuum Compression Molding to Develop Cannabidiol Solid Sedds for Improved Solubility
Eman Ashour
Favorite
(T0930-03-14) Toward Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding and Cryogenic Milling
Eman Ashour
Favorite
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Eman Ashour
Favorite
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Eman Ashour
Favorite
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Eman Ashour
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Eman Ashour
Favorite
Ashraf Uz Zaman, Md

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Md Ashraf Uz Zaman
Favorite
Ashraf, Muhammad

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Muhammad Ashraf
Favorite
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Muhammad Ashraf
Favorite
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Muhammad Ashraf
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Muhammad Ashraf
Favorite
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Muhammad Ashraf
Favorite
Aso, Makoto

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Makoto Aso
Favorite
Aso, Shogo

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Shogo Aso
Favorite
Assi, K.H.

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
K.H. Assi
Favorite
Assis, Joao Marcos

BASF Corporation
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Joao Marcos Assis
Favorite
(W0930-07-41) Evaluation of Plasticizer and Stabilizer Effect on Drug Release Profiles of Taste-Masked Vardenafil MUPS ODT
Joao Marcos Assis
Favorite
Ata Saei, Amir

Karolinska Institutet
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Amir Ata Saei
Favorite
Ataide, Janaina Artem

University of Campinas
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Janaina Artem Ataide
Favorite
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Janaina Artem Ataide
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Janaina Artem Ataide
Favorite
Athar, Mohammad

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Mohammad Athar
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Mohammad Athar
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Mohammad Athar
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Mohammad Athar
Favorite
Attia, Sara

University of Southern California
(M1030-07-37) GRP78 Targeting of Long-Acting Hydra-Elastin-Like Polypeptides (ELPs) Carrying Rapamycin to Breast Cancer
Sara Attia
Favorite
Auel, Tobias

Heinrich-Heine-University Dusseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Tobias Auel
Favorite
(T1230-02-09) Examination of the Diffusion Properties of Hydrogels as Optimized Preclinical In Vitro Models for the Human Vitreous Body
Tobias Auel
Favorite
Auguste, Davonne

Aliri Bioanalysis
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Davonne Auguste
Favorite
Avdeef, Alex

in-ADME Research
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Alex Avdeef
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Alex Avdeef
Favorite
Avril, Stefanie

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Stefanie Avril
Favorite
Avvari, Suvarchala

Simulations Plus, Inc.
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Suvarchala Avvari
Favorite
Awad, Ahmed

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Ahmed Awad
Favorite
Awari, Gajanan

BASF Corporation
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Gajanan Awari
Favorite
Awasthi, Shivangi

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Shivangi Awasthi
Favorite
Azam, Zulfikar

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Zulfikar Azam
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Zulfikar Azam
Favorite
Azer, Nicole

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Nicole Azer
Favorite
B
Babalola, Kabirat

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Kabirat Babalola
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Kabirat Babalola
Favorite
Babu, Milan

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Milan Babu
Favorite
Babu, R. Jayachandra

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
R. Jayachandra Babu
Favorite
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
R. Jayachandra Babu
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
R. Jayachandra Babu
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
R. Jayachandra Babu
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
R. Jayachandra Babu
Favorite
Badger, Sydney

Colorcon, Inc.
(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity
Sydney Badger
Favorite
Badola, Muskan

University of Minnesota
(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium
Muskan Badola
Favorite
Badruddoza, Abu Zayed

Pfizer Inc.
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Abu Zayed Badruddoza
Favorite
Baek, Eun Jin

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Eun Jin Baek
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Eun Jin Baek
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Eun Jin Baek
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Eun Jin Baek
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Eun Jin Baek
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Eun Jin Baek
Favorite
Bae, Sung Hun

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Sung Hun Bae
Favorite
Bagde, Arvind

Florida A&M University
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Arvind Bagde
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Arvind Bagde
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Arvind Bagde
Favorite
Bagde, Shapali

US Food and Drug Administration
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Shapali Bagde
Favorite
Baghla, Rahul

SCIEX
(T1130-04-24) Automated Workflow for Targeted Protein Degrader (TPD) Metabolite Identification Using Collision-Induced Dissociation (CID) and Electron-Activated Dissociation (EAD)
Rahul Baghla
Favorite
Bagwe, Priyal

US Food and Drug Administration
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Priyal Bagwe
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Priyal Bagwe
Favorite
Bahamondez, Tania

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Tania Bahamondez
Favorite
Baisa, Srikanth

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Srikanth Baisa
Favorite
Baker, Manasi

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Manasi Baker
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Manasi Baker
Favorite
Baldizar, Christie

Anton Paar USA, Inc.
(M0930-11-64) Low Surface Area Measurements of Excipients, Replacing Krypton with Nitrogen
Christie Baldizar
Favorite
Baliu-Rodriguez, David

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
David Baliu-Rodriguez
Favorite
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
David Baliu-Rodriguez
Favorite
Ballantyne, Joanne

Waters Corporation
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Joanne Ballantyne
Favorite
Balmert, Stephen

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Stephen Balmert
Favorite
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Stephen Balmert
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Stephen Balmert
Favorite
Baltrip, Emanuel

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Emanuel Baltrip
Favorite
Balu-iyer, Sathy

University at Buffalo
(W0930-02-12) Oral Tolerance Mediated by Phosphatidylserine Containing Lipid Nanoparticle
Sathy Balu-iyer
Favorite
Bambarkar, Sunil

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Sunil Bambarkar
Favorite
Banach, Grzegorz

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Grzegorz Banach
Favorite
Banda, Brenda Natalia

University of North Texas Health Science Center
(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle
Brenda Natalia Banda
Favorite
Bande, Divya

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Divya Bande
Favorite
Banella, Sabrina

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Sabrina Banella
Favorite
Banerjee, Anurag

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Anurag Banerjee
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Anurag Banerjee
Favorite
Banga, Ajay

Mercer University
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Ajay Banga
Favorite
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Ajay Banga
Favorite
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Ajay Banga
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Ajay Banga
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Ajay Banga
Favorite
(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect
Ajay Banga
Favorite
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Ajay Banga
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Ajay Banga
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Ajay Banga
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Ajay Banga
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Ajay Banga
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Ajay Banga
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Ajay Banga
Favorite
Bankali, Amrutharaj

Intera Healthcare
(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation
Amrutharaj Bankali
Favorite
Bano, Nazneen

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Nazneen Bano
Favorite
Bao, Qing

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Qing Bao
Favorite
Bao, Quanying

Alexion Pharmaceuticals, Inc.
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Quanying Bao
Favorite
Bao, Wei

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Wei Bao
Favorite
Barbas, Rafael

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Rafael Barbas
Favorite
Barbour, Tara

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Tara Barbour
Favorite
Barhydt, Tracy

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Tracy Barhydt
Favorite
Barnes, Jeffrey

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Jeffrey Barnes
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Jeffrey Barnes
Favorite
Barnhart, Scott

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Scott Barnhart
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Scott Barnhart
Favorite
Barros, Caio

NIBRT
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Caio Barros
Favorite
Barry, Jessica

University of Minnesota
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Jessica Barry
Favorite
Bartlett, Amy

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Amy Bartlett
Favorite
Basarkar, Ashwin

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Ashwin Basarkar
Favorite
Bashar, Mohamed

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Mohamed Bashar
Favorite
Bashetty, Sujith Raj

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Sujith Raj Bashetty
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Sujith Raj Bashetty
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Sujith raj Bashetty
Favorite
Basim, Pratap

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Pratap Basim
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Pratap Basim
Favorite
Basit, Abdul

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Abdul Basit
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Abdul Basit
Favorite
Baskaran, Padmamalini

Howard University
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Padmamalini Baskaran
Favorite
Bataille Backer, Perpetue

Howard University
(W1030-05-25) Targeted Peptide Dual Drug Conjugate for the Treatment of Glioblastoma
Perpetue Bataille Backer
Favorite
Baudelet, Margot

Ghent University Hospital
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Margot Baudelet
Favorite
Baumann, Michael

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Michael Baumann
Favorite
Baumhof, Patrick

CureVac
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Patrick Baumhof
Favorite
Bauser, Haley

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Haley Bauser
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Haley Bauser
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Haley Bauser
Favorite
Bayne, Anne-Cecile

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Anne-Cecile Bayne
Favorite
(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance
Anne-Cecile Bayne
Favorite
Baynham, Michael

Waters Corporation
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Michael Baynham
Favorite
Bayoumy, Shariff

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Shariff Bayoumy
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Shariff Bayoumy
Favorite
Becker, Carly

Huntsman Cancer Institute
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Carly Becker
Favorite
Bedogni, Giselle

Universidad Nacional de Rosario
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Giselle Bedogni
Favorite
Begley, Ben

Aliri Bioanalysis
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
Ben Begley
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Ben Begley
Favorite
Begley, John

Aliri Bioanalysis
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
John Begley
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
John Begley
Favorite
Begley, Matthew

Aliri Bioanalysis
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Matthew Begley
Favorite
Behrend-Keim, Beatriz

University of Texas at Austin
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Beatriz Behrend-Keim
Favorite
Behrs, Jonathan

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jonathan Behrs
Favorite
Belem, Bruna

University of Sao Paulo
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Bruna Belem
Favorite
(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification
Bruna Belem
Favorite
Belhadj, Zakia

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Zakia Belhadj
Favorite
Bellantone, Robert

Physical Pharmaceutica, LLC
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
Robert Bellantone
Favorite
Bembridge, Dawn

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Dawn Bembridge
Favorite
Bendayan, Reina

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Reina Bendayan
Favorite
Bennett, Daniel

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Daniel Bennett
Favorite
Bennette, nathan

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
nathan Bennette
Favorite
Bennett-Lenane, Harriet

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Harriet Bennett-Lenane
Favorite
Bentley, Elizabeth

University of Pittsburgh
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Elizabeth Bentley
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Elizabeth Bentley
Favorite
Bentley, Mackenzie

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Mackenzie Bentley
Favorite
Berchielli, Alfred

Pfizer Inc.
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Alfred Berchielli
Favorite
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Alfred Berchielli
Favorite
Berezwick, Elizabeth

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Elizabeth Berezwick
Favorite
Berthold, Erin

University of Florida
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Erin Berthold
Favorite
Bertrand, Holly

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Holly Bertrand
Favorite
Betram, Lee

Agilent Technologies, Inc
(M1430-06-31) A Sensitive Bioanalysis Method for Antisense Oligonucleotides using LC-MS/MS
Lee Betram
Favorite
Bettencourt, Brian

Torque Bio
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brian Bettencourt
Favorite
Bhagali, Vedant

Seran Bioscience, LLC
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Vedant Bhagali
Favorite
Bhalkikar, Anuja

Sciex
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Anuja Bhalkikar
Favorite
Bhalla, Aanya

University of Texas at Austin
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Aanya Bhalla
Favorite
Bhalla, Amardeep

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Amardeep Bhalla
Favorite
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Amardeep Bhalla
Favorite
Bhat, Divya

University of Iowa
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Divya Bhat
Favorite
Bhat, Roopal

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Roopal Bhat
Favorite
Bhattarai, Nirajan

Idaho State University
(W1230-04-19) Explainable Artificial Intelligence (XAI) for Generation of Library of Novel Potential Acetylcholinesterase Inhibitors
Nirajan Bhattarai
Favorite
Bhattarai, Prapanna

Texas A&M University
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Prapanna Bhattarai
Favorite
Bhattarakosol, Parvapan

Chulalongkorn University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Parvapan Bhattarakosol
Favorite
Bhongade, Yogeshwary

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Yogeshwary Bhongade
Favorite
Bhoopathy, Siddhartha

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Siddhartha Bhoopathy
Favorite
Bhorkade, Saurabh

University of Connecticut
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Saurabh Bhorkade
Favorite
Bhosale, Devyani

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Devyani Bhosale
Favorite
Bhusane, Nitin

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement
Nitin Bhusane
Favorite
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Nitin Bhusane
Favorite
Bianchet-David, Samuele

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Samuele Bianchet-David
Favorite
Bielski, Elizabeth

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Elizabeth Bielski
Favorite
Bigos, Pawel

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Pawel Bigos
Favorite
Bilchak, Connor

BASF Corporation
(M1130-05-29) Rapid Detection of Formulation Stability for Fast Product Development
Connor Bilchak
Favorite
(T1130-09-53) Smart Formulating of Pharmaceutical Emulsions Using HLD-NAC Theory
Connor Bilchak
Favorite
Billa Nys, Cecile

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Cecile Billa Nys
Favorite
Billa, Nashiru

Qatar University
(M1330-01-01) The Anti-Colon Cancer Potential of Succinylated Curcumin Encapsulated in Mannosylated Chitosan
Nashiru Billa
Favorite
Bing, Tiejun

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Tiejun Bing
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Tiejun Bing
Favorite
Binzet, Gulsilan

UNM College of Pharmacy
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Gulsilan Binzet
Favorite
Birdsall, Robert

Waters Corporation
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Robert Birdsall
Favorite
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Robert Birdsall
Favorite
Birkmire, Andrew

GEA Process Engineering, Inc.
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Andrew Birkmire
Favorite
Birnbaum, Angela

University of Minnesota
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Angela Birnbaum
Favorite
Bishop, Hannah

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Hannah Bishop
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Hannah Bishop
Favorite
Bis, Joanna

Alcami Corporation
(M1230-04-19) Guaifenesin: Discovery and Attributes of Novel Racemic Compound
Joanna Bis
Favorite
(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction
Joanna Bis
Favorite
Bist, Ganesh

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Ganesh Bist
Favorite
Blakely, Kyle

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Kyle Blakely
Favorite
Blanco, Marco

Merck & Co., Inc.
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Marco Blanco
Favorite
Blass, Benjamin

Temple University
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Benjamin Blass
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Benjamin Blass
Favorite
Blattner, simone

Boehringer Ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
simone Blattner
Favorite
Boateng, Morrison

Roquette America Inc.
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Morrison Boateng
Favorite
Bobbala, Sharan

West Virginia University
(M1530-09-48) Dual Adjuvanted Ionizable Lipid Nanoparticles for Vaccine Delivery
Sharan Bobbala
Favorite
Boc, Susan

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Susan Boc
Favorite
Bodycomb, Jeffrey

Horiba
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Jeffrey Bodycomb
Favorite
Bogdanowich-Knipp, Susan

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Susan Bogdanowich-Knipp
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Susan Bogdanowich-Knipp
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Susan Bogdanowich-Knipp
Favorite
Bogner, Robin

University of Connecticut
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Robin Bogner
Favorite
Bohack, Leigh

Pfizer Inc.
(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach
Leigh Bohack
Favorite
Boini, Krishna M.

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Krishna M. Boini
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Krishna M. Boini
Favorite
Boirie, Breana

Florida A&M University
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Breana Boirie
Favorite
Bois, Frederic

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Frederic Bois
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Frederic Bois
Favorite
Bokharaei, Mehrdad

Evonik Canada, Inc.
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Mehrdad Bokharaei
Favorite
Bokma, Evert

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Evert Bokma
Favorite
Bolger, Michael

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Michael Bolger
Favorite
Bollini, Stephanie

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Stephanie Bollini
Favorite
Bong, Yong-Sik

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Yong-Sik Bong
Favorite
Bonnaire, Thierry

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Thierry Bonnaire
Favorite
Bonnel, David

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
David Bonnel
Favorite
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
David Bonnel
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
David Bonnel
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
David Bonnel
Favorite
Bonon, Anderson

Horiba
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Anderson Bonon
Favorite
Bookwala, Mustafa

Merck & Co., Inc.
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Mustafa Bookwala
Favorite
Boonyasuppayakorn, Siwaporn

Chulalongkorn University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Siwaporn Boonyasuppayakorn
Favorite
Borbridge, Lisa

AbbVie Inc.
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Lisa Borbridge
Favorite
Borrelli, Matthew

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Matthew Borrelli
Favorite
Bortolotti, Fabrizio

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Fabrizio Bortolotti
Favorite
Borza, Chloe

GEA Process Engineering, Inc.
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Chloe Borza
Favorite
Bosco, Geoffrey

Thermo Fisher Scientific
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Geoffrey Bosco
Favorite
Bose, Neelanjan

Emery Pharma
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Neelanjan Bose
Favorite
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Neelanjan Bose
Favorite
Botoy, Teslin

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Teslin Botoy
Favorite
Böttger, Roland

CureVac
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Roland Böttger
Favorite
(T1430-03-14) Delivery of mRNA-LNP Vaccine via Refrigerator-Stable Microneedle Array Patch
Roland Böttger
Favorite
Bouchard, Beth

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Beth Bouchard
Favorite
Boulet, Pascal

Institut Jean Lamour
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Pascal Boulet
Favorite
Bourcy, Quentin

University of Liege
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Quentin Bourcy
Favorite
Boute, Melodie

Aliri Bioanalysis
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Melodie Boute
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Melodie Boute
Favorite
Boxer, Matt

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Matt Boxer
Favorite
Boyce, Heather

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Heather Boyce
Favorite
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Heather Boyce
Favorite
Braddy, April

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
April Braddy
Favorite
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
April Braddy
Favorite
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
April Braddy
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
April Braddy
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
April Braddy
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
April Braddy
Favorite
Bradley, Logan

Mount St. Joseph University
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Logan Bradley
Favorite
Braithwaite, Christian

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Christian Braithwaite
Favorite
Brandl, Ferdinand

BASF Corporation
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Ferdinand Brandl
Favorite
Brantley, Scott

BioCryst Pharmaceuticals, Inc.
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Scott Brantley
Favorite
Braun, michael

Boehringer-ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
michael Braun
Favorite
Breitkreutz, Joerg

Heinrich Heine University Duesseldorf
(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Joerg Breitkreutz
Favorite
(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Joerg Breitkreutz
Favorite
Brewer, Edward

Aliri Bioanalysis
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Edward Brewer
Favorite
Breydo, Leonid

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Leonid Breydo
Favorite
Bridges, Riley

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Riley Bridges
Favorite
Brishti, Masuma Akter

University of Tennessee Health Sciences Center
(M1530-06-31) Insulin Resistance Triggers Histamine Release from Endothelial Cells Which Disrupts Endothelial Barrier Function and Causes Vasoconstriction
Masuma Akter Brishti
Favorite
Brogden, Nicole

University of Iowa
(M1230-09-49) Microneedle-Based Co-Delivery System for Naproxen Sodium and Caffeine in Migraine Therapy
Nicole Brogden
Favorite
Broocks, Stefanie

University of Greifswald
(W1030-05-30) One Like the Other? A Novel In Vitro Release Method to Ensure Proper Drug Release of Extended-Release Mini-Tablets for Paediatric Use
Stefanie Broocks
Favorite
Brooks, Ashley

Fortrea Clinical Research Unit Ltd
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Ashley Brooks
Favorite
Brooks, Catherine

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Catherine Brooks
Favorite
Brown, David

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
David Brown
Favorite
Brown, Dustin

US Food and Drug Administration
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Dustin Brown
Favorite
Brown, Jason

Adare Pharmaceuticals, Inc.
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Jason Brown
Favorite
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
Jason Brown
Favorite
Brown, Rayven

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Rayven Brown
Favorite
Brumm, Jochen

Genentech, Inc
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Jochen Brumm
Favorite
Brunaugh, Ashlee

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Ashlee Brunaugh
Favorite
Bryniarski, Mark

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Mark Bryniarski
Favorite
Buchholtz, Bruce

Lawrence Livermore National Laboratory
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Bruce Buchholtz
Favorite
Buchholz, Bruce

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
Bruce Buchholz
Favorite
Buckner, Ira

Duquesne University
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Ira Buckner
Favorite
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Ira Buckner
Favorite
Bunce, Campbell

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Campbell Bunce
Favorite
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Campbell Bunce
Favorite
Bunce, Lucy

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Lucy Bunce
Favorite
Burgess, Diane

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Diane Burgess
Favorite
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Diane Burgess
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Diane Burgess
Favorite
Burgess, Diane

University of Connecicut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Diane Burgess
Favorite
Burke, Erin

Univar Solutions
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Erin Burke
Favorite
Burns, Sarah

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Sarah Burns
Favorite
Burton, Shawn

Aliri Bioanalysis
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Shawn Burton
Favorite
Bush, Xin

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Xin Bush
Favorite
Butikofer, Sydney

Eli Lilly and Company
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Sydney Butikofer
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Sydney Butikofer
Favorite
Butler, Phil

BASF Corporation
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Phil Butler
Favorite
Butterworth, Sara

Rayner Surgical
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Sara Butterworth
Favorite
Bu, Yingzi

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Yingzi Bu
Favorite
Byrn, Stephen

Purdue University
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Stephen Byrn
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Stephen Byrn
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Stephen Byrn
Favorite
(W0930-11-64) Developing an Assessment Framework, Items, and Expert Reviews for an Educational Instrument for the Proper Use of the USP/NF Pharmacopeia
Stephen Byrn
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Stephen Byrn
Favorite
Byun, Sanghwan

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Sanghwan Byun
Favorite
C
C. Lourenço, Eva

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Eva C. Lourenço
Favorite
Cady, Andrea

Thermo Fisher Scientific
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Andrea Cady
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Andrea Cady
Favorite
Cahill, Heather

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Heather Cahill
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Heather Cahill
Favorite
Cai, Hao

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Hao Cai
Favorite
Caisse, Philippe

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Philippe Caisse
Favorite
Cai, Yuncheng

Huazhong University of Science and Technology
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Yuncheng Cai
Favorite
Calderon, Marcelo

University of the Basque Country
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Marcelo Calderon
Favorite
Callahan, Jordan

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Jordan Callahan
Favorite
Campbell, Beverley

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Beverley Campbell
Favorite
Campbell, Joey

Prolytix
(M1330-10-58) A Multiple Component, Indirect Analysis of Ammonium: Analysis of Sulfate Ion in a Commercial Biotherapeutic via HPLC to Measure Ammonium Content
Joey Campbell
Favorite
Campos-Teran, Jose

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Jose Campos-Teran
Favorite
Canally, Caroline

Moderna Therapeutics
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Caroline Canally
Favorite
Cancino, Nicolas

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Nicolas Cancino
Favorite
Cano, Chris

TFF Pharmaceuticals, Inc.
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Chris Cano
Favorite
Cao, Albert

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Albert Cao
Favorite
Cappucci, Mark

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Mark Cappucci
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Mark Cappucci
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Mark Cappucci
Favorite
Caratozzolo, Anders

BioAgilytix
(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System
Anders Caratozzolo
Favorite
Carbol, Jason

Dow Development Laboratories, LLC
(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics
Jason Carbol
Favorite
(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations
Jason Carbol
Favorite
(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents
Jason Carbol
Favorite
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jason Carbol
Favorite
Cardot, Jean-Michel

Borvo
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Jean-Michel Cardot
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Jean-Michel Cardot
Favorite
Carnes, Katie

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Katie Carnes
Favorite
Carrier, Rebecca

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Rebecca Carrier
Favorite
Casadevall, Gemma

Nutraresearch
(T1530-01-01) Proven New Sustainable Eco-Friendly Packaging for Challenging Formulation Compositions
Gemma Casadevall
Favorite
Cassidy, Kenneth

Eli Lilly and Company
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Kenneth Cassidy
Favorite
Castiglioni, Alessandra

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Alessandra Castiglioni
Favorite
Castillo, Kevin

Biopact LLC
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Kevin Castillo
Favorite
Castro, monica

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
monica Castro
Favorite
Catalano, Carlos

University of Colorado
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Carlos Catalano
Favorite
Catarata, Ruginn

St. John's University
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Ruginn Catarata
Favorite
Cave, Joseph

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Joseph Cave
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Joseph Cave
Favorite
Cedran Coco, Julia

University of Campinas
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Julia Cedran Coco
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Julia Cedran Coco
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Julia Cedran Coco
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Julia Cedran Coco
Favorite
Ceulemans, Jens

Janssen Pharceutica NV
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Jens Ceulemans
Favorite
Chacra, Nadia

Universidade de Sao Paulo
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Nadia Chacra
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Nadia Chacra
Favorite
Chadwick, Jessica

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Jessica Chadwick
Favorite
Chahley, Nick

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Nick Chahley
Favorite
Chai, Lili

ICE Bioscience
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Lili Chai
Favorite
Chakka, Jaidev

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Jaidev Chakka
Favorite
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Jaidev Chakka
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Jaidev Chakka
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Jaidev Chakka
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Jaidev Chakka
Favorite
(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
Jaidev Chakka
Favorite
Chak, Vincent

University at Buffalo
(W0930-02-12) Oral Tolerance Mediated by Phosphatidylserine Containing Lipid Nanoparticle
Vincent Chak
Favorite
Cha, Kwangho

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Kwangho Cha
Favorite
Chal, Ben

Gilead Sciences, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Ben Chal
Favorite
Chan, Brian

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Brian Chan
Favorite
Chan, Chun Man Jones

Prince of Wales Hospital, Hospital Authority
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Chun Man Jones Chan
Favorite
Chanda, Arani

Sarepta Therapeutics
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Arani Chanda
Favorite
Chandran, Uma

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Uma Chandran
Favorite
Chandrashekar, Aishwarya

University of Michigan
(M1430-09-49) Remote Encapsulation of Exenatide in PLGA Microspheres Using Cationic Excipients
Aishwarya Chandrashekar
Favorite
Chang, Calvin

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Calvin Chang
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Calvin Chang
Favorite
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Calvin Chang
Favorite
Chang-Guo, Zhan

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Zhan Chang-Guo
Favorite
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Zhan Chang-Guo
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Zhan Chang-Guo
Favorite
Chang, Rui

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Rui Chang
Favorite
Chan, Ho Yin Edwin

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Ho Yin Edwin Chan
Favorite
Chan, Larry

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Larry Chan
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Larry Chan
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Larry Chan
Favorite
Chao, Chih-Jia

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Chih-Jia Chao
Favorite
Chapa, Revathi

Simulations Plus, Inc.
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Revathi Chapa
Favorite
Chapdelaine, John

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
John Chapdelaine
Favorite
Chapman, Jerry

Redica Systems
(T1330-11-63) Developing a Risk Score for Critical Suppliers Using Artificial Intelligence (AI)
Jerry Chapman
Favorite
Chatterjee, Kaustav

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Kaustav Chatterjee
Favorite
Chatterjee, Parnali

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Parnali Chatterjee
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Parnali Chatterjee
Favorite
Chaturvedi, Kaushalendra

J-Star Research
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Kaushalendra Chaturvedi
Favorite
Chaturvedi, Kaushalendra

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Kaushalendra Chaturvedi
Favorite
Chaudhuri, Bodhisattwa

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Bodhisattwa Chaudhuri
Favorite
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Bodhisattwa Chaudhuri
Favorite
Chauhan, Anjali

Pharmaeutical Sciences Northeastern University
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Anjali Chauhan
Favorite
Chauhan, Neha

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Neha Chauhan
Favorite
Chaulagain, Bivek

North Dakota State University
(T1030-04-19) Cannabidiol and BDNF-Encapsulated Brain-Targeted Lipid Nanoparticles Reduce Inflammation, Lower Pathological Amyloid and Tau Levels, and Improve Cognition in Transgenic Models of Alzheimer’s disease
Bivek Chaulagain
Favorite
Chavan, Neelam

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Neelam Chavan
Favorite
Chavan, Tejashri

Kenox Pharmaceuticals Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Tejashri Chavan
Favorite
Chawareeyawong, Pai

23andMe Inc.
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Pai Chawareeyawong
Favorite
Chen, Aochiu

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Aochiu Chen
Favorite
Chen, David

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
David Chen
Favorite
Chendo, Catarina

Hovione
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Catarina Chendo
Favorite
Chen, Elva

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Elva Chen
Favorite
Cheng, Celine

Hong Kong Pharmaceutical Manufacturers Association
(M1130-11-62) Network Analysis of Pharmaceutical Products from Hong Kong PIC/S GMP Manufacturers
Celine Cheng
Favorite
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Celine Cheng
Favorite
Cheng, Hao

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Hao Cheng
Favorite
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Hao Cheng
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Hao Cheng
Favorite
Cheng, Joan

University of Minnesota
(M1430-07-37) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro BBB Model
Joan Cheng
Favorite
Cheng, Ming

Boehringer Ingelheim
(T1430-02-12) Ocular Pharmacokinetic Model for Intravitreal Antibody Injection
Ming Cheng
Favorite
Cheng, Rui

Wake Forest University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Rui Cheng
Favorite
cheng, yuan

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
yuan cheng
Favorite
Cheng, Yu-En

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Yu-En Cheng
Favorite
Chen, Hongyu

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Hongyu Chen
Favorite
Chen, Hui

Chinese Academy of Science
(T1230-01-03) A High Oral Bioavailable Berberine-Lornoxicam Cocrystal with Improved Caco-2 Permeability, Tunable Dissolution, and Improved Taste
Hui Chen
Favorite
Chen, HuiLing

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
HuiLing Chen
Favorite
Chen, Hunter

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Hunter Chen
Favorite
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Hunter Chen
Favorite
Chen, Ida

Dow Chemical Company
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Ida Chen
Favorite
Chen, Jing

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Jing Chen
Favorite
Chen, Julie

HORIBA
(M1030-11-62) Orthogonal Measurement of Number Concentration Standards for NTA Calibration
Julie Chen
Favorite
Chen, Kun

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Kun Chen
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Kun Chen
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Kun Chen
Favorite
Chen, Lih-Geeng

National Chiayi University
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Lih-Geeng Chen
Favorite
Chen, Pengyu

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Pengyu Chen
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Pengyu Chen
Favorite
Chen, Qing

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Qing Chen
Favorite
Chen, Shirley

Binghamton university
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Shirley Chen
Favorite
Chen, Shiuan-Yin

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Shiuan-Yin Chen
Favorite
Chen, Tina

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Tina Chen
Favorite
Chen, Tse-Hong

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Tse-Hong Chen
Favorite
Chen, Weiqiang

New York University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Weiqiang Chen
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Weiqiang Chen
Favorite
Chen, Yih-Wen

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Yih-Wen Chen
Favorite
Chen, Yuan

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Yuan Chen
Favorite
Chen, Ziting

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Ziting Chen
Favorite
Cheong, Fook Chiong

Spheryx, Inc.
(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates
Fook Chiong Cheong
Favorite
Cheon, Seunghyun

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Seunghyun Cheon
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Seunghyun Cheon
Favorite
Cherif, Achref

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Achref Cherif
Favorite
(T0930-03-14) Toward Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding and Cryogenic Milling
Achref Cherif
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Achref Cherif
Favorite
Cheu, Ryan

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ryan Cheu
Favorite
Chevrier, Anik

Polytechnique Montreal
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Anik Chevrier
Favorite
Chevrier, Stephanie

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Stephanie Chevrier
Favorite
Chhibber, Tanya

University of Utah
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Tanya Chhibber
Favorite
Chiang, Yi-Hua

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Yi-Hua Chiang
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Yi-Hua Chiang
Favorite
Chiap, Patrice

Academic Hospital of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Patrice Chiap
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Patrice Chiap
Favorite
Chi, Chun-Wei

University at Buffalo
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Chun-Wei Chi
Favorite
Chilamula, Srikanth

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Srikanth Chilamula
Favorite
Chilewski, Shannon

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Shannon Chilewski
Favorite
Chiluisa, Anelis

Eli Lilly and Company
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Anelis Chiluisa
Favorite
Chinnici, Caitlin

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Caitlin Chinnici
Favorite
Chitnis, Kshitij

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Kshitij Chitnis
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Kshitij Chitnis
Favorite
Cho, Dea Jin

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Dea Jin Cho
Favorite
Cho, Hyeongeun (Tony)

Northeastern University
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Hyeongeun (Tony) Cho
Favorite
Cho, Hyunah

St. John's University
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Hyunah Cho
Favorite
Choi, Han-Gon

Hanyang University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Han-Gon Choi
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Han-Gon Choi
Favorite
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Han-Gon Choi
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Han-Gon Choi
Favorite
Choi, Heejae

Yonsei University
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Heejae Choi
Favorite
Choi, Seo-Hyeong

Gangnam Weedahm Korean Medicine Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Seo-Hyeong Choi
Favorite
Choo, Gwangho

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Gwangho Choo
Favorite
Chopski, Steven

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Steven Chopski
Favorite
Choudhary, Narmada

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Narmada Choudhary
Favorite
Choudhary, Suman

St. John's University
(W1030-03-18) Exploring the Potential of Inhaled Clofazimine Liposomes for Mesothelioma Treatment
Suman Choudhary
Favorite
Choudhury, Samrat

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Samrat Choudhury
Favorite
Chougule, Mahavir

Mercer University
(T1230-06-34) PEGylated Nanoparticles Conjugated with LHRH Receptor Binding Peptide for Treatment of Lung Cancer
Mahavir Chougule
Favorite
Chouirfa, Hamza

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Hamza Chouirfa
Favorite
Chow, Diana S.L.

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Diana S.L. Chow
Favorite
Cho, William C.S.

Queen Elizabeth Hospital
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
William C.S. Cho
Favorite
Chow, Keat Theng

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Keat Theng Chow
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Keat Theng Chow
Favorite
Cho, Yejin

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Yejin Cho
Favorite
Choy, Robert K.M.

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Robert K.M. Choy
Favorite
Christian E, Ogaugwu

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Ogaugwu Christian E
Favorite
Chui, Cherry

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Cherry Chui
Favorite
Chung, Cindy

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Cindy Chung
Favorite
Chung, Hee Sun

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Hee Sun Chung
Favorite
Chure, Chetan

Contract Pharmaceuticals Limited
(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management
Chetan Chure
Favorite
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Chetan Chure
Favorite
Chu, Xiaoyan

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Xiaoyan Chu
Favorite
Chvila, Stanislav

University of Chemistry and Technology
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Stanislav Chvila
Favorite
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Stanislav Chvila
Favorite
Clark, Abe

University of North Texas Health Science Center
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Abe Clark
Favorite
Clark, Andrew

digiM Solution
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Andrew Clark
Favorite
Clarke, Samuel

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Samuel Clarke
Favorite
Clark, Richard

NeoMatrix Therapeutics, Inc.
(M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Richard Clark
Favorite
(M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Richard Clark
Favorite
Claude, Emmanuelle

Waters Corporation
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Emmanuelle Claude
Favorite
Cleary, Hannah

Trinity College Dublin
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Hannah Cleary
Favorite
Clements, Brianna

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Brianna Clements
Favorite
Clerman, Andrew

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Andrew Clerman
Favorite
Clikeman, Tyler

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Tyler Clikeman
Favorite
Cloake, Edward

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Edward Cloake
Favorite
Cojocariu, Cristian

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Cristian Cojocariu
Favorite
Colandene, James

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
James Colandene
Favorite
Colletti, Kelly

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Kelly Colletti
Favorite
Collins, Mary

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Mary Collins
Favorite
Colombo, Gaia

University of Ferrara
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Gaia Colombo
Favorite
Colombo, Paolo

University of Parma
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Paolo Colombo
Favorite
Columba-Palomares, Maria Crystal

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Maria Crystal Columba-Palomares
Favorite
Concannon, Amy

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Amy Concannon
Favorite
Cone, Roger

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Roger Cone
Favorite
Confer, Alex

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Alex Confer
Favorite
Conner, Kip

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Kip Conner
Favorite
Cook, Kevin

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Kevin Cook
Favorite
Cooley, Megan

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Megan Cooley
Favorite
Cooper, Bailey

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Bailey Cooper
Favorite
Coralie, Schneider

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Schneider Coralie
Favorite
Corbeil, Sophie

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Sophie Corbeil
Favorite
Corbo, Julie

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Julie Corbo
Favorite
Cornell, Tom

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Tom Cornell
Favorite
Cornett, Taylor

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Taylor Cornett
Favorite
Corona-Gomez, Lysett

National Autonomous University of Mexico
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Lysett Corona-Gomez
Favorite
Corrado, Tanner

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Tanner Corrado
Favorite
Cortes-Nunez, Samaria

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Samaria Cortes-Nunez
Favorite
Costa, Eunice

Hovione FarmaCiencia SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Eunice Costa
Favorite
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Eunice Costa
Favorite
Cotrim, Joana

Hovione
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Joana Cotrim
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Joana Cotrim
Favorite
Cottingham, Andrea

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Andrea Cottingham
Favorite
Cotton, Joanne

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Joanne Cotton
Favorite
Coulter, Don

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Don Coulter
Favorite
Cousineau, Christopher

Arrowhead Pharmaceuticals
(M1030-06-35) Development and Optimization of a Highly Sensitive and Selective Anion Exchange Liquid Chromatography with Fluorescence Detection Assay for Quantitation of siRNA Oligonucleotide Therapeutic Compounds
Christopher Cousineau
Favorite
Cowans, Brett

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Brett Cowans
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Brett Cowans
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Brett Cowans
Favorite
Cox, Elizabeth

Alcami Corporation
(M1330-04-24) High-Performance Liquid Chromatography Method with Refractive-Index Detection for Quantitation of Memantine Hydrochloride in Memantine Hydrochloride Extended-Release Dissolution Samples
Elizabeth Cox
Favorite
Crampon, Eric

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Eric Crampon
Favorite
Crawford, Lisa

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Lisa Crawford
Favorite
Crawford, Mitch

Freund-Vector Corporation
(M1430-10-54) Designing Spray Dried Particles with a Pressure Nozzle at Small Scale
Mitch Crawford
Favorite
Craye, Goedele

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Goedele Craye
Favorite
Crean, Abina

University College Cork
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Abina Crean
Favorite
Cristóvão, Joana

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Joana Cristóvão
Favorite
Cristini, Vittorio

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Vittorio Cristini
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Vittorio Cristini
Favorite
Cristofoletti, Rodrigo

University of Florida
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Rodrigo Cristofoletti
Favorite
Croom, Jordan

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Jordan Croom
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Jordan Croom
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Jordan Croom
Favorite
Cross, Donna

University of Utah
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Donna Cross
Favorite
Crowell, Eric

University of Texas at Austin
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Eric Crowell
Favorite
(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant
Eric Crowell
Favorite
Croyle, Maria

University of Texas at Austin
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Maria Croyle
Favorite
(T1030-05-28) Characterizing the Effects of a Novel Surfactant on Growth Inhibition and Preservation of Different Bacterial Species
Maria Croyle
Favorite
Croy, Scott

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Scott Croy
Favorite
Cruz, Eric

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Eric Cruz
Favorite
Cruz, Matthew

Merck & Co., Inc.
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Matthew Cruz
Favorite
Cui, Dapeng

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Dapeng Cui
Favorite
Cui, Haixi

University of Maryland, Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Haixi Cui
Favorite
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Haixi Cui
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Haixi Cui
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Haixi Cui
Favorite
Cui, Yi

Wake Forest University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Yi Cui
Favorite
Cui, Zhengrong

University of Texas at Austin
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Zhengrong Cui
Favorite
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Zhengrong Cui
Favorite
Cui, Zhiyi

GSK
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Zhiyi Cui
Favorite
Cunha Filho, Marcilio

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Marcilio Cunha Filho
Favorite
Cunningham, Charlie

Colorcon, Inc.
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Charlie Cunningham
Favorite
Curran, Geoffry

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Geoffry Curran
Favorite
Curry, Stacy

North Texas Eye Research Institute
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Stacy Curry
Favorite
Cushing, Matt

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Matt Cushing
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Matt Cushing
Favorite
Cusin, Lucas

Evonik Corporation
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Lucas Cusin
Favorite
Custodio, Joseph

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Joseph Custodio
Favorite
Czeskis, Boris

Eli Lilly and Company
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Boris Czeskis
Favorite
D
Dürig, Thomas

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Thomas Dürig
Favorite
Dachineni, Rakesh

Teva Branded Pharmaceutical Products R&D, Inc.
(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility
Rakesh Dachineni
Favorite
Dagher, Fatima

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Fatima Dagher
Favorite
Dai, Haiting

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Haiting Dai
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Haiting Dai
Favorite
Dalton, Caleb

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Caleb Dalton
Favorite
Damle, Shantanu

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Shantanu Damle
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Shantanu Damle
Favorite
Damm, Michael

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Michael Damm
Favorite
Dandamudi, Suman

US Food and Drug Administration
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Suman Dandamudi
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Suman Dandamudi
Favorite
Danielak, Dorota

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Dorota Danielak
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Dorota Danielak
Favorite
Daniels, Austin

Yokogawa Fluid Imaging Technologies
(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies
Austin Daniels
Favorite
Dan, Nirnoy

University of Connecticut
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Nirnoy Dan
Favorite
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Nirnoy Dan
Favorite
Dao, Huy

University of Texas at Austin
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Huy Dao
Favorite
Daram, Apoorva

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Apoorva Daram
Favorite
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Apoorva Daram
Favorite
D'Arcy, Deirdre M

Trinity College Dublin
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Deirdre M D'Arcy
Favorite
Darji, Mittal

University of Connecticut
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Mittal Darji
Favorite
Darmohusodo, Vincent

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Vincent Darmohusodo
Favorite
Darna, Mahesh

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Mahesh Darna
Favorite
Darwesh, Alaa

University of Mississippi
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Alaa Darwesh
Favorite
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Alaa Darwesh
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Alaa Darwesh
Favorite
Das, Ashish

University of Nebraska Medical Center
(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)
Ashish Das
Favorite
Das, Deb

Bayer Consumer Care
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Deb Das
Favorite
(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Deb Das
Favorite
Das, Debanjan

Bayer USA
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Debanjan Das
Favorite
(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Debanjan Das
Favorite
Dash, Alekha

Creighton University
(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
Alekha Dash
Favorite
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Alekha Dash
Favorite
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Alekha Dash
Favorite
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Alekha Dash
Favorite
Das, Hiramoy

Texas Tech University
(W0930-04-20) Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Hiramoy Das
Favorite
Das, Nandita

Butler University
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Nandita Das
Favorite
Das, Sudip

Butler University, College of Pharmacy & Health Sciences
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Sudip Das
Favorite
Date, Abhijit A.

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Abhijit A. Date
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Abhijit A. Date
Favorite
Datta- Mannan, Amita

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Amita Datta- Mannan
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Amita Datta- Mannan
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Amita Datta- Mannan
Favorite
Datta, Manu

PharmaPro Consulting
(T1230-02-12) Gaps in Non-Binary Populations in Clinical Trial Participation: A Comparative Analysis of Cardiovascular and Solid Tumor Studies
Manu Datta
Favorite
Datta, Sayantap

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Sayantap Datta
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Sayantap Datta
Favorite
Dauphin-Chanard, Elise

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Elise Dauphin-Chanard
Favorite
Dave, Rajesh

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Rajesh Dave
Favorite
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Rajesh Dave
Favorite
Dave, Shivani Amarbhai

Massachusetts College of Pharmacy and Health Sciences
(W1230-09-50) Preparation and Characterization of an Ultraflexible Liposomal Gel for Transdermal Delivery of a Novel Pan-RAS Inhibitor for Melanoma
Shivani Amarbhai Dave
Favorite
Dave, Vivek

St. John's University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Vivek Dave
Favorite
Davies, Brandon

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brandon Davies
Favorite
Davies, Daryl L.

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Daryl L. Davies
Favorite
Davies, Neal

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Neal Davies
Favorite
(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products
Neal Davies
Favorite
Davis, Daniel

AustinPx
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Daniel Davis
Favorite
Daware, Snehal

St. John's University
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Snehal Daware
Favorite
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Snehal Daware
Favorite
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Snehal Daware
Favorite
Daware, Snehal

St. John's University
(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity
Snehal Daware
Favorite
De Borba, Brian

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Brian De Borba
Favorite
De Coninck, Elien

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Elien De Coninck
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Elien De Coninck
Favorite
De Leon Ortega, Ricardo Diaz

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Ricardo Diaz De Leon Ortega
Favorite
de Margerie, Victoire

Rondol Industrie
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Victoire de Margerie
Favorite
De Mario, Deidre

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Deidre De Mario
Favorite
De Paiva, Igor

AstraZeneca
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Igor De Paiva
Favorite
De Smedt, Frank

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Frank De Smedt
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Frank De Smedt
Favorite
De Smet, Lieselotte

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Lieselotte De Smet
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Lieselotte De Smet
Favorite
Dean, Nicholas

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Nicholas Dean
Favorite
Dear, Barton

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Barton Dear
Favorite
Debad, Jeff

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Jeff Debad
Favorite
Debies, Michael

Medpace
(W1030-02-07) Determination of the Concentration of Monoclonal Antibodies (Mab) Drug in Human Serum Using an Enzyme-Linked Immunosorbent Assay (ELISA)
Michael Debies
Favorite
Debnath, Sujit

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Sujit Debnath
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Sujit Debnath
Favorite
Deb, Sarmistha

DiponED Biointelligence
(M1130-02-07) The Significance of Biotransformation in Discovery Research of NCEs (New Chemical Entity): Examples of Unique Case Studies
Sarmistha Deb
Favorite
Debunne, Ann

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Ann Debunne
Favorite
DelCarpini, Jason

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Jason DelCarpini
Favorite
Delebecq, Sandra

Aliri Bioanalysis
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Sandra Delebecq
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Sandra Delebecq
Favorite
Delgado, Dennis

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Dennis Delgado
Favorite
Dellaripa, Michael

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Michael Dellaripa
Favorite
Dema, Krysten

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Krysten Dema
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Krysten Dema
Favorite
Dematteis, Giorgia

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Giorgia Dematteis
Favorite
(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments
Giorgia Dematteis
Favorite
Deng, Jing

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Jing Deng
Favorite
Denis, Lucas

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Lucas Denis
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Lucas Denis
Favorite
Denninger, Alexander

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Alexander Denninger
Favorite
Dent, Alecia

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Alecia Dent
Favorite
Desai, Kashappa

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Kashappa Desai
Favorite
Desai, Mehul

Enable Injections
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Mehul Desai
Favorite
Desai, Pankaj

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Pankaj Desai
Favorite
Desai, Pooja

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Pooja Desai
Favorite
Deshmukh, Janhavi

University of Mississippi
(M1230-05-29) Employing Hot Melt Extrusion and Vacuum Compression Molding to Develop Cannabidiol Solid Sedds for Improved Solubility
Janhavi Deshmukh
Favorite
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Janhavi Deshmukh
Favorite
Deshmukh, Ketkee

Gattefosse India Pvt. Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Ketkee Deshmukh
Favorite
Desu, Hari

Intera Healthcare
(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation
Hari Desu
Favorite
Devalapally, Harikrishna

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Harikrishna Devalapally
Favorite
Develin, Corey

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Corey Develin
Favorite
Deveney, Katherine

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Katherine Deveney
Favorite
Dev, Satyanarayan

Florida A&M University
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Satyanarayan Dev
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Satyanarayan Dev
Favorite
Dey Chowdhury, Sumana

Nova Southereastern University
(M0930-07-38) Evaluating Mucoadhesion of Polymer Films Using Wax Substrates with Mucin Coating
Sumana Dey Chowdhury
Favorite
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Sumana Dey Chowdhury
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Sumana Dey Chowdhury
Favorite
Dey, Anuradha

Mercer University
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Anuradha Dey
Favorite
Dhawan, Punita

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Punita Dhawan
Favorite
Dhawan, Vivek

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Vivek Dhawan
Favorite
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Vivek Dhawan
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Vivek Dhawan
Favorite
Dholariya, Bhoomi

St. John's University
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Bhoomi Dholariya
Favorite
Dhungana, Suraj

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Suraj Dhungana
Favorite
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Suraj Dhungana
Favorite
(T1230-04-19) Novel Targeted Drug and Metabolites Mapping Using DESI MRM Triple Quadrupole Mass Spectrometer Providing Increased Sensitivity and Acquisition Speed for Mass Spectrometry Imaging
Suraj Dhungana
Favorite
Di Gallo, Nicole

Merck Life Science KGaA
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Nicole Di Gallo
Favorite
Diao, Jianbo

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Jianbo Diao
Favorite
Dias, Camila

State University of Campinas
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Camila Dias
Favorite
DiazDavila, Karelys

Palm Beach Atlantic University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Karelys DiazDavila
Favorite
Diaz, Patricia

University of Buffalo
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Patricia Diaz
Favorite
DiBlasi, Robert

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Robert DiBlasi
Favorite
Diep, Anh

23andMe Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Anh Diep
Favorite
Dietrich, Shirin

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Shirin Dietrich
Favorite
Digby, Matthew

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Matthew Digby
Favorite
Digigow, Reinaldo

CSL Vifor
(T1430-02-07) Exploring the Potential Influence of Physicochemical Characteristics on Biodistribution of Iron-Carbohydrate Nanoparticles Using a Chicken Embryo Model
Reinaldo Digigow
Favorite
Diluzio, Willow

Sarepta Therapeutics
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Willow Diluzio
Favorite
Dimen, Rain

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Rain Dimen
Favorite
Dinge, Aditya

Bayer AG
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Aditya Dinge
Favorite
Ding, Kai

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Kai Ding
Favorite
Ding, Ling

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Ling Ding
Favorite
Ding, Tao

US Food and Drug Administration
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Tao Ding
Favorite
Ding, Wenping

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Wenping Ding
Favorite
Ding, Xiaoyi

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Xiaoyi Ding
Favorite
Dinh, Jean

Certara Predictive Technologies
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Jean Dinh
Favorite
Diogo, Joana

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Joana Diogo
Favorite
Diorio, Alec

St. John's University
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Alec Diorio
Favorite
Ditschun, Tanya

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Tanya Ditschun
Favorite
Diwan, Rimpy

University of Michigan
(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes
Rimpy Diwan
Favorite
Dixon-Anderson, Erik

Roquette America Inc.
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Erik Dixon-Anderson
Favorite
Djehizian, Alexandre

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Alexandre Djehizian
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Alexandre Djehizian
Favorite
D'mello, Anil

St. Joseph's University
(T1430-04-24) Method Optimization to Reduce Leakage of Encapsulated Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as a Model Protein
Anil D'mello
Favorite
Dobariya, Gunvant

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Gunvant Dobariya
Favorite
Do, Bernard

Gustave Roussy Cancer Campus
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Bernard Do
Favorite
Dobosz, Justyna

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Justyna Dobosz
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Justyna Dobosz
Favorite
Dobrovolskaia, Marina

National Cancer Institute
(W1030-02-11) Immunotoxicity of Silica Nanoparticles as a Function of Physicochemical Properties
Marina Dobrovolskaia
Favorite
Dogra, Prashant

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Prashant Dogra
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Prashant Dogra
Favorite
Doluisioa, Nicholas

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Nicholas Doluisioa
Favorite
Domanski, Brian

Shimadzu Scientific Instruments, Inc.
(T1530-06-34) Ion-pairing Agent-Free SFC Separation of Polypeptides Using Automated Method Development Tools
Brian Domanski
Favorite
Donaldson, Douglas

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Douglas Donaldson
Favorite
Donaldson, Kirsteen

Jade Consultants (Cambridge) Limited
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Kirsteen Donaldson
Favorite
Dongala, Bhanu Prakash

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Bhanu Prakash Dongala
Favorite
Dong, Lynn

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Lynn Dong
Favorite
Dong, Quyen

Merck Sharp & Dohme Corp.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Quyen Dong
Favorite
Dong, Tao

University of California San Diego
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Tao Dong
Favorite
Dong, Yuxiang

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Yuxiang Dong
Favorite
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Yuxiang Dong
Favorite
Donnelly, Ryan

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Ryan Donnelly
Favorite
(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide
Ryan Donnelly
Favorite
(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants
Ryan Donnelly
Favorite
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Ryan Donnelly
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Ryan Donnelly
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Ryan Donnelly
Favorite
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Ryan Donnelly
Favorite
(W0930-02-07) Revolutionising Microneedle-Based Transdermal Delivery: A Colourful Approach to Efficiency Feedback and User Navigation
Ryan Donnelly
Favorite
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Ryan Donnelly
Favorite
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Ryan Donnelly
Favorite
Donovan, Maureen

University of Iowa
(M1130-03-18) Model-Informed Approach for Formulation Development of Extended-Release Phenserine Tablets to Mitigate pH-Dependent Degradation
Maureen Donovan
Favorite
Don, Ranganath Wahalathantrige

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Ranganath Wahalathantrige Don
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Ranganath Wahalathantrige Don
Favorite
Doole, Fathima

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Fathima Doole
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Fathima Doole
Favorite
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Fathima Doole
Favorite
Doran, Delaney

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Delaney Doran
Favorite
Doran, Jake

University of Pittsburgh
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Jake Doran
Favorite
Dorfman, Ryan

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Ryan Dorfman
Favorite
Doroski, Todd

Alcami Corporation
(M1330-04-24) High-Performance Liquid Chromatography Method with Refractive-Index Detection for Quantitation of Memantine Hydrochloride in Memantine Hydrochloride Extended-Release Dissolution Samples
Todd Doroski
Favorite
Dos Santos, Erica

Unicamp
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Erica Dos Santos
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Erica Dos Santos
Favorite
Dow, Alex

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Alex Dow
Favorite
Dowek, Antoine

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Antoine Dowek
Favorite
Downey, Andrew

Bill & Melinda Gates Medical Research Institute
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Andrew Downey
Favorite
Dow, Ximeng

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Ximeng Dow
Favorite
Doyle, Jailen

University of Texas at Austin
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Jailen Doyle
Favorite
Dreibelbis, Mark

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Mark Dreibelbis
Favorite
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Mark Dreibelbis
Favorite
Drelich, Aleksandra

University of Texas Medical Branch
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Aleksandra Drelich
Favorite
Drennen, James K.

Duquesne University
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
James K. Drennen
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
James K. Drennen
Favorite
D'Souza, Arun

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Arun D'Souza
Favorite
D'Souza, Marissa

University of Michigan
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Marissa D'Souza
Favorite
D'Souza, Martin

Mercer University
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Martin D'Souza
Favorite
D'Souza, Martin J.

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Martin J. D'Souza
Favorite
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Martin J. D'Souza
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Martin J. D'Souza
Favorite
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Martin J. D'Souza
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Martin J. D'Souza
Favorite
Dube, Gabriella

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Gabriella Dube
Favorite
Dube, Maricar

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Maricar Dube
Favorite
Dubey, Kiran

Jamia Hamdard University
(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment
Kiran Dubey
Favorite
Ducros, Malaury

Gattefosse SAS
(M1430-11-61) Toward Improving the In Vitro, In Vivo Correlation of Lipid-Based Formulations Using a Simplified Gastro-Intestinal Lipolysis Protocol
Malaury Ducros
Favorite
Dudhipala, Narendar

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Narendar Dudhipala
Favorite
Duffy, Patrick

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Patrick Duffy
Favorite
Dugas, Helene

Dow Chemical Company
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Helene Dugas
Favorite
Duggirala, Naga Kiran

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Naga Kiran Duggirala
Favorite
Duhamel, Paul

Aliri Bioanalysis
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Paul Duhamel
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Paul Duhamel
Favorite
Dukaj, Suada

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Suada Dukaj
Favorite
Dukes, Kyle

Biotage LLC
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Kyle Dukes
Favorite
Dukhande, Vikas

St. John's University
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Vikas Dukhande
Favorite
Dumpa, Nagireddy

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Nagireddy Dumpa
Favorite
Dunn, Gabrielle

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Gabrielle Dunn
Favorite
Duong, Tu

Purdue University
(M1330-07-38) Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance
Tu Duong
Favorite
Duran, Tibo

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Tibo Duran
Favorite
Durig, Thomas

Ashland Life Sciences
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Thomas Durig
Favorite
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Thomas Durig
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Thomas Durig
Favorite
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Thomas Durig
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Thomas Durig
Favorite
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Thomas Durig
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Thomas Durig
Favorite
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Thomas Durig
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Thomas Durig
Favorite
DuRoss, Allison

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Allison DuRoss
Favorite
Durve, Sanjana

St. John's University
(W1130-04-20) A Nano-Emulsion-Based Formulation of Sorafenib for Oral Bioavailability Enhancement and Repurposing against Non-small Cell Lung Cancer (NSCLC)
Sanjana Durve
Favorite
Dusane, Apurva

University of Iowa
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Apurva Dusane
Favorite
Du, Xiangsha

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Xiangsha Du
Favorite
Du, Xiaoqing

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Xiaoqing Du
Favorite
Dwivedi, Pankaj

University of Health Science and Pharmacy in Saint Louis
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Pankaj Dwivedi
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Pankaj Dwivedi
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Pankaj Dwivedi
Favorite
Dwivedi, Subash

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Subash Dwivedi
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Subash Dwivedi
Favorite
Dysinger, Mark

Alexion Pharmaceuticals, Inc.
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Mark Dysinger
Favorite
E
Eckenrode, Joseph

Merck & Co., Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Joseph Eckenrode
Favorite
Eckert, Carolin

University of Greifswald
(T1230-05-25) How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
Carolin Eckert
Favorite
Edgecomb, Sara

University of Mississippi
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Sara Edgecomb
Favorite
Edvall, Connor

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Connor Edvall
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Connor Edvall
Favorite
Edwards, Christopher

Frontage Laboratories, Inc.
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Christopher Edwards
Favorite
Eggleston, Timothy

Iowa Lions Eye Bank
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Timothy Eggleston
Favorite
Egito, E. Socrates

Federal University of Rio Grande Do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
E. Socrates Egito
Favorite
Ehsanian, Reza

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Reza Ehsanian
Favorite
Ekladious, Iriny

Merck & Co., Inc.
(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions
Iriny Ekladious
Favorite
Ekomaye, Nkemdilim

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Nkemdilim Ekomaye
Favorite
Ekpenyong, Andrew

Creighton University
(M1230-06-33) Evaluation of Anti-Proliferative Effect of Vorinostat (a pan-HDAC Inhibitor) on Glioblastoma Multiforme Using 3-D Cell Culture Model of T98G
Andrew Ekpenyong
Favorite
Elagouri, Ghada

Benghazi University
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Ghada Elagouri
Favorite
Elamrawy, Fatema

Medical Research Institute
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Fatema Elamrawy
Favorite
Elballa, Waleed

University of Kansas
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Waleed Elballa
Favorite
Elgendy, Sara M

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Sara M Elgendy
Favorite
Elhasany, Kholod

University of Utah
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Kholod Elhasany
Favorite
Elkanayati, Rasha

University of Mississippi
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Rasha Elkanayati
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Rasha Elkanayati
Favorite
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Rasha Elkanayati
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Rasha Elkanayati
Favorite
Elnaggar, Marwa

Purdue University
(T1130-07-37) Albumin Corona Improves Colloidal Stability of Nanosac, a Non-Cationic Polyphenol Gene Carrier
Marwa Elnaggar
Favorite
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Marwa Elnaggar
Favorite
El-Saleh, Firas

Ashland Specialty Ingredients
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Firas El-Saleh
Favorite
Elsheikh, Ahmed

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Ahmed Elsheikh
Favorite
ElSohly, Mahmoud A.

University of Mississippi
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Mahmoud A. ElSohly
Favorite
Eltanameli, Bassma

University of Florida
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Bassma Eltanameli
Favorite
Embrey, Elizabeth

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Elizabeth Embrey
Favorite
Emond, Jared

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Jared Emond
Favorite
Eneli, Adaeze

University of Michigan
(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes
Adaeze Eneli
Favorite
Eng, Colleen

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Colleen Eng
Favorite
Engers, David

Improved Pharma
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
David Engers
Favorite
Ensign, Laura

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Laura Ensign
Favorite
Erickson, Sarah

Harvard University
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Sarah Erickson
Favorite
Esfahani, Shiva Hadi

Oakland University
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Shiva Hadi Esfahani
Favorite
Esposito, Alexandra

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Alexandra Esposito
Favorite
Esposito, Amalia

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Amalia Esposito
Favorite
Essex, Mattison

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Mattison Essex
Favorite
Etchart-Liechtenstein, Nathalie

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Nathalie Etchart-Liechtenstein
Favorite
(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments
Nathalie Etchart-Liechtenstein
Favorite
Ethell, Brian

Foghorn Therapeutics
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Brian Ethell
Favorite
Etim, Imoh

Merck & Co Inc
(M1330-02-07) Understanding the Influence of Drug Metabolizing Enzyme Activity on Small Molecule Stability Within a Commonly Used Preclinical Tumor Model
Imoh Etim
Favorite
Evangelista, Michael

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Michael Evangelista
Favorite
Evani, Surya T.

Johns Hopkins University
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Surya T. Evani
Favorite
Evans, Christina

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Christina Evans
Favorite
Evans, James

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
James Evans
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
James Evans
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
James Evans
Favorite
Evans, Jared

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Jared Evans
Favorite
Everlof, Gerry

Bristol Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Gerry Everlof
Favorite
Evrard, Brigitte

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Brigitte Evrard
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Brigitte Evrard
Favorite
Exner, Agata A.

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Agata A. Exner
Favorite
Eyerman, David

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
David Eyerman
Favorite
Ezewudo, Emmanuella

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Emmanuella Ezewudo
Favorite
F
Fadem, Adam

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Adam Fadem
Favorite
Faden, Geoffrey

MAC-MOD Analytical
(M1330-06-31) Optimising the Extraction of Oligonucleotides by SPE
Geoffrey Faden
Favorite
Fael, Hanan

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Hanan Fael
Favorite
Falatek, Mary

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Mary Falatek
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Mary Falatek
Favorite
Falo, Louis

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Louis Falo
Favorite
Fang, Lanyan

US Food and Drug Administration
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Lanyan Fang
Favorite
Fang, Pu

Janssen Research & Development, LLC
(T1030-06-33) Development of Novel Cis-Receptor Occupancy Method for Bispecific Antibodies
Pu Fang
Favorite
Fang, Terry

Third Rock Ventures
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Terry Fang
Favorite
Fang, Yi-Ya

Eli Lilly and Company
(W0930-10-55) Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF
Yi-Ya Fang
Favorite
Fang, Yuan

Binghamton University
(T1330-02-08) Machine Learning Approaches for Assessing Medication Transfer to Human Breast Milk: Estimating Milk/Plasma Drug Ratios
Yuan Fang
Favorite
Farkas, Dale

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Dale Farkas
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Dale Farkas
Favorite
Farmer, John

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
John Farmer
Favorite
Faruque, Hasan

University of Utah
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Hasan Faruque
Favorite
Faruque, Md Hasan Al

University of Utah
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Md Hasan Al Faruque
Favorite
Fasina, Oladiran

Auburn University
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Oladiran Fasina
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Oladiran Fasina
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Oladiran Fasina
Favorite
Fassihi, Reza

Temple University
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Reza Fassihi
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Reza Fassihi
Favorite
Fatima, Iram

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Iram Fatima
Favorite
Faustino, Patrick J

US Food and Drug Administration
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Patrick J Faustino
Favorite
Fazily, Rizan

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Rizan Fazily
Favorite
Feldberg, Lewis

Sophrosyne Pharmaceuticals Limited
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Lewis Feldberg
Favorite
Felton, Linda

University of New Mexico
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Linda Felton
Favorite
Fenelon, Jerry

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Jerry Fenelon
Favorite
Feng, Hanping

University of Maryland Baltimore
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Hanping Feng
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Hanping Feng
Favorite
Feng, Shao-Ching

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Shao-Ching Feng
Favorite
(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
Shao-Ching Feng
Favorite
Feng, Wenyi

University College London
(T1230-04-20) Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Wenyi Feng
Favorite
Fenton, Maire

Avadel
(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Maire Fenton
Favorite
(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM
Maire Fenton
Favorite
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Maire Fenton
Favorite
Ferguson, Amarae

Mercer University
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Amarae Ferguson
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Amarae Ferguson
Favorite
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Amarae Ferguson
Favorite
Feris, Sherri

North Texas Eye Research Institute
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Sherri Feris
Favorite
Ferraz, Humberto

University of Sao Paulo
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Humberto Ferraz
Favorite
(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification
Humberto Ferraz
Favorite
Ferreira, Ana Filipa

Hovione
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Ana Filipa Ferreira
Favorite
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Ana Filipa Ferreira
Favorite
Ferrizzi, David

Colorcon, Inc.
(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity
David Ferrizzi
Favorite
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
David Ferrizzi
Favorite
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
David Ferrizzi
Favorite
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
David Ferrizzi
Favorite
(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets
David Ferrizzi
Favorite
Fetse, John

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
John Fetse
Favorite
Fichorova, Raina

Harvard Medical School
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Raina Fichorova
Favorite
Filipczak, Nina

Northeastern University
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Nina Filipczak
Favorite
Finch, John

AstraZeneca
(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies
John Finch
Favorite
Fisher, Brianna

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Brianna Fisher
Favorite
Fisher, Robert

Massachusetts Institute of Technology
(M1030-07-40) Drug Release Rate Characterization of Double Nanoemulsions (W1/O/W)
Robert Fisher
Favorite
Fitzpatrick, Christopher

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Christopher Fitzpatrick
Favorite
Fitzpatrick, Dara

University College Cork
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Dara Fitzpatrick
Favorite
Flühmann, Beat

CSL Vifor
(T1430-02-07) Exploring the Potential Influence of Physicochemical Characteristics on Biodistribution of Iron-Carbohydrate Nanoparticles Using a Chicken Embryo Model
Beat Flühmann
Favorite
Flank, Sharon

InfraTrac
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Sharon Flank
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Sharon Flank
Favorite
Flanner, Henry

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Henry Flanner
Favorite
Flores-Morales, Virginia

Universidad Autonoma de Zacatecas
(M1330-04-22) In Silico Evaluation of Coumarin Derivatives as Potential Antioxidant Agents on Psoriasis Treatment
Virginia Flores-Morales
Favorite
Flye, Leanne

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Leanne Flye
Favorite
Foertsch, Sebastian

International Flavors and Fragrances
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Sebastian Foertsch
Favorite
Fong, Karen

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Karen Fong
Favorite
Fontana, Lauren

Sanofi
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Lauren Fontana
Favorite
Foody, Henry

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Henry Foody
Favorite
Foote, Aaron

Biopact LLC
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Aaron Foote
Favorite
Foster, Kimberly

Bristol-Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Kimberly Foster
Favorite
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Kimberly Foster
Favorite
Fotaki, Nikoletta

University of Bath
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Nikoletta Fotaki
Favorite
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Nikoletta Fotaki
Favorite
(T1130-09-50) Biopharmaceutical Tools for De-risking Paediatric Formulation Development
Nikoletta Fotaki
Favorite
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Nikoletta Fotaki
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Nikoletta Fotaki
Favorite
Foti, Chris

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Chris Foti
Favorite
Foti, Robert

Merck & Co., Inc.
(M1330-02-07) Understanding the Influence of Drug Metabolizing Enzyme Activity on Small Molecule Stability Within a Commonly Used Preclinical Tumor Model
Robert Foti
Favorite
Fotsing, Joseph

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Joseph Fotsing
Favorite
Fowler, Lauren

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Lauren Fowler
Favorite
Francqui, Filip

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Filip Francqui
Favorite
Frandsen, Mette

Bioneer A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Mette Frandsen
Favorite
Fratz-Berilla, Erica

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Erica Fratz-Berilla
Favorite
Freed, Peter

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Peter Freed
Favorite
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Peter Freed
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Peter Freed
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Peter Freed
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Peter Freed
Favorite
Freel, Keith

University of Maryland
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Keith Freel
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Keith Freel
Favorite
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Keith Freel
Favorite
Freerks, Lisa

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Lisa Freerks
Favorite
Frehner, Anna

Catalent Pharma Solutions
(M1430-10-58) Rapid Material-Sparing Approach to Address Hairline Fractures in Low Drug Load Tablets via Compaction Simulation
Anna Frehner
Favorite
Frenzel, Johannes

University Bonn
(M1430-10-59) High Drug Load Metformin ER 1000 mg Tablets Processed via Roller Compaction in Combination with High Molecular Weight HPC
Johannes Frenzel
Favorite
Frericks Schmidt, Heather

Pfizer Inc.
(T0930-07-38) Understanding Dibasic Calcium Phosphate Impact on Chemical Stability - Trends in Immediate Release Tablet Formulations
Heather Frericks Schmidt
Favorite
Frigerio, Giorgia

Universita Degli Studi Di Milano
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Giorgia Frigerio
Favorite
Frisbie, James

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
James Frisbie
Favorite
Fu, Evan

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Evan Fu
Favorite
Fuguet, Elisabet

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Elisabet Fuguet
Favorite
Fujisawa, Tomohisa

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Tomohisa Fujisawa
Favorite
Fujita, Yuito

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Yuito Fujita
Favorite
Fukami, Toshiro

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Toshiro Fukami
Favorite
Furtado, Milton

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Milton Furtado
Favorite
Fu, Xin

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Xin Fu
Favorite
G
Gabani, Bhavesh

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Bhavesh Gabani
Favorite
Gacheru, Stephen

Frontage Laboratories, Inc.
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Stephen Gacheru
Favorite
Gadal, Bhim

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Bhim Gadal
Favorite
Gadalla, Hytham

Purdue University
(T1130-07-37) Albumin Corona Improves Colloidal Stability of Nanosac, a Non-Cationic Polyphenol Gene Carrier
Hytham Gadalla
Favorite
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Hytham Gadalla
Favorite
Gadgil, Sidharth

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Sidharth Gadgil
Favorite
Gadhave, Dnyandev

St. John's University
(W1130-01-06) DoE-Enabled Development of Osimertinib-Encapsulated PLGA Nanoparticles for the Treatment of Non-Small Cell Lung Cancer
Dnyandev Gadhave
Favorite
(W1130-04-20) A Nano-Emulsion-Based Formulation of Sorafenib for Oral Bioavailability Enhancement and Repurposing against Non-small Cell Lung Cancer (NSCLC)
Dnyandev Gadhave
Favorite
Gadlawar, Vitthal

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Vitthal Gadlawar
Favorite
Gadsden, Jay

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Jay Gadsden
Favorite
Gagnon, Hugo

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Hugo Gagnon
Favorite
Gajera, Bhavin

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Bhavin Gajera
Favorite
Gajul, Shruti

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Shruti Gajul
Favorite
Galdavini, Camila

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Camila Galdavini
Favorite
Galeano, Juan

Colorcon, Inc.
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Juan Galeano
Favorite
Galermo, Eshani

SCIEX
(T1130-04-24) Automated Workflow for Targeted Protein Degrader (TPD) Metabolite Identification Using Collision-Induced Dissociation (CID) and Electron-Activated Dissociation (EAD)
Eshani Galermo
Favorite
Gali, Chaitanya

Medical University of Graz
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Chaitanya Gali
Favorite
Galindo-Perez, Moises Job

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Moises Job Galindo-Perez
Favorite
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Moises Job Galindo-Perez
Favorite
Gallagher, M. J. Sousa

University College Cork
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
M. J. Sousa Gallagher
Favorite
Gallas, Mael

Rondol Industrie
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Mael Gallas
Favorite
Gamage, Prabhath

US Food and Drug Administration
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Prabhath Gamage
Favorite
(W0930-11-61) Quantitative and Qualitative Analysis of Lipids and Cholesterol Derivatives in SMOF Lipids 20% Intravenous Lipid Emulsion
Prabhath Gamage
Favorite
Gambles, M. Tommy

University of Utah
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
M. Tommy Gambles
Favorite
Gambles, Michael

University of Utah
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Michael Gambles
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Michael Gambles
Favorite
Ganapathy, Balaji

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Balaji Ganapathy
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Balaji Ganapathy
Favorite
Gangam, Rekha

Merck & Co., Inc.
(T1130-10-54) Developing Robust Control Strategies for an Unexpected Fluorination Process Investigation
Rekha Gangam
Favorite
Ganji, Nasim

AbbVie Inc
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Nasim Ganji
Favorite
Ganugula, Raghu

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Raghu Ganugula
Favorite
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Raghu Ganugula
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Raghu Ganugula
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Raghu Ganugula
Favorite
Gao, Yi

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Yi Gao
Favorite
Gao, Yu

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Yu Gao
Favorite
Gao, Zongming

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Zongming Gao
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Zongming Gao
Favorite
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Zongming Gao
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Zongming Gao
Favorite
Garbacz, Grzegorz

Physiolution GmbH
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Grzegorz Garbacz
Favorite
(M1530-03-15) Biopredictive Dissolution of Budesonide Enteric Pellets under Simulated Fasted Intake Conditions
Grzegorz Garbacz
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Grzegorz Garbacz
Favorite
García-Faroldi, Gianni

Mercodia Inc.
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Gianni García-Faroldi
Favorite
Garcia, Daniel

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Daniel Garcia
Favorite
Garg, Nidhi

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Nidhi Garg
Favorite
Garg, Sanjay

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Sanjay Garg
Favorite
Garigapati, Venkat

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Venkat Garigapati
Favorite
Garrastazu Pereira, Gabriela

University of Bath
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Gabriela Garrastazu Pereira
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Gabriela Garrastazu Pereira
Favorite
Garrett, Meredith

University of North Texas Health Science Center
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Meredith Garrett
Favorite
Gates, Dana

Pfizer Inc.
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Dana Gates
Favorite
Gattu, Kranthi

St. John's University
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Kranthi Gattu
Favorite
Gaudin, Mathieu

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
Mathieu Gaudin
Favorite
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Mathieu Gaudin
Favorite
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Mathieu Gaudin
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Mathieu Gaudin
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Mathieu Gaudin
Favorite
Gautreau, Jonah

DigiM Solution LLC
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Jonah Gautreau
Favorite
(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis
Jonah Gautreau
Favorite
Gbadegesin, Omotola

National Institutes of Health
(T0930-04-19) Gemcitabine/Doxorubicin-Combination Polymer-Drug Conjugate Synthesized by SPAAC Click Chemistry: Characterization and Evaluation in OVCAR-3 Ovarian Cancer Cells
Omotola Gbadegesin
Favorite
Geary, Sean

University of Iowa
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Sean Geary
Favorite
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Sean Geary
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Sean Geary
Favorite
Gelfuso, Guilherme

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Guilherme Gelfuso
Favorite
Gemeinhart, Richard

University of Illinois Chicago
(T0930-01-06) Combatting Pseudomonas aeruginosa Biofilms: A Strategy with Glutathione-Conjugated Hydrogels for Disruption and Biofouling Mitigation
Richard Gemeinhart
Favorite
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Richard Gemeinhart
Favorite
Gemine, Thomas

University of Liege
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Thomas Gemine
Favorite
Gendelman, Howard

University of Nebraska Medical Center
(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
Howard Gendelman
Favorite
Gentry, Carleen

Nido Biosciences, Inc.
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Carleen Gentry
Favorite
George, Christopher

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Christopher George
Favorite
George, Shilpa

University of Colorado Anschutz Medical Campus
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Shilpa George
Favorite
George, Susan

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Susan George
Favorite
Gerritsen, Arnout

Genmab
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Arnout Gerritsen
Favorite
Gerstenberg, Amandine

Aliri Bioanalysis
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Amandine Gerstenberg
Favorite
Gesenberg, Christoph

Bristol-Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Christoph Gesenberg
Favorite
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Christoph Gesenberg
Favorite
Gethings, Lee

Waters Corporation
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Lee Gethings
Favorite
Geweda, Mona

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Mona Geweda
Favorite
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems
Mona Geweda
Favorite
Ghaderi, Samuel

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Samuel Ghaderi
Favorite
Ghandehari, Hamid

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Hamid Ghandehari
Favorite
(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer
Hamid Ghandehari
Favorite
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Hamid Ghandehari
Favorite
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Hamid Ghandehari
Favorite
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Hamid Ghandehari
Favorite
(W1030-02-11) Immunotoxicity of Silica Nanoparticles as a Function of Physicochemical Properties
Hamid Ghandehari
Favorite
Gharibi, Hassan

Karolinska Institute
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Hassan Gharibi
Favorite
Ghimire, Biwash

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Biwash Ghimire
Favorite
Ghodsian, Nooshin

Evonik Canada, Inc.
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
Nooshin Ghodsian
Favorite
Ghonge, Mihir

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Mihir Ghonge
Favorite
(W0930-07-39) Development and Characterization of Cannabidiol and Rho Kinase Inhibitor Combination Formulations for Ophthalmic Use
Mihir Ghonge
Favorite
Ghosal, Arpita

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Arpita Ghosal
Favorite
(T1330-01-06) A Novel Liposome Delivering Adavosertib for Ovarian Cancer Treatment
Arpita Ghosal
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Arpita Ghosal
Favorite
Ghosh, Debadyuti

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Debadyuti Ghosh
Favorite
Ghosh, Meheli

Mercer University
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Meheli Ghosh
Favorite
(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect
Meheli Ghosh
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Meheli Ghosh
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Meheli Ghosh
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Meheli Ghosh
Favorite
Ghosh, Priyanka

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Priyanka Ghosh
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Priyanka Ghosh
Favorite
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Priyanka Ghosh
Favorite
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Priyanka Ghosh
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Priyanka Ghosh
Favorite
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Priyanka Ghosh
Favorite
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Priyanka Ghosh
Favorite
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Priyanka Ghosh
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Priyanka Ghosh
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Priyanka Ghosh
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Priyanka Ghosh
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Priyanka Ghosh
Favorite
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Priyanka Ghosh
Favorite
Giarola, Leila

Ashland Specialty Ingredients
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Leila Giarola
Favorite
Gibson, Christopher

Merck & Co., Inc.
(M1330-02-07) Understanding the Influence of Drug Metabolizing Enzyme Activity on Small Molecule Stability Within a Commonly Used Preclinical Tumor Model
Christopher Gibson
Favorite
Gillen, Owen

University of Florida
(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Owen Gillen
Favorite
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Owen Gillen
Favorite
Gill, Erma

Nova Southeastern University
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Erma Gill
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Erma Gill
Favorite
Gillespie, Ian

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Ian Gillespie
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Ian Gillespie
Favorite
Gimbel, Jeffrey

Colorcon, Inc.
(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets
Jeffrey Gimbel
Favorite
Giraud, Laure

Patheon, part of Thermo Fisher Scientific
(W0930-05-27) Compaction Simulation as a Risk Mitigation Strategy for Dual Sourcing on Commercial Drug Products
Laure Giraud
Favorite
Giri, Paras

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Paras Giri
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Paras Giri
Favorite
Giri, Pradeep

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Pradeep Giri
Favorite
Glatt, Dylan

23andMe Inc.
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Dylan Glatt
Favorite
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Dylan Glatt
Favorite
Gleeson, John

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
John Gleeson
Favorite
Gnatzy, Lea

National and Kapodistrian University of Athens
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Lea Gnatzy
Favorite
Gobbooru, Shruthi

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Shruthi Gobbooru
Favorite
Godfrey, Alva

LCI Corp.
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Alva Godfrey
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Alva Godfrey
Favorite
Gogad, Vishal

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Vishal Gogad
Favorite
Goh, Lucas

Roquette Asia Pacific Pte Ltd
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Lucas Goh
Favorite
Gokhale, Rajeev

Roquette America Inc.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Rajeev Gokhale
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Rajeev Gokhale
Favorite
Gonçalves, Ricardo

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Ricardo Gonçalves
Favorite
Goncalves Dias, Camila

University of Campinas
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Camila Goncalves Dias
Favorite
Gong, Li

US Food and Drug Administration
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
Li Gong
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Li Gong
Favorite
Gong, Wei

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Wei Gong
Favorite
Gonzalez, Alexandra

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Alexandra Gonzalez
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Alexandra Gonzalez
Favorite
Gonzalez-Juarrero, Mercedes

Colorado State University
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Mercedes Gonzalez-Juarrero
Favorite
Gonzalez, Vanessa

Lonza
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Vanessa Gonzalez
Favorite
Goossens, Laurien

Xedev
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Laurien Goossens
Favorite
Gopalakrishnan, Mathangi

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Mathangi Gopalakrishnan
Favorite
Gopalan, R.C.

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
R.C. Gopalan
Favorite
Gorelick, Lorraine

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Lorraine Gorelick
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Lorraine Gorelick
Favorite
Gosselin, Michael

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Michael Gosselin
Favorite
Goswami, Ritabrita

University of Massachusetts
(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation
Ritabrita Goswami
Favorite
Goswell, Colin

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Colin Goswell
Favorite
Gothwal, Avinash

North Dakota State University
(T1230-04-21) Synthesis and Characterization of Multi-Functionalized Chitosan Polymeric Micelles for Intranasal Delivery of pApoE2 to PS19 Tauopathy Mice
Avinash Gothwal
Favorite
Gottschalk, Nadine

Merck Life Science KGaA
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Nadine Gottschalk
Favorite
Gou, Deming

Shenzhen University
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Deming Gou
Favorite
Goyal, Mimansa

St. John's University
(W1030-03-18) Exploring the Potential of Inhaled Clofazimine Liposomes for Mesothelioma Treatment
Mimansa Goyal
Favorite
(W1030-05-28) Liposomal Amodiaquine for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC)
Mimansa Goyal
Favorite
Goyanes, Álvaro

FabRx Ltd
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Álvaro Goyanes
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Álvaro Goyanes
Favorite
Graham, Andrew

Queen's University Belfast
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Andrew Graham
Favorite
Granados, Pedro

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Pedro Granados
Favorite
Grant, Jennifer

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Jennifer Grant
Favorite
Grater, Richard

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Richard Grater
Favorite
Gratieri, Tais

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Tais Gratieri
Favorite
Graves, Briana

Alcami Corporation
(M1230-04-19) Guaifenesin: Discovery and Attributes of Novel Racemic Compound
Briana Graves
Favorite
(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction
Briana Graves
Favorite
Graves, Rebecca

Simulations Plus, Inc.
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Rebecca Graves
Favorite
Green, Shelby

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Shelby Green
Favorite
Greiner, Mark

University of Iowa
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Mark Greiner
Favorite
Greth, Megan

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Megan Greth
Favorite
Grewal, Gursirat

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Gursirat Grewal
Favorite
Gridley, Kate

University of Bath
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Kate Gridley
Favorite
Griffin, Brendan

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Brendan Griffin
Favorite
(W1030-04-21) Computational Pharmaceutics Approaches to Guide Lipid Based Formulation Development: How Data Mining Can Improve the Process
Brendan Griffin
Favorite
Griffin-Medellin, Benjamin

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Benjamin Griffin-Medellin
Favorite
Gross, Idejan

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Idejan Gross
Favorite
Gross, Kyle

University of Kansas
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Kyle Gross
Favorite
Gruber, James V

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
James V Gruber
Favorite
Grugan, Katharine

Janssen Research & Development, LLC
(T1030-06-33) Development of Novel Cis-Receptor Occupancy Method for Bispecific Antibodies
Katharine Grugan
Favorite
Grumbach, Isabella

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Isabella Grumbach
Favorite
Grunberger, Jason

University of Utah
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Jason Grunberger
Favorite
(W1030-02-11) Immunotoxicity of Silica Nanoparticles as a Function of Physicochemical Properties
Jason Grunberger
Favorite
Grun, Molly

Alexion Pharmaceuticals, Inc.
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Molly Grun
Favorite
Guadagnoli, Nicholas

University of Florida
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Nicholas Guadagnoli
Favorite
Guan, Danyingzi

Wuhan Hiteck Bio-Pharma Research Institute Ltd.
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Danyingzi Guan
Favorite
Gu, Chong-Hui

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Chong-Hui Gu
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Chong-Hui Gu
Favorite
Gudelsky, Gary

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Gary Gudelsky
Favorite
Gudipati, Lakshmi priyanka

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Lakshmi priyanka Gudipati
Favorite
Guimaraes, Guiherme

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Guiherme Guimaraes
Favorite
Gukasyan, Hovhannes

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Hovhannes Gukasyan
Favorite
Gu, Landy

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Landy Gu
Favorite
Gulani, Mahek Anil

Mercer University
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Mahek Anil Gulani
Favorite
Gumireddy, Ashwini

Duquesne University
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Ashwini Gumireddy
Favorite
Gummerlich, Angela

Boehringer Ingelheim
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
Angela Gummerlich
Favorite
Gunawardana, Geeth

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Geeth Gunawardana
Favorite
Gundagiri, Shravan

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Shravan Gundagiri
Favorite
Gunn, George

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
George Gunn
Favorite
Guo, Annie

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Annie Guo
Favorite
Guo-Avrutin, Yingying

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Yingying Guo-Avrutin
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Yingying Guo-Avrutin
Favorite
Guo, Mason

ICE Bioscience Inc.
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Mason Guo
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Mason Guo
Favorite
Guo, Xin

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Xin Guo
Favorite
Guo, Yi

St. John's University
(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer
Yi Guo
Favorite
(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules
Yi Guo
Favorite
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Yi Guo
Favorite
(T1430-02-10) Modified Dissolution-Permeation Assembly Mimicking In Vivo Condition: An Ideal Method to Test Dissolution Profile of Nanosuspension Formulation
Yi Guo
Favorite
Guo, Yiwang

University of Minnesota
(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery
Yiwang Guo
Favorite
Gupta, Aditya

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Aditya Gupta
Favorite
Gupta, Neha

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Neha Gupta
Favorite
Gupta, Pardeep

St. Joseph's University
(M1430-04-20) Coarse-Grained Molecular Dynamics Simulations Evaluating Formation and Structural Stability of Nystatin-Loaded DOPC and DPPC Vesicles
Pardeep Gupta
Favorite
(M1530-06-34) Molecular Dynamics Study Using Coarse-Grained Simulation with Martini Force Field for Structural Stability and Formation of Docetaxel Loaded DOPC and DPPC Lipid Vesicle
Pardeep Gupta
Favorite
(T1430-09-48) Exploring Mannitol's Influence on Protein Stability: Spray-Dried rHGH Formulations
Pardeep Gupta
Favorite
Gupta, Paridhi

University of Tennessee Health Sciences Center
(M1030-02-12) Investigating Differences in the Pharmacokinetics of Monoclonal Antibodies in Japanese and Non-Japanese Subjects
Paridhi Gupta
Favorite
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
Paridhi Gupta
Favorite
Gupta, Seema

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Seema Gupta
Favorite
Gupta, Shashwat

Eli Lilly and Company
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Shashwat Gupta
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Shashwat Gupta
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Shashwat Gupta
Favorite
Gupta, Vishal

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Vishal Gupta
Favorite
Gupta, Vivek

St. John's University
(M1030-09-52) Development of a Self-Emulsifying Drug Delivery System (SEDDS) of Fenofibrate Using ZoomLab^TM
Vivek Gupta
Favorite
(T1330-03-17) Developing Biosustane SAIB NF as a Novel Excipient for Oral Dosage Forms
Vivek Gupta
Favorite
(W1030-03-18) Exploring the Potential of Inhaled Clofazimine Liposomes for Mesothelioma Treatment
Vivek Gupta
Favorite
(W1030-05-28) Liposomal Amodiaquine for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC)
Vivek Gupta
Favorite
(W1130-01-06) DoE-Enabled Development of Osimertinib-Encapsulated PLGA Nanoparticles for the Treatment of Non-Small Cell Lung Cancer
Vivek Gupta
Favorite
(W1130-04-20) A Nano-Emulsion-Based Formulation of Sorafenib for Oral Bioavailability Enhancement and Repurposing against Non-small Cell Lung Cancer (NSCLC)
Vivek Gupta
Favorite
Gu, Qimei

US Food and Drug Administration
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Qimei Gu
Favorite
Gurvich, Vadim J.

University of Minnesota
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Vadim J. Gurvich
Favorite
Guth, Felicitas

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Felicitas Guth
Favorite
Gutierrez, Mario

Merck & Co., Inc.
(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition
Mario Gutierrez
Favorite
Guttha, Vineetha

University of Minnesota
(T1530-06-35) Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling
Vineetha Guttha
Favorite
Guy, Alen

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Alen Guy
Favorite
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Alen Guy
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Alen Guy
Favorite
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Alen Guy
Favorite
H
Hache, Sophie

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Sophie Hache
Favorite
Hacker, Michael

Heinrich-Heine-University Dusseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Michael Hacker
Favorite
Hackett, Jennifer

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Jennifer Hackett
Favorite
Haddad, Fatma

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Fatma Haddad
Favorite
Hageman, Michael

University of Kansas
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Michael Hageman
Favorite
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Michael Hageman
Favorite
Hahm, Astra

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Astra Hahm
Favorite
Hahn, Annina

University of Bonn
(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin
Annina Hahn
Favorite
Haight, Brian

Leistritz Extrusion
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Brian Haight
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Brian Haight
Favorite
Hall, Felicia

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Felicia Hall
Favorite
Hall, Stephen

Eli Lilly and Company
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Stephen Hall
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Stephen Hall
Favorite
Halpern, Wendy

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Wendy Halpern
Favorite
Halquist, Matthew

Virginia Commonwealth University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Matthew Halquist
Favorite
Hamadani, Christine

University of Mississippi
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Christine Hamadani
Favorite
Hamid, Khuriah

Universiti Teknologi MARA
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Khuriah Hamid
Favorite
Hammell, Dana

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Dana Hammell
Favorite
Hampl, Vojtech

University of Chemistry and Technology
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Vojtech Hampl
Favorite
Hancock, Bruno

Aleurites LLC
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Bruno Hancock
Favorite
Han, Daewoo

University of Cincinnati
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Daewoo Han
Favorite
Han, Duanduan

Waters Corporation
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Duanduan Han
Favorite
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Duanduan Han
Favorite
Han, Gavin

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Gavin Han
Favorite
Han, Gyoonhee

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Gyoonhee Han
Favorite
Han, Hyojin

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Hyojin Han
Favorite
Han, Jiwon

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jiwon Han
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jiwon Han
Favorite
Hanna, Michael

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Michael Hanna
Favorite
Hanrahan, Michael

Kansas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Michael Hanrahan
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Michael Hanrahan
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Michael Hanrahan
Favorite
Han, Sang-Duk

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sang-Duk Han
Favorite
Hanson, Joshua

Eli Lilly and Company
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Joshua Hanson
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Joshua Hanson
Favorite
Han, SungKyun

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
SungKyun Han
Favorite
Hao, Xiaoyu

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Xiaoyu Hao
Favorite
Haque, Safiya

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Safiya Haque
Favorite
Hardcastle, Chris

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Chris Hardcastle
Favorite
Hardwick, Rhiannon

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Rhiannon Hardwick
Favorite
Harkins, Seth

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Seth Harkins
Favorite
Harrell, Charles

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Charles Harrell
Favorite
Harrington, Brent

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Brent Harrington
Favorite
Harris, Denise

Alcami Corp
(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software
Denise Harris
Favorite
Harris, Gerald

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Gerald Harris
Favorite
Harris, Jeremy

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Jeremy Harris
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Jeremy Harris
Favorite
Hartig, Michael Uwe

University of Bonn
(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder
Michael Uwe Hartig
Favorite
Hartle, Matthew

Aliri Bioanalysis
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Matthew Hartle
Favorite
Harvey, Ian

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Ian Harvey
Favorite
Harvie, Pierrot

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Pierrot Harvie
Favorite
Harville, Tiffany

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Tiffany Harville
Favorite
Hasabnis, Aakash

University of Minnesota
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Aakash Hasabnis
Favorite
Hasan, Izhar

RH Nanopharmaceuticals
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Izhar Hasan
Favorite
Hasan, Md Mahedi

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Md Mahedi Hasan
Favorite
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
Md Mahedi Hasan
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Md Mahedi Hasan
Favorite
Hasan, Md Mahmudul

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Md Mahmudul Hasan
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Md Mahmudul Hasan
Favorite
Hasan, Md. Nahid

Duquesne University
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Md. Nahid Hasan
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Md. Nahid Hasan
Favorite
Hasan, Raquib

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Raquib Hasan
Favorite
Hasan, Raquibul

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Raquibul Hasan
Favorite
Hase, Takeshi

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Takeshi Hase
Favorite
Hassiba, Maryam

Qatar University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Maryam Hassiba
Favorite
Hatsis, Panos

Nido Biosciences, Inc.
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Panos Hatsis
Favorite
Haulenbeek, Jonathan

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Jonathan Haulenbeek
Favorite
Hauther, Christine

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Christine Hauther
Favorite
Havenith, Vanessa

SE Tylose GmbH & Co. KG
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Vanessa Havenith
Favorite
Haverick, Mark

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Mark Haverick
Favorite
Hayashi, Yuji

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Yuji Hayashi
Favorite
Hayata, Nozomi

Eisai Co. Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Nozomi Hayata
Favorite
Hays, Amanda

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Amanda Hays
Favorite
Heacock, Nathan

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Nathan Heacock
Favorite
Hearn, Aaron

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Aaron Hearn
Favorite
Hearn, Arkeen

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Arkeen Hearn
Favorite
He, Brian

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Brian He
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Brian He
Favorite
Hedaya, Mohsen

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Mohsen Hedaya
Favorite
Heikkinen, Aki

Certara Predictive Technologies
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Aki Heikkinen
Favorite
Heinrich, Emmanuel

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Emmanuel Heinrich
Favorite
Heinrich, John

Kanas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
John Heinrich
Favorite
Heise, Rebecca

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Rebecca Heise
Favorite
Heiser, Patrick

Ferring Pharmaceuticals A/S
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Patrick Heiser
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Patrick Heiser
Favorite
Hejmady, Siddhanth

University of Iowa
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Siddhanth Hejmady
Favorite
He, Lei

Chinese University of Hong Kong, The
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Lei He
Favorite
Henner-Kulkarni, Véronique

SE Tylose GmbH & Co. KG
(M0930-09-50) Predicting Filaments Behavior in Milling and Printing via 3 Point Bend Test
Véronique Henner-Kulkarni
Favorite
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Véronique Henner-Kulkarni
Favorite
Henner-Kulkarni, Veronique

SE Tylose GmbH (Shin-Etsu)
(M0930-09-50) Predicting Filaments Behavior in Milling and Printing via 3 Point Bend Test
Veronique Henner-Kulkarni
Favorite
Henry, Connor

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Connor Henry
Favorite
Henson, Samuel

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Samuel Henson
Favorite
He, Qianying

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Qianying He
Favorite
Herbert, Aidan

DigiM Solution LLC
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Aidan Herbert
Favorite
Hernandez-Aceves, Zaira Aydee

Universidad Autónoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Zaira Aydee Hernandez-Aceves
Favorite
Herold, Nick

SCIEX
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Nick Herold
Favorite
Herr, Alicia

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Alicia Herr
Favorite
Hervas, Manuel

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Manuel Hervas
Favorite
He, Shan

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Shan He
Favorite
Heshmati, Niloofar

Ashland Specialty Ingredients
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Niloofar Heshmati
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Niloofar Heshmati
Favorite
Hess, Samantha

Alexion
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Samantha Hess
Favorite
Hettiarachchi, Suraj

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Suraj Hettiarachchi
Favorite
He, Yanying

Purdue University
(W0930-07-37) Nanoparticle Development for Systemic Delivery of Resiquimod to Reactivate Immunosuppressive Tumor Microenvironment
Yanying He
Favorite
He, Yixin

Aptacure Therapeutics Ltd
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Yixin He
Favorite
Heyns, Ingrid

University of Alabama
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Ingrid Heyns
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Ingrid Heyns
Favorite
Hickey, Anthony

RTI International
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Anthony Hickey
Favorite
Hiew, Tze Ning

University of Iowa
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Tze Ning Hiew
Favorite
Higashino, Chie

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Chie Higashino
Favorite
Higashino, Haruki

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Haruki Higashino
Favorite
Higuchi, Masaharu

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Masaharu Higuchi
Favorite
Hill, Salisha

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Salisha Hill
Favorite
Hindle, Michael

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Michael Hindle
Favorite
Hinterberg, Michael

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Michael Hinterberg
Favorite
Hirabayashi, Manabu

Chugai Research Institute for Medical Science Inc.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Manabu Hirabayashi
Favorite
Hiranita, Takato

University of Texas Health Science Center
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Takato Hiranita
Favorite
Hirschman, Jordan

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Jordan Hirschman
Favorite
Hivin, Elisa

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
Elisa Hivin
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Elisa Hivin
Favorite
Hoag, Stephen

University of Maryland
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Stephen Hoag
Favorite
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Stephen Hoag
Favorite
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Stephen Hoag
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Stephen Hoag
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Stephen Hoag
Favorite
(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?
Stephen Hoag
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Stephen Hoag
Favorite
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Stephen Hoag
Favorite
Hochart, Guillaume

Aliri Bioanalysis
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Guillaume Hochart
Favorite
Hofasaess, Martin

BASF Corporation
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Martin Hofasaess
Favorite
Ho, Gloria

BASF Corporation
(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis
Gloria Ho
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Gloria Ho
Favorite
Holgate, Rob

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Rob Holgate
Favorite
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Rob Holgate
Favorite
Holkunde, Aditi

University of Mississippi
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Aditi Holkunde
Favorite
Hollenbeck, Gary

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Gary Hollenbeck
Favorite
Hollmann, Travis

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Travis Hollmann
Favorite
Holstein, Sarah

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Sarah Holstein
Favorite
Hong, Paula

Waters Corporation
(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration
Paula Hong
Favorite
Hong, Shiqi

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Shiqi Hong
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Shiqi Hong
Favorite
Hopkins, Corey R.

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Corey R. Hopkins
Favorite
Hopkins, Phillip

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Phillip Hopkins
Favorite
Hoque, Md. Tozammel

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Md. Tozammel Hoque
Favorite
Hornick, Timothy

DigiM Solution LLC
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Timothy Hornick
Favorite
Ho, Rodney

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Rodney Ho
Favorite
Horvath, Robert

University of Cincinnati
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Robert Horvath
Favorite
Hoshino, Takafumi

Shin-Etsu Chemical Co., Ltd.
(T1030-09-51) Simplification Study of Feed System in HPMCAS Dry Coating
Takafumi Hoshino
Favorite
Hossain, Jasmin

Long Island University
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
Jasmin Hossain
Favorite
Hossain, Md Nayeem

US Food and Drug Administration
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Md Nayeem Hossain
Favorite
Ho, Tien

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Tien Ho
Favorite
Hough, Loren

University of Colorado Boulder
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Loren Hough
Favorite
Hou, Shuyu

Medpace
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Shuyu Hou
Favorite
(W1030-02-07) Determination of the Concentration of Monoclonal Antibodies (Mab) Drug in Human Serum Using an Enzyme-Linked Immunosorbent Assay (ELISA)
Shuyu Hou
Favorite
Howlader, Md Sariful Islam

Texas Tech University Health Science Center
(W0930-04-20) Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Md Sariful Islam Howlader
Favorite
Ho, Yenyi

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Yenyi Ho
Favorite
Ho, Yunn-Fang

National Taiwan University
(T1430-02-08) Ontogeny of Drug Metabolizing Enzymes and Its Impact on Valproic Acid Hepatotoxicity: Insights from In Vitro and PBPK Modeling Studies
Yunn-Fang Ho
Favorite
Ho, Ziyu

Virginia Polytechnic Institute and State University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Ziyu Ho
Favorite
Hsuan Su, Tien

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Tien Hsuan Su
Favorite
Huang, Chunghui

Auburn University
(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer
Chunghui Huang
Favorite
Huang, Cong

ICE Bioscience
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Cong Huang
Favorite
Huang, Haibin

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Haibin Huang
Favorite
Huang, Hui Yu

Meiji Biopharmaceutical Corporation (Guangzhou) Limited
(M1030-09-50) Rediscovery of Paclitaxel: A Novel Oral Paclitaxel Softgel Capsule Product for Improving Cancer Therapeutics
Hui Yu Huang
Favorite
Huang, Jiayi

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Jiayi Huang
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Jiayi Huang
Favorite
Huang, Jing

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Jing Huang
Favorite
Huang, Pin-Syuan

University of Minnesota
(M1130-11-64) Decreased Crystal Plasticity by Solvation-The Case of Levofloxacin Acesulfame
Pin-Syuan Huang
Favorite
Huang, Qiao

Chinese University of Hong Kong, The
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Qiao Huang
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Qiao Huang
Favorite
Huang, Richard jun

Meiji Biopharmaceutical Corporation(Guangzhou) Limited
(M1030-09-50) Rediscovery of Paclitaxel: A Novel Oral Paclitaxel Softgel Capsule Product for Improving Cancer Therapeutics
Richard jun Huang
Favorite
Huang, Ruea-Yea

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Ruea-Yea Huang
Favorite
Huang, Yang

Yurogen Biosystems (an ABclonal Company)
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Yang Huang
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Yang Huang
Favorite
Huang, Yicheng

University of Queensland
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Yicheng Huang
Favorite
Huang, Yongzhuo

Chinese Academy of Sciences
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Yongzhuo Huang
Favorite
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Yongzhuo Huang
Favorite
Huang, Yu

City University of Hong Kong
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Yu Huang
Favorite
Huang, Yu-Ting

National Taiwan University
(T1430-02-08) Ontogeny of Drug Metabolizing Enzymes and Its Impact on Valproic Acid Hepatotoxicity: Insights from In Vitro and PBPK Modeling Studies
Yu-Ting Huang
Favorite
Hubbard, Oliver

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Oliver Hubbard
Favorite
Hu, Bohan

InnoGI Technologies
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
Bohan Hu
Favorite
Hu, Dan

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Dan Hu
Favorite
Hu, Jiun-Wen

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Jiun-Wen Hu
Favorite
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Jiun-Wen Hu
Favorite
Hu-Lieskovan, Siwen

University of Utah
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Siwen Hu-Lieskovan
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Siwen Hu-Lieskovan
Favorite
Huls, Nicholas

Purdue University
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Nicholas Huls
Favorite
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Nicholas Huls
Favorite
Humes, Matt

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Matt Humes
Favorite
Hu, Ming

University of Houston
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Ming Hu
Favorite
Hu, Mingxin

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Mingxin Hu
Favorite
Humphrey, James

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
James Humphrey
Favorite
Huncosky, Emily

PPD Laboratories
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Emily Huncosky
Favorite
Hunt, Hazel

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Hazel Hunt
Favorite
Huo, Jiaheng

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Jiaheng Huo
Favorite
Hurley, Casey

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Casey Hurley
Favorite
Hu, Yang

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Yang Hu
Favorite
Hu, Yanjun

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Yanjun Hu
Favorite
Hwa, Joyce

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Joyce Hwa
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Joyce Hwa
Favorite
Hwang, Jee-Yeon

Creighton University
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Jee-Yeon Hwang
Favorite
Hwang, Sung Joo

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Sung Joo Hwang
Favorite
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
Sung Joo Hwang
Favorite
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Sung Joo Hwang
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Sung Joo Hwang
Favorite
Hyun, Sangmin

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Sangmin Hyun
Favorite
I
Iacoban, Paulina

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Paulina Iacoban
Favorite
Ibrahim, Ahmed

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Ahmed Ibrahim
Favorite
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Ahmed Ibrahim
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Ahmed Ibrahim
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Ahmed Ibrahim
Favorite
(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?
Ahmed Ibrahim
Favorite
Idoudi, Sourour

Qatar University
(M1330-01-01) The Anti-Colon Cancer Potential of Succinylated Curcumin Encapsulated in Mannosylated Chitosan
Sourour Idoudi
Favorite
Ignjatovic, Jelisaveta

Boehringer-Ingelheim
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
Jelisaveta Ignjatovic
Favorite
Iida, Yoritsugu

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Yoritsugu Iida
Favorite
Ikeda, Ryuji

University of Miyazaki Hospital
(M1130-04-22) DEC2 Enhancement of Gemcitabine and Oxaliplatin Sensitivity of Pancreatic Cancer Cells through Suppression of IGFBP4
Ryuji Ikeda
Favorite
Ikeuchi-Takahashi, Yuri

Hoshi University
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Yuri Ikeuchi-Takahashi
Favorite
Illamola, Sílvia

University of Minnesota
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Sílvia Illamola
Favorite
Imaeda, Kodai

Shimadzu Scientific Instruments, Inc.
(T1530-06-34) Ion-pairing Agent-Free SFC Separation of Polypeptides Using Automated Method Development Tools
Kodai Imaeda
Favorite
Imhoff, Daniel

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Daniel Imhoff
Favorite
Immanuel, Susan

Texas A&M University
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Susan Immanuel
Favorite
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Susan Immanuel
Favorite
Indulkar, Anura

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Anura Indulkar
Favorite
Ingkaninan, Kornkanok

Naresuan University
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Kornkanok Ingkaninan
Favorite
Injety, Harold

Roquette America Inc.
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Harold Injety
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Harold Injety
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Harold Injety
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Harold Injety
Favorite
Iqubal, Mohammad Kashif

Texas A&M Health Science Center
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Mohammad Kashif Iqubal
Favorite
Ishida, Kazuya

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Kazuya Ishida
Favorite
Ishiwata, Yasuyoshi

Tokyo Medical and Dental University
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Yasuyoshi Ishiwata
Favorite
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Yasuyoshi Ishiwata
Favorite
Ishizuka, Yuya

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Yuya Ishizuka
Favorite
Islam, Farhana

University of Nebraska Medical Center
(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)
Farhana Islam
Favorite
(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
Farhana Islam
Favorite
Islam, Tamanna

University of Utah
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
Tamanna Islam
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Tamanna Islam
Favorite
Ismailos, George

ELPEN Pharmaceuticals
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
George Ismailos
Favorite
Ito, Takaaki

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Takaaki Ito
Favorite
J
Jaber, Rima

Evonik Operations GmbH
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
Rima Jaber
Favorite
Jadhav, Ajinkya

Sun Pharmaceutical Industries Limited
(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment
Ajinkya Jadhav
Favorite
Jadhav, Gopal

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Gopal Jadhav
Favorite
Jadhav, Sanika

University of Iowa
(M1130-09-51) Engineered Cocrystals to Improve Solution Behavior of Poorly Soluble NAR
Sanika Jadhav
Favorite
Jadhav, Sejal

Texas Tech University Health Sciences Center
(M0930-04-21) Evaluation of the Blood-Brain Barrier Protective Effects of Metformin after Mixed Exposures to Cigarette Smoke, e-Cigarette Vapor, and Stroke Conditions
Sejal Jadhav
Favorite
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Sejal Jadhav
Favorite
Jadvar, Hossein

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Hossein Jadvar
Favorite
Jafari, Paris

University of Utah
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Paris Jafari
Favorite
Jain, Anshu

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Anshu Jain
Favorite
Jain, Harsha

University of Iowa
(M1230-09-49) Microneedle-Based Co-Delivery System for Naproxen Sodium and Caffeine in Migraine Therapy
Harsha Jain
Favorite
Jain, Krutika

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Krutika Jain
Favorite
Jain, Nikita

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Nikita Jain
Favorite
Jain, Nishant

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Nishant Jain
Favorite
Jain, Sanyog

National Institute of Pharmaceutical Education and Research
(W1030-01-02) Harnessing the Potential of Self-Assembled Hyaluronic Acid Nanoparticles for Tumor Targeted Co-Delivery of Betulinic Acid and Paclitaxel
Sanyog Jain
Favorite
Jaiswal, Shivam

University of Mississippi
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Shivam Jaiswal
Favorite
Jakob, Andreas

Evonik Operations GmbH
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
Andreas Jakob
Favorite
Jakubik, Jocelyn

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Jocelyn Jakubik
Favorite
Jamei, Masoud

Certara UK Ltd.
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Masoud Jamei
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Masoud Jamei
Favorite
(W1130-02-12) Virtual Bioequivalence (VBE) Outcome May Depend on Choice of Dissolution Inputs in Physiologically Based Pharmacokinetic Modelling
Masoud Jamei
Favorite
James, Matt

Avantor Sciences
(M1330-06-31) Optimising the Extraction of Oligonucleotides by SPE
Matt James
Favorite
James, Roshan

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Roshan James
Favorite
Jamsandekar, Rhea

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Rhea Jamsandekar
Favorite
Janardhanam, Leela Sai Lokesh

University of Iowa
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Leela Sai Lokesh Janardhanam
Favorite
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Leela Sai Lokesh Janardhanam
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Leela Sai Lokesh Janardhanam
Favorite
Jang, Bong Seok

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Bong Seok Jang
Favorite
Jang, Seonmi

Hanyang university
(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation
Seonmi Jang
Favorite
Jani, Darshana

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Darshana Jani
Favorite
Janilkarn-Urena, Isis

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Isis Janilkarn-Urena
Favorite
Janke, Franz-Ferdinand

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Franz-Ferdinand Janke
Favorite
Jankovsky, Corinne

Boehringer Ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
Corinne Jankovsky
Favorite
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
Corinne Jankovsky
Favorite
Jannin, Vincent

Lonza
(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C
Vincent Jannin
Favorite
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Vincent Jannin
Favorite
Janssen Blankenship, Mandy (Maria)

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Mandy (Maria) Janssen Blankenship
Favorite
Jaquier, Andre

University of Applied Sciences and Arts Northwestern Switzerland
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Andre Jaquier
Favorite
Jara, Miguel

University of Texas at Austin
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Miguel Jara
Favorite
Jarrahian, Courtney

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Courtney Jarrahian
Favorite
Jasti, Bhaskara

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Bhaskara Jasti
Favorite
Java, Antoniette

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Antoniette Java
Favorite
JAWA, VIBHA

Bristol-Myers Squibb Company
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
VIBHA JAWA
Favorite
Jayaraj, Savithra

US Food and Drug Administration
(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin
Savithra Jayaraj
Favorite
Jayaraman, Nitin

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Nitin Jayaraman
Favorite
Jennotte, Olivier

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Olivier Jennotte
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Olivier Jennotte
Favorite
Jeong, Haewon

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Haewon Jeong
Favorite
Jeong, Jin-Hyuk

Chungbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Jin-Hyuk Jeong
Favorite
Jeon, Hyewon

Chung-Ang University
(M1130-01-05) Novel Cell-Penetrating Peptide-Based Therapy for Treating Atopic Dermatitis
Hyewon Jeon
Favorite
Jeon, Taewon

Massachusetts Institute of Technology
(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
Taewon Jeon
Favorite
Jeremic, Jelena

Nostpharma
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Jelena Jeremic
Favorite
Jewell, Christopher

University of Maryland
(M1230-10-54) 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance
Christopher Jewell
Favorite
Jiang, Jun

Lawrence Livermore National Laboratory
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Jun Jiang
Favorite
Jiang, Qian

Peking University People's Hospital
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Qian Jiang
Favorite
Jiang, Wenlei

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Wenlei Jiang
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Wenlei Jiang
Favorite
(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin
Wenlei Jiang
Favorite
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Wenlei Jiang
Favorite
(W0930-11-61) Quantitative and Qualitative Analysis of Lipids and Cholesterol Derivatives in SMOF Lipids 20% Intravenous Lipid Emulsion
Wenlei Jiang
Favorite
Jiang, Xiaojian

US Food and Drug Administration
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Xiaojian Jiang
Favorite
Jiang, Ying

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Ying Jiang
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Ying Jiang
Favorite
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Ying Jiang
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Ying Jiang
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Ying Jiang
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Ying Jiang
Favorite
Jiao, Xinyu

University College London
(W1230-04-21) Assessment of Various Lactobacillus Spp as Potential Candidate for Treatment of Bacterial Vaginosis
Xinyu Jiao
Favorite
Jihoon, Lee

Kyungpook National University
(T1230-09-49) Complex of Paclitaxel Mesoporous Silica Nanoparticles with Curcumin, TPGS Exerts Higher Anticancer Potency in B16F10 Melanoma
Lee Jihoon
Favorite
Ji, Ming

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Ming Ji
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Ming Ji
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Ming Ji
Favorite
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Ming Ji
Favorite
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Ming Ji
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Ming Ji
Favorite
(T1430-02-11) Alcohol Dose Dumping in Modified Release Formulations: Critical Considerations for Regulatory Guidance(s)
Ming Ji
Favorite
(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation
Ming Ji
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Ming Ji
Favorite
Jing, Xuefang

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Xuefang Jing
Favorite
Jin, Sung Giu

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Sung Giu Jin
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Sung Giu Jin
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Sung Giu Jin
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Sung Giu Jin
Favorite
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sung Giu Jin
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sung Giu Jin
Favorite
Jin, Xiaoying

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Xiaoying Jin
Favorite
Joergensen, Jacob Rune

Bioneer A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Jacob Rune Joergensen
Favorite
Jogdeo, Chinmay M.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Chinmay M. Jogdeo
Favorite
John, Rijo

Philadelphia College of Pharmacy
(M1430-04-20) Coarse-Grained Molecular Dynamics Simulations Evaluating Formation and Structural Stability of Nystatin-Loaded DOPC and DPPC Vesicles
Rijo John
Favorite
(M1530-06-34) Molecular Dynamics Study Using Coarse-Grained Simulation with Martini Force Field for Structural Stability and Formation of Docetaxel Loaded DOPC and DPPC Lipid Vesicle
Rijo John
Favorite
Johnson, Chad

University of Maryland Baltimore
(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?
Chad Johnson
Favorite
Johnson, Coleman

University of Texas at Austin
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Coleman Johnson
Favorite
(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant
Coleman Johnson
Favorite
Johnson, Colleen

CDJ Tox, LLC
(M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Colleen Johnson
Favorite
(M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Colleen Johnson
Favorite
Johnston, Laura

GlaxoSmithKline plc
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Laura Johnston
Favorite
Jolly, Kevon

University of Florida
(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Kevon Jolly
Favorite
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Kevon Jolly
Favorite
Joly, Anne-Christine

AP-HP
(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C
Anne-Christine Joly
Favorite
Jonassen, Brooklynn

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Brooklynn Jonassen
Favorite
Jones, Marie-Christine

University of Birmingham
(T1130-01-01) Active Targeting to the Hepatocytes: How Important is Tailoring the Liposomes and Physicochemical Properties and Surface Modification in Targeting the Hepatocytes?
Marie-Christine Jones
Favorite
Jones, Morgan

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Morgan Jones
Favorite
Jonnalagadda, Sriramakamal

Philadelphia College of Pharmacy
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Sriramakamal Jonnalagadda
Favorite
(M1430-04-20) Coarse-Grained Molecular Dynamics Simulations Evaluating Formation and Structural Stability of Nystatin-Loaded DOPC and DPPC Vesicles
Sriramakamal Jonnalagadda
Favorite
(M1530-06-34) Molecular Dynamics Study Using Coarse-Grained Simulation with Martini Force Field for Structural Stability and Formation of Docetaxel Loaded DOPC and DPPC Lipid Vesicle
Sriramakamal Jonnalagadda
Favorite
Jony, Md. Jobair Hossen

Creighton University
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Md. Jobair Hossen Jony
Favorite
Joo, Sung Hyun

Purdue University
(T1530-06-36) DoE-Based Optimization of RNA Nanosac Lyophilization for Cold-Chain-Free Storage and Transportation
Sung Hyun Joo
Favorite
Jorgensen, Anna Kirstine

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Anna Kirstine Jorgensen
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Anna Kirstine Jorgensen
Favorite
Joshi, Ameya

Creighton University
(M1230-06-33) Evaluation of Anti-Proliferative Effect of Vorinostat (a pan-HDAC Inhibitor) on Glioblastoma Multiforme Using 3-D Cell Culture Model of T98G
Ameya Joshi
Favorite
Joshi, Ashish

BASF Corporation
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Ashish Joshi
Favorite
Joshi, Medha

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Medha Joshi
Favorite
Joshi, Neelambari

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Neelambari Joshi
Favorite
Joshi, Poorva

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Poorva Joshi
Favorite
Joshi, Vikram Chandrasekhar

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Vikram Chandrasekhar Joshi
Favorite
(W0930-01-01) Are Amorphous Drugs More Compressible Than Their Crystalline Counterparts?
Vikram Chandrasekhar Joshi
Favorite
Joshi, Vivek

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Vivek Joshi
Favorite
Jozefiak, Thomas

Glyscend Therapeutics
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Thomas Jozefiak
Favorite
Juang, Vivian

University of Michigan
(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes
Vivian Juang
Favorite
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
Vivian Juang
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Vivian Juang
Favorite
Judson-Torres, Robert

University of Utah
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Robert Judson-Torres
Favorite
Juluri, Abhishek

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Abhishek Juluri
Favorite
Jump, Geneva

Dow Development Laboratories, LLC
(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations
Geneva Jump
Favorite
(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents
Geneva Jump
Favorite
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Geneva Jump
Favorite
Junaid, Mohammad Shajid Ashraf

Mercer University
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Mohammad Shajid Ashraf Junaid
Favorite
Jung, David

Evonik Canada, Inc.
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
David Jung
Favorite
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
David Jung
Favorite
Ju, Tian

University College London
(W1030-07-41) Phage-Antibiotic Loaded Coaxial Electrospun Fibres for Antibiotic Resistant Wound Infections
Tian Ju
Favorite
(W1030-07-41) Phage-Antibiotic Loaded Coaxial Electrospun Fibres for Antibiotic Resistant Wound Infections
Tian Ju
Favorite
K
Kümmel, Anne

IntiQuan AG
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Anne Kümmel
Favorite
Kabir, Abbas

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Abbas Kabir
Favorite
Kaczynski, Edward J.

AbbVie Inc.
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Edward J. Kaczynski
Favorite
Kadajji, Veeran

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Veeran Kadajji
Favorite
Kadam, Ankur

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Ankur Kadam
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Ankur Kadam
Favorite
Kadota, Kazunori

Wakayama Medical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Kazunori Kadota
Favorite
Kaffash, Ehsan

Virginia Commonwealth University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Ehsan Kaffash
Favorite
Kafle, Prapti

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Prapti Kafle
Favorite
Kalari, Krishna

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Krishna Kalari
Favorite
Kale, Parv

Waterford School
(M0930-10-55) Protective Effects of Angiotensin Receptor Blockers on Knee Joint Cartilage Volume: A Retrospective Analysis of Osteoarthritis Initiative Study
Parv Kale
Favorite
Kale, Vijay

Roseman University of Health Sciences
(M0930-10-55) Protective Effects of Angiotensin Receptor Blockers on Knee Joint Cartilage Volume: A Retrospective Analysis of Osteoarthritis Initiative Study
Vijay Kale
Favorite
Kalla, Chamundeswara Srinivasa Akash

University of Mississippi
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Chamundeswara Srinivasa Akash Kalla
Favorite
Kalra, Arjun

Fairleigh Dickinson University
(M1230-05-25) A Molecular Dynamics Study of the Impact of Water Content on Pre-nucleation Aggregates in Amorphous 2-Phenylamino Nicotinic Acid
Arjun Kalra
Favorite
Kalra, Priyata

Simulations Plus, Inc.
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Priyata Kalra
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Priyata Kalra
Favorite
Kamala, Poornima

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Poornima Kamala
Favorite
Kamal, Nahid

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Nahid Kamal
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Nahid Kamal
Favorite
Kamath, Amrita

Genentech, Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Amrita Kamath
Favorite
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Amrita Kamath
Favorite
Kamath, Satish

Bayer USA
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Satish Kamath
Favorite
Kamble, Shyam

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Shyam Kamble
Favorite
Kamel, Eman

University of Iowa
(W1130-11-61) Forced Degradation of Cell-Based Therapeutic Products Using Various Stresses and Use of Flow Imaging Microscopy for Identification of Damaged Cells and Cell Debris
Eman Kamel
Favorite
Kanabar, Pinal

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Pinal Kanabar
Favorite
Kanagala, Vijaya Sri

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Vijaya Sri Kanagala
Favorite
Kancharla, Vijayalakshmi

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Vijayalakshmi Kancharla
Favorite
Kandagatla, Hari Priya

St. John's University
(M1030-01-06) Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by Applying Acid-Base Supersolubilization (ABS) Principle
Hari Priya Kandagatla
Favorite
(M1330-05-28) Application of Acid-Base Supersolubilization Principle to Telmisartan, a Weakly Acidic, High Melting, and Low Solubility Drug, to Lower Hot Melt Extrusion Temperature and Increase Drug Dissolution
Hari Priya Kandagatla
Favorite
(M1430-05-28) Development of 3D Printed Tablets of Weakly Acidic Drug-Flurbiprofen by Acid-Base Super-Solubilization at Lower Extrusion Temperature and Improved Printability
Hari Priya Kandagatla
Favorite
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Hari Priya Kandagatla
Favorite
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Hari Priya Kandagatla
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Hari Priya Kandagatla
Favorite
Kandimalla, Karunya

University of Minnesota
(M1030-04-22) Amyloid Beta Peptides Inhibit Insulin Trafficking at the Blood-Brain-Barrier in Alzheimer's disease Brain
Karunya Kandimalla
Favorite
(M1430-07-37) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro BBB Model
Karunya Kandimalla
Favorite
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Karunya Kandimalla
Favorite
(T1530-06-35) Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling
Karunya Kandimalla
Favorite
(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium
Karunya Kandimalla
Favorite
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Karunya Kandimalla
Favorite
Kanehl, Melina

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Melina Kanehl
Favorite
Kane, Maureen

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Maureen Kane
Favorite
Kane, Zoe

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Zoe Kane
Favorite
Kanfer, Isadore

University of Toronto
(T1230-02-10) Revisiting Potency Classification of Topical Corticosteroids Using a Standardized Approach Involving Vasoconstrictor Assay (VCA)
Isadore Kanfer
Favorite
Kang, Il-Mo

Korea Institue of Geoscience and Mineral Resources
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Il-Mo Kang
Favorite
Kang, Ji-Hyun

Jeonbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Ji-Hyun Kang
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Ji-Hyun Kang
Favorite
Kang, Minseo

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Minseo Kang
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Minseo Kang
Favorite
Kang, Sangoh

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sangoh Kang
Favorite
Kang, Xuejia

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Xuejia Kang
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Xuejia Kang
Favorite
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Xuejia Kang
Favorite
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Xuejia Kang
Favorite
(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform
Xuejia Kang
Favorite
Kanna, Umakanth

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Umakanth Kanna
Favorite
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Umakanth Kanna
Favorite
(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets
Umakanth Kanna
Favorite
Kannheiser, Kristina

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Kristina Kannheiser
Favorite
Kanumuri, Siva Rama Raju

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Siva Rama Raju Kanumuri
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Siva Rama Raju Kanumuri
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Siva Rama Raju Kanumuri
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Siva Rama Raju Kanumuri
Favorite
Kanwal, Shahla

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Shahla Kanwal
Favorite
Kapadia, Chhanda

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Chhanda Kapadia
Favorite
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Chhanda Kapadia
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Chhanda Kapadia
Favorite
Kapre, Sumedha

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Sumedha Kapre
Favorite
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Sumedha Kapre
Favorite
Karagianni, Spyridoula

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Spyridoula Karagianni
Favorite
Karamyan, Vardan

Oakland University
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Vardan Karamyan
Favorite
Karan, Kapish

Ashland Specialty Ingredients
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Kapish Karan
Favorite
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Kapish Karan
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Kapish Karan
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Kapish Karan
Favorite
Karim, Mazharul

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Mazharul Karim
Favorite
Karkossa, Frank

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Frank Karkossa
Favorite
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Frank Karkossa
Favorite
Karnik, Indrajeet

University of Mississippi
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Indrajeet Karnik
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Indrajeet Karnik
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Indrajeet Karnik
Favorite
Karnik, Shane

Aliri USA, Inc.
(M1130-06-33) A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol
Shane Karnik
Favorite
(M1430-06-34) Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma
Shane Karnik
Favorite
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Shane Karnik
Favorite
Karry, Krizia

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Krizia Karry
Favorite
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Krizia Karry
Favorite
Karunanithi, Sheela

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Sheela Karunanithi
Favorite
Karve, Aniruddha

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
Aniruddha Karve
Favorite
Karve, Tanvi

Mercer University
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Tanvi Karve
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Tanvi Karve
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Tanvi Karve
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Tanvi Karve
Favorite
Kashyap, Purna

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Purna Kashyap
Favorite
Kassel, Lynn

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Lynn Kassel
Favorite
Kassim, Brittany

Merck & Co., Inc.
(T1130-10-54) Developing Robust Control Strategies for an Unexpected Fluorination Process Investigation
Brittany Kassim
Favorite
Kastantin, Mark

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Mark Kastantin
Favorite
Kastellorizios, Michail

University of North Texas Health Science Center
(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle
Michail Kastellorizios
Favorite
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Michail Kastellorizios
Favorite
Kathawala, Mufaddal H

St. John's University
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Mufaddal H Kathawala
Favorite
Kathawala, Mufaddal H.

St. John's University
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Mufaddal H. Kathawala
Favorite
Kathiria, Lalji

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Lalji Kathiria
Favorite
Katragadda, Usha

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Usha Katragadda
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Usha Katragadda
Favorite
Katsikis, Dimitris

National and Kapodistrian University of Athens
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Dimitris Katsikis
Favorite
Katsumata, Toru

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Toru Katsumata
Favorite
Katz, Jonathan

National Institute on Drug Abuse
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Jonathan Katz
Favorite
Kaur, Manjinder

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Manjinder Kaur
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Manjinder Kaur
Favorite
Kaushal, Gagan

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Gagan Kaushal
Favorite
Kawakami, Kohsaku

National Institute for Materials Science
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Kohsaku Kawakami
Favorite
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Kohsaku Kawakami
Favorite
Kawakita, Ryan

Gilead Sciences, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Ryan Kawakita
Favorite
Kawamoto, Ariumi

Tomita Pharmacaeutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Ariumi Kawamoto
Favorite
Kazi, Mohsin

King Saud University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mohsin Kazi
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Mohsin Kazi
Favorite
Keeton, Adam

Auburn University
(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer
Adam Keeton
Favorite
Keir, Raya

St. John's University
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Raya Keir
Favorite
Kelchen, Megan

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Megan Kelchen
Favorite
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Megan Kelchen
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Megan Kelchen
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Megan Kelchen
Favorite
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Megan Kelchen
Favorite
Kell, Sariah

23andMe Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Sariah Kell
Favorite
Kells, Siobhan

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Siobhan Kells
Favorite
Kelwadkar, Ruchita

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Ruchita Kelwadkar
Favorite
Kemper, Benedict

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Benedict Kemper
Favorite
Kenchappa, Ramesh

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Ramesh Kenchappa
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Ramesh Kenchappa
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Ramesh Kenchappa
Favorite
Kendell, Isaac

University of Utah
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
Isaac Kendell
Favorite
KenKnight, Hattie

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Hattie KenKnight
Favorite
Kent, Thomas

Texas A&M University
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Thomas Kent
Favorite
Kenz, Zackary

Simulations Plus, Inc.
(W0930-10-57) Orforglipron Weight Loss and Nausea Accurately Simulated with OBESITYsym
Zackary Kenz
Favorite
Kerdsiri, Jeerakit

Naresuan University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Jeerakit Kerdsiri
Favorite
Kerry, Michael

International Flavors and Frangrances
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Michael Kerry
Favorite
Kesisoglou, Filippos

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Filippos Kesisoglou
Favorite
Keyhani, Anahita

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Anahita Keyhani
Favorite
Keys, Adelle

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Adelle Keys
Favorite
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Adelle Keys
Favorite
Khairnar, Sakshi

University of Nebraska Medical Center
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
Sakshi Khairnar
Favorite
Khajeh Pour, Sana

AbbVie Inc.
(M1030-02-07) Review of First-in-Human Trials for Gene Therapy in Ocular Diseases
Sana Khajeh Pour
Favorite
Khalil, Elie

University of Illinois Chicago
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Elie Khalil
Favorite
Khan, Aashna

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Aashna Khan
Favorite
Khanfar, Rami

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Rami Khanfar
Favorite
Khan, Jasim

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Jasim Khan
Favorite
Khan, Mansoor

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Mansoor Khan
Favorite
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Mansoor Khan
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Mansoor Khan
Favorite
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Mansoor Khan
Favorite
Khanna, Pooja

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Pooja Khanna
Favorite
Khare, Purva

Duquesne University
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Purva Khare
Favorite
Khatun, Rahima

Duquesne University
(M1530-07-39) Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions
Rahima Khatun
Favorite
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Rahima Khatun
Favorite
Khondoker, Alam

US Food and Drug Administration
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Alam Khondoker
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Alam Khondoker
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Alam Khondoker
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Alam Khondoker
Favorite
Khurana, Nitish

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Nitish Khurana
Favorite
(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer
Nitish Khurana
Favorite
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Nitish Khurana
Favorite
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Nitish Khurana
Favorite
Khuroo, Tahir Gani

Texas A&M University
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Tahir Gani Khuroo
Favorite
Kiang, San

Porton, J-Star
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
San Kiang
Favorite
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
San Kiang
Favorite
Kidd-Cartwright, Danica

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Danica Kidd-Cartwright
Favorite
Kihara, Tsubasa

University of Shizuoka
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Tsubasa Kihara
Favorite
Kimball, Joseph

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Joseph Kimball
Favorite
Kim, Bo Mi

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Bo Mi Kim
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Bo Mi Kim
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Bo Mi Kim
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Bo Mi Kim
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Bo Mi Kim
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Bo Mi Kim
Favorite
kim, Chae-Jeong

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Chae-Jeong kim
Favorite
Kim, Dong-Seon

Korea Institute of Oriental Medicine
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Dong-Seon Kim
Favorite
Kim, DongWon

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
DongWon Kim
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
DongWon Kim
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
DongWon Kim
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
DongWon Kim
Favorite
Kim, Dong-Wook

Wonkwang University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Dong-Wook Kim
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Dong-Wook Kim
Favorite
Kim, Gwanyoung

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Gwanyoung Kim
Favorite
Kim, Haesun

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Haesun Kim
Favorite
Kim, Haley

Auburn University
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Haley Kim
Favorite
Kim, Haneul

Yonsei University
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
Haneul Kim
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Haneul Kim
Favorite
Kim, Hee Eun

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Hee Eun Kim
Favorite
Kim, Hee Joo

23andMe Inc.
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Hee Joo Kim
Favorite
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Hee Joo Kim
Favorite
Kim, Heeseo

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Heeseo Kim
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Heeseo Kim
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Heeseo Kim
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Heeseo Kim
Favorite
Kim, Hye Soo

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Hye Soo Kim
Favorite
Kim, Hyeonjeong

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Hyeonjeong Kim
Favorite
Kim, Hyunjung

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Hyunjung Kim
Favorite
Kim, Jaehwan

Korea Institute of Geoscience and Mineral Resources
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jaehwan Kim
Favorite
Kim, Jinho

Daewoong Pharmaceutical, Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Jinho Kim
Favorite
Kim, Jiwon

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jiwon Kim
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jiwon Kim
Favorite
Kim, Joonhee

Sungkyunkwan University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Joonhee Kim
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Joonhee Kim
Favorite
Kim, Juhyun

US Food and Drug Administration
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
Juhyun Kim
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Juhyun Kim
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Juhyun Kim
Favorite
Kim, Jung Suk

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Jung Suk Kim
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Jung Suk Kim
Favorite
Kim, Junghyun

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Junghyun Kim
Favorite
Kim, Junsik

Daewoong Pharmaceutical Co., Ltd.
(W0930-10-54) Comparative In Vitro Release and Clinical Pharmacokinetics of Leuprorelin Depot 3.75mg, a One-Month Sustained-Release Formulation of Leuprorelin Acetate
Junsik Kim
Favorite
Kim, Keon

Sungkyunkwan University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Keon Kim
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Keon Kim
Favorite
Kim, Keon-woong

Chungbuk National University
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Keon-woong Kim
Favorite
Kim, Kilyoung

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Kilyoung Kim
Favorite
Kimmerling, KIrk

Fitebac
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
KIrk Kimmerling
Favorite
Kim, MinYoung

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
MinYoung Kim
Favorite
Kim, Myong-Jin

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Myong-Jin Kim
Favorite
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Myong-Jin Kim
Favorite
Kim, Na Yun

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Na Yun Kim
Favorite
Kim, Nam Hyuck

Samyang Holdings Corporation
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Nam Hyuck Kim
Favorite
Kim, Sewon

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Sewon Kim
Favorite
Kim, Soohyun

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Soohyun Kim
Favorite
Kim, Sung Rae

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sung Rae Kim
Favorite
Kim, Taehyung

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
Taehyung Kim
Favorite
Kimura, Takayuki

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Takayuki Kimura
Favorite
Kim, Ye Ji

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Ye Ji Kim
Favorite
Kim, Yulia

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Yulia Kim
Favorite
Kim, Yurah

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Yurah Kim
Favorite
Kinjo, Minori

US Food and Drug Administration
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Minori Kinjo
Favorite
Kipping, Thomas

Merck KGaA
(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease
Thomas Kipping
Favorite
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Thomas Kipping
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Thomas Kipping
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Thomas Kipping
Favorite
(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect
Thomas Kipping
Favorite
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Thomas Kipping
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Thomas Kipping
Favorite
Klein, Sandra

University of Greifswald
(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs
Sandra Klein
Favorite
(T1230-05-25) How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles
Sandra Klein
Favorite
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Sandra Klein
Favorite
(W1030-05-30) One Like the Other? A Novel In Vitro Release Method to Ensure Proper Drug Release of Extended-Release Mini-Tablets for Paediatric Use
Sandra Klein
Favorite
Klimsa, Vojtech

University of Chemistry and Technology
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Vojtech Klimsa
Favorite
Klinken, Stefan

Heinrich Heine University Duesseldorf
(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Stefan Klinken
Favorite
(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Stefan Klinken
Favorite
Knappenburger, Terri

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Terri Knappenburger
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Terri Knappenburger
Favorite
Knarr, Matthias

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Matthias Knarr
Favorite
Knievel, Ryan

Thermo Fisher Scientific
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Ryan Knievel
Favorite
K, Niharika

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Niharika K
Favorite
Knopp, Matthias

Bioneer A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Matthias Knopp
Favorite
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Matthias Knopp
Favorite
Kobayashi, Hideo

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Hideo Kobayashi
Favorite
Kobyra, Julie

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Julie Kobyra
Favorite
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Julie Kobyra
Favorite
Koch, Nathan

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Nathan Koch
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Nathan Koch
Favorite
Kodange, Niyati

University of Texas at Austin
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Niyati Kodange
Favorite
Kogan, Michael

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Michael Kogan
Favorite
Kohn, Bozena Michniak

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Bozena Michniak Kohn
Favorite
(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch
Bozena Michniak Kohn
Favorite
Kohnhorst, Casey

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
Casey Kohnhorst
Favorite
Koka, Saisudha

Texas A&M University
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Saisudha Koka
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Saisudha Koka
Favorite
Kolar, Jiři

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Jiři Kolar
Favorite
Koleilat, Line

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Line Koleilat
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Line Koleilat
Favorite
Koleti, Varun

Contract Pharmaceuticals Limited
(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management
Varun Koleti
Favorite
Kolhe, Parag

Pfizer Inc.
(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach
Parag Kolhe
Favorite
Kolipauka, Ajay Reddy

University of Mississippi
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Ajay Reddy Kolipauka
Favorite
Kollala, Sai Sundeep

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Sai Sundeep Kollala
Favorite
Kombian, Samuel

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Samuel Kombian
Favorite
Komiyama, Natsuko

Chugai Research Institute for Medical Science Inc.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Natsuko Komiyama
Favorite
Kommineni, Nagavendra

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Nagavendra Kommineni
Favorite
Kompella, Uday B.

University of Colorado Denver
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Uday B. Kompella
Favorite
Konagurthu, Sanjay

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Sanjay Konagurthu
Favorite
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Sanjay Konagurthu
Favorite
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Sanjay Konagurthu
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Sanjay Konagurthu
Favorite
Kondappan, Arasu

Thermo Fisher Scientific
(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments
Arasu Kondappan
Favorite
Konfortova, Galia

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Galia Konfortova
Favorite
Kong, Sarah

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Sarah Kong
Favorite
Konishi, Koh

Tomita Pharmaceutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Koh Konishi
Favorite
Kono, Marina

Hoshi University
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Marina Kono
Favorite
Kontoudios, Niko

Seattle Children's Research Institute
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Niko Kontoudios
Favorite
Kopajtic, Theresa

National Institute on Drug Abuse
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Theresa Kopajtic
Favorite
Kopecek, Jindrich

University of Utah
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Jindrich Kopecek
Favorite
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
Jindrich Kopecek
Favorite
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Jindrich Kopecek
Favorite
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Jindrich Kopecek
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Jindrich Kopecek
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Jindrich Kopecek
Favorite
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jindrich Kopecek
Favorite
Korang-Yeboah, Maxwell

US Food and Drug Administration
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Maxwell Korang-Yeboah
Favorite
Kordorwu, Victus

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Victus Kordorwu
Favorite
Kossor, Christopher

New Jersey Institute of Technology
(M1430-11-65) Particle Engineering Approach to Formulating Hot Melt Extrusion Amorphous Solid Dispersion Tablets
Christopher Kossor
Favorite
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Christopher Kossor
Favorite
Kostaridis, Alexandros

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Alexandros Kostaridis
Favorite
Kosuri, Shashank

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Shashank Kosuri
Favorite
Kota, Sri Sai Nikitha

Creighton University
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Sri Sai Nikitha Kota
Favorite
Kothandapani, Anbarasi

PPD Laboratories
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Anbarasi Kothandapani
Favorite
Kothapalli, Sri-Rajasekhar

Pennsylvania State University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Sri-Rajasekhar Kothapalli
Favorite
Kothari, Khyati

Merck & Co., Inc.
(W0930-10-59) Matrix Comparability Assessment between 3.2% Sodium Citrate and 3.8% Sodium Citrate Human Plasma in PK and ADA Assays
Khyati Kothari
Favorite
Kousba, Ahmed

Bioagilytix San Diego
(M0930-02-11) Toxicokinetics of 23ME-01473, a Novel Anti-ULBP6/2/5 Monoclonal Antibody, in Cynomolgus Monkeys Following Intravenous Bolus Injections in a 4-Week Toxicity Study
Ahmed Kousba
Favorite
(M1130-02-11) Toxicokinetics of cNP8, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Ahmed Kousba
Favorite
(M1330-02-11) Toxicokinetics of cP12, a Fibronectin-Derived Peptides, in Rats and Dogs Following a Single Intravenous Injection in an Expanded Acute Toxicity Study
Ahmed Kousba
Favorite
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Ahmed Kousba
Favorite
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Ahmed Kousba
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Ahmed Kousba
Favorite
Kovacs, Erika

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Erika Kovacs
Favorite
Krüse, Jacob
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Jacob Krüse
Favorite
Kraft, Walter

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Walter Kraft
Favorite
Kramer, William

Kramer Consulting, LLC
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
William Kramer
Favorite
Krull, Brett

Arrowhead Pharmaceuticals, Inc.
(M1030-06-35) Development and Optimization of a Highly Sensitive and Selective Anion Exchange Liquid Chromatography with Fluorescence Detection Assay for Quantitation of siRNA Oligonucleotide Therapeutic Compounds
Brett Krull
Favorite
Krull, Scott

US Food and Drug Administration
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Scott Krull
Favorite
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Scott Krull
Favorite
Kshirsagar, Sharvari

Mercer University
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Sharvari Kshirsagar
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Sharvari Kshirsagar
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Sharvari Kshirsagar
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Sharvari Kshirsagar
Favorite
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Sharvari Kshirsagar
Favorite
(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride
Sharvari Kshirsagar
Favorite
Kubal, Bhakti

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Bhakti Kubal
Favorite
Kubova, Hana

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Hana Kubova
Favorite
Kudo, Takayuki

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Takayuki Kudo
Favorite
Kudova, Eva

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Eva Kudova
Favorite
Kuebler, Sigrid

Yokogawa Fluid Imaging Technologies
(T1330-11-60) Flow Imaging Microscopy for Monitoring Subvisible and Submicron Particles in Cell and Gene Therapies
Sigrid Kuebler
Favorite
Kuentz, Martin

University of Applied Sciences and Arts Northwestern Switzerland
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Martin Kuentz
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Martin Kuentz
Favorite
Kulkarni, Nishant

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Nishant Kulkarni
Favorite
Kulkarni, Pushkar

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Pushkar Kulkarni
Favorite
Kulkarni, Sameer

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Sameer Kulkarni
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Sameer Kulkarni
Favorite
Kumar, Balawant

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Balawant Kumar
Favorite
Kumari, Neha

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Neha Kumari
Favorite
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Neha Kumari
Favorite
Kumari, Shikha

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Shikha Kumari
Favorite
Kumar, Narender

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Narender Kumar
Favorite
Kumar, Ravi

University of Alabama
(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE
Ravi Kumar
Favorite
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Ravi Kumar
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Ravi Kumar
Favorite
(T1530-04-19) Lymphatic Targeting of Cyclosporine Improves Survival and Ameliorates Lupus-Like Autoimmune Disease in NZB/W Mice
Ravi Kumar
Favorite
Kummel, Andrew

University of California San Diego
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Andrew Kummel
Favorite
Kunamneni, Adinarayana

Mayo Clinic
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Adinarayana Kunamneni
Favorite
Kunda, Nitesh

St. John's University
(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer
Nitesh Kunda
Favorite
Kunta, Jeevan

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Jeevan Kunta
Favorite
Kuntz, Michelle

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Michelle Kuntz
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Michelle Kuntz
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Michelle Kuntz
Favorite
Kuo, Hsiaohsuan

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Hsiaohsuan Kuo
Favorite
Kuo, Lawrence

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Lawrence Kuo
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Lawrence Kuo
Favorite
Kusakabe, Yuna

Tokyo Medical and Dental University
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Yuna Kusakabe
Favorite
Kutsche, Spencer

Alcami Corporation
(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software
Spencer Kutsche
Favorite
Kwarteng, Priscilla

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Priscilla Kwarteng
Favorite
kwon, ji-hyeon

Chungbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
ji-hyeon kwon
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
ji-hyeon kwon
Favorite
Kyomuhangi, Annet

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Annet Kyomuhangi
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Annet Kyomuhangi
Favorite
L
Löbmann, Korbinian

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Korbinian Löbmann
Favorite
LaBella, Gus

Mikart
(T1330-10-59) High Shear Wet Granulation Scale-Up Using Basic Principles
Gus LaBella
Favorite
Lachman, Marek

Biogrund GmbH
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Marek Lachman
Favorite
Lacin, Nursima

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Nursima Lacin
Favorite
Lackey, Alan

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Alan Lackey
Favorite
Lacombe, Justin

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Justin Lacombe
Favorite
Ladi, Rukmini

Butler University
(M1230-04-21) Self-Assembling β-cyclodextrin siRNA Nanoparticle Complex in Silencing Mutant Huntingtin Protein (mHtt)
Rukmini Ladi
Favorite
Lahaie, Mathieu

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Mathieu Lahaie
Favorite
Lai, Ju-Ping

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Ju-Ping Lai
Favorite
Laing, Catherine

Fortrea Clinical Research Unit Ltd
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Catherine Laing
Favorite
Lai, Weidong George

Alltrna, Inc.
(M1530-02-08) PK/PD Modeling for Liver Targeting LNP Formulated tRNA in Transgenic Mice Containing a Premature Termination Codon on the Human Methylmalonyl-CoA Mutase (hMMut)
Weidong George Lai
Favorite
Lai, Yuen Sze

Chinese University of Hong Kong, The
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Yuen Sze Lai
Favorite
Lai, Yurong

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Yurong Lai
Favorite
Lakatosh, Eric

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Eric Lakatosh
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Eric Lakatosh
Favorite
Lakkakula, Harini

Novi High School
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Harini Lakkakula
Favorite
Lakkala, Preethi

University of Mississippi
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Preethi Lakkala
Favorite
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Preethi Lakkala
Favorite
Lakshmi, Divya

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Divya Lakshmi
Favorite
Laliwala, Aayushi

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Aayushi Laliwala
Favorite
Lal, Manjari

PATH
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Manjari Lal
Favorite
Lamm, Matthew

Merck & Co., Inc.
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Matthew Lamm
Favorite
Lamprecht, Alf

University of Bonn
(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles
Alf Lamprecht
Favorite
(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin
Alf Lamprecht
Favorite
(W1030-11-63) Crystalline Craftsmanship: Controlling Surface Roughness of Spray-Freeze-Dried Particles
Alf Lamprecht
Favorite
(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder
Alf Lamprecht
Favorite
Lamptey, Richard

Palm Beach Atlantic University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Richard Lamptey
Favorite
Lam, Stephanie

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Stephanie Lam
Favorite
Landry, France

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
France Landry
Favorite
Lan, Jing

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Jing Lan
Favorite
Lao, Yeh-Hsing

University at Buffalo
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Yeh-Hsing Lao
Favorite
Laptieva, Oksana

Physiolution GmbH
(M1530-03-15) Biopredictive Dissolution of Budesonide Enteric Pellets under Simulated Fasted Intake Conditions
Oksana Laptieva
Favorite
Larmon, Ryan

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Ryan Larmon
Favorite
Larraneta, Eneko

Queen's University Belfast
(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants
Eneko Larraneta
Favorite
Lassman, Michael

Merck & Co., Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Michael Lassman
Favorite
Lautner, Gergely

University of Michigan
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Gergely Lautner
Favorite
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Gergely Lautner
Favorite
Lavasanifar, Afsaneh

University of Alberta
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Afsaneh Lavasanifar
Favorite
Lavertu, Marc

Polytechnique Montréal
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Marc Lavertu
Favorite
Lawal, Kamaru

Ashland Specialty Ingredients
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Kamaru Lawal
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Kamaru Lawal
Favorite
Lawal, Temitope

University of Ibadan
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Temitope Lawal
Favorite
Law, Devalina

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Devalina Law
Favorite
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Devalina Law
Favorite
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Devalina Law
Favorite
Laws, Amy

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Amy Laws
Favorite
Layek, Buddhadev

North Dakota State University
(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer
Buddhadev Layek
Favorite
(T1330-01-06) A Novel Liposome Delivering Adavosertib for Ovarian Cancer Treatment
Buddhadev Layek
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Buddhadev Layek
Favorite
Layton, Catharine E.

Waters Corporation
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Catharine E. Layton
Favorite
Lazarte, Jassy Mary

Florida A&M University
(M0930-04-19) Genetically Engineered PD-L1 Targeted Exosomes for Immunotherapy of Doxorubicin Resistant Triple Negative Breast Cancers
Jassy Mary Lazarte
Favorite
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Jassy Mary Lazarte
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Jassy Mary Lazarte
Favorite
Lazeration, Madison

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Madison Lazeration
Favorite
Le Merdy, Maxime

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Maxime Le Merdy
Favorite
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Maxime Le Merdy
Favorite
Lechanteur, Anna

University of Liege
(M0930-02-08) Evaluation of Amorphous and Lipid-Based Formulation Strategies to Increase Oral Cannabidiol Bioavailability
Anna Lechanteur
Favorite
(M1230-02-08) In Vitro – In Vivo Correlation Studies of Amorphous and Lipid-Based Oral Cannabidiol Formulations
Anna Lechanteur
Favorite
Lee, Beom-Jin

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Beom-Jin Lee
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Beom-Jin Lee
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Beom-Jin Lee
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Beom-Jin Lee
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Beom-Jin Lee
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Beom-Jin Lee
Favorite
Lee, Christine

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Christine Lee
Favorite
Lee, Chunggeon

Korea Institue of Toxicology
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Chunggeon Lee
Favorite
Lee, Cylivia

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Cylivia Lee
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Cylivia Lee
Favorite
Lee, Devin

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
Devin Lee
Favorite
Lee, Dong Yun

Hanyang University
(M1030-03-14) Enhancing Glycyrrhizin Delivery to White Adipose Tissue: A Promising Approach for Safe and Effective Obesity Treatment
Dong Yun Lee
Favorite
(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation
Dong Yun Lee
Favorite
Lee, Ernest

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Ernest Lee
Favorite
Lee, Eun Hee

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Eun Hee Lee
Favorite
Lee, Gong Yeal

Il-Yang Pharm
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Gong Yeal Lee
Favorite
Lee, Hyo Jung

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Hyo Jung Lee
Favorite
Lee, Jangik

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jangik Lee
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jangik Lee
Favorite
Lee, Jennifer

US Food and Drug Administration
(M1330-02-08) In Vitro Assays for the Evaluation of Innate Immunogenicity in Generic Peptide Drug Products
Jennifer Lee
Favorite
Lee, Jongchan

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Jongchan Lee
Favorite
Lee, Jong-Ju

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Jong-Ju Lee
Favorite
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Jong-Ju Lee
Favorite
Lee, Juseung

Yonsei University
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Juseung Lee
Favorite
Lee, Sang Min

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Sang Min Lee
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Sang Min Lee
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Sang Min Lee
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Sang Min Lee
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Sang Min Lee
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Sang Min Lee
Favorite
Lee, Sanghwa

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Sanghwa Lee
Favorite
Lee, Steve

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Steve Lee
Favorite
(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels
Steve Lee
Favorite
Lee, Tae Suk

Sungkyunkwan University
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Tae Suk Lee
Favorite
Lee, Yerin

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Yerin Lee
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Yerin Lee
Favorite
Lefancheck, Jenna

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Jenna Lefancheck
Favorite
Leff, Isaac

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Isaac Leff
Favorite
Lehocky, Robert

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Robert Lehocky
Favorite
Leightner, Andrew

Waters Corp
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Andrew Leightner
Favorite
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Andrew Leightner
Favorite
Leipold, Douglas

Genentech, Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Douglas Leipold
Favorite
Leite-Silva, Vânia

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Vânia Leite-Silva
Favorite
Lei, Yuchen

University of Michigan
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Yuchen Lei
Favorite
Leo, M. Dennis

University of Tennessee Health Sciences Center
(M1530-06-31) Insulin Resistance Triggers Histamine Release from Endothelial Cells Which Disrupts Endothelial Barrier Function and Causes Vasoconstriction
M. Dennis Leo
Favorite
Leone, Anthony

Bristol-Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Anthony Leone
Favorite
LeSaint, Johnathan

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Johnathan LeSaint
Favorite
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Johnathan LeSaint
Favorite
Le, Sunny

BioPharma Services Inc.
(M0930-02-12) Sex, Racial, and Ethnic Representation in COVID-19 Vaccine Clinical Trials Conducted in US - A Systematic Review Compared to 2020 US Census Data
Sunny Le
Favorite
Leung, Sharon Shui Yee

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Sharon Shui Yee Leung
Favorite
(M1230-01-05) Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants
Sharon Shui Yee Leung
Favorite
Leung, Zeno

Jean-Marie Pharmacal Co., Ltd.
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Zeno Leung
Favorite
Lewis, Julie

Harvard Medical School
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Julie Lewis
Favorite
Lewis, Mae

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Mae Lewis
Favorite
Li, Airong

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Airong Li
Favorite
Liang, Hong

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Hong Liang
Favorite
Liang, Huan

Pharmascience, Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Huan Liang
Favorite
Liang, Peipei

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Peipei Liang
Favorite
Liang, Wentao

Wake Forest University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Wentao Liang
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Wentao Liang
Favorite
Liang, Wenzhong

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Wenzhong Liang
Favorite
Liang, Xiaomin

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Xiaomin Liang
Favorite
Liang, Xu

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Xu Liang
Favorite
Liao, Lili

Frontage Laboratories, Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Lili Liao
Favorite
Liao, Xiaolu

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Xiaolu Liao
Favorite
Li, Chenglong

University of Florida
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Chenglong Li
Favorite
Liebler, Daniel

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Daniel Liebler
Favorite
Li, Fangfang

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Fangfang Li
Favorite
Li, Gloria

Bristol-Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Gloria Li
Favorite
Li, Ho Yuet

ZSHK Laboratories Ltd.
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Ho Yuet Li
Favorite
Li, Huanhuan

Queen's University Belfast
(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide
Huanhuan Li
Favorite
(W0930-02-07) Revolutionising Microneedle-Based Transdermal Delivery: A Colourful Approach to Efficiency Feedback and User Navigation
Huanhuan Li
Favorite
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Huanhuan Li
Favorite
Li, Jessica

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Jessica Li
Favorite
Li, Ji

University of Michigan
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Ji Li
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Ji Li
Favorite
Li, Jiahao

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Jiahao Li
Favorite
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Jiahao Li
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Jiahao Li
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Jiahao Li
Favorite
Li, Jiahui

University of Utah
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Jiahui Li
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Jiahui Li
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Jiahui Li
Favorite
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jiahui Li
Favorite
Li, Jinghan

University of Minnesota
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Jinghan Li
Favorite
Li, Jingzhe

Boehringer Ingelheim Pharmaceuticals, Inc.
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Jingzhe Li
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Jingzhe Li
Favorite
Li, Keith

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Keith Li
Favorite
Li, Lan

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Lan Li
Favorite
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Lan Li
Favorite
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Lan Li
Favorite
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Lan Li
Favorite
Li, Lu

University of Buffalo
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Lu Li
Favorite
Li, Mengyue

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Mengyue Li
Favorite
Lim, Hye Lim

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Hye Lim Lim
Favorite
Li, Ming

ZSHK Laboratories Ltd.
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Ming Li
Favorite
Li, Ming

Alexion Pharmaceuticals, Inc.
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Ming Li
Favorite
Lim, Tyler

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Tyler Lim
Favorite
Lim, Yun-Seo

Chungju Weedahm Integrative Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Yun-Seo Lim
Favorite
Li, Na

University of Connecticut
(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
Na Li
Favorite
Lingappa, Vishwanath R.

Prosetta Biosciences, Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Vishwanath R. Lingappa
Favorite
Ling, Jing

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Jing Ling
Favorite
Lin, Jennifer

St. John's School
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Jennifer Lin
Favorite
Lin, John

Frontage Laboratories, Inc.
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
John Lin
Favorite
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
John Lin
Favorite
Lino, Paulo

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Paulo Lino
Favorite
Lin, Sarah

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Sarah Lin
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Sarah Lin
Favorite
Lin, Shin-Yan

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Shin-Yan Lin
Favorite
Lin, Xinhao

University of Connecticut
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Xinhao Lin
Favorite
Lin, Yi Yu

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Yi Yu Lin
Favorite
Lin, Zhe-Ju

Andros Pharmaceuticals Co., Ltd.
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Zhe-Ju Lin
Favorite
Lin, Zhixing

New Jersey Institute of Technology
(T1030-11-64) Mechanistic Prediction of Tablet Breaking Force for Binary Blends Based on Individual Component Properties
Zhixing Lin
Favorite
Lin, Zhoumeng

University of Florida
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Zhoumeng Lin
Favorite
Li, Ping

Washington University School of Medicine in Saint Louis
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Ping Li
Favorite
Li, Ran

Genentech Inc.
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Ran Li
Favorite
Li, Shannuo

University of Utah, College of Pharmacy
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Shannuo Li
Favorite
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Shannuo Li
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Shannuo Li
Favorite
Li, Shawn

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Shawn Li
Favorite
Li, Shengni

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Shengni Li
Favorite
Li, Shu

Queen's University Belfast
(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus
Shu Li
Favorite
Li, Tao

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Tao Li
Favorite
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Tao Li
Favorite
Little, Steven

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Steven Little
Favorite
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Steven Little
Favorite
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Steven Little
Favorite
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Steven Little
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Steven Little
Favorite
Littrel, Chad A.

University of Florida
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Chad A. Littrel
Favorite
Liu, Aihua

Resolian
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
Aihua Liu
Favorite
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Aihua Liu
Favorite
Liu, Anita Ping-wen

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Anita Ping-wen Liu
Favorite
Liu, David

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
David Liu
Favorite
Liu, Fang

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Fang Liu
Favorite
Liu, Hanghui

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Hanghui Liu
Favorite
Liu, Jia-Jhen

Andros Pharmaceuticals Co., Ltd.
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Jia-Jhen Liu
Favorite
Liu, Jixin

Croda Inc.
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Jixin Liu
Favorite
Liu, Joseph

University of Texas at Austin
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Joseph Liu
Favorite
Liu, Mingtao

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Mingtao Liu
Favorite
Liu, Peng

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Peng Liu
Favorite
Liu, Qing

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Qing Liu
Favorite
Liu, Stephanie

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Stephanie Liu
Favorite
Liu, Tongzhou

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Tongzhou Liu
Favorite
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Tongzhou Liu
Favorite
Liu, Tony

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Tony Liu
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Tony Liu
Favorite
Liu, Yang

United States Pharmacopeia
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Yang Liu
Favorite
Liu, Zhanjie (Jason)

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Zhanjie (Jason) Liu
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Zhanjie (Jason) Liu
Favorite
Liu, Zhiwei

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Zhiwei Liu
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Zhiwei Liu
Favorite
Li, Xiaoling

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Xiaoling Li
Favorite
Li, Xiaotong

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Xiaotong Li
Favorite
Li, XinMing

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
XinMing Li
Favorite
Li, Xun

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Xun Li
Favorite
Li, Xuni

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Xuni Li
Favorite
Li, Yan

FAMU-FSU College of Engineering
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Yan Li
Favorite
Li, Yan

Apellis Pharmaceuticals
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Yan Li
Favorite
Li, Yan

FAMU-FSU College of Engineering
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Yan Li
Favorite
Liyanage, Ishanka

US Food and Drug Administration
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Ishanka Liyanage
Favorite
Li, Yang

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Yang Li
Favorite
Li, Yaocun

Queen's University Belfast
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Yaocun Li
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Yaocun Li
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Yaocun Li
Favorite
Li, Yi

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Yi Li
Favorite
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Yi Li
Favorite
Li, Yongzhe

Purdue University
(T1530-06-36) DoE-Based Optimization of RNA Nanosac Lyophilization for Cold-Chain-Free Storage and Transportation
Yongzhe Li
Favorite
Li, Yuan

Biotage LLC
(T1430-06-31) Automated Supporting Liquid Extraction (SLE) Workflow to Extract Zolmitriptan from Plasma Samples for Bioanalysis
Yuan Li
Favorite
Li, Yunsong

Wuxi Biologics
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Yunsong Li
Favorite
Li, Zhiyu

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Zhiyu Li
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Zhiyu Li
Favorite
Lobo, Shabbir

Bayer Consumer Care
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Shabbir Lobo
Favorite
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Shabbir Lobo
Favorite
(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Shabbir Lobo
Favorite
(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Shabbir Lobo
Favorite
Lo, Chi-Sheng

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Chi-Sheng Lo
Favorite
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Chi-Sheng Lo
Favorite
Lockwood, Chris

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Chris Lockwood
Favorite
Lo, Dakshesh

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Dakshesh Lo
Favorite
Loebenberg, Raimar

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Raimar Loebenberg
Favorite
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Raimar Loebenberg
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Raimar Loebenberg
Favorite
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Raimar Loebenberg
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Raimar Loebenberg
Favorite
(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections
Raimar Loebenberg
Favorite
(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products
Raimar Loebenberg
Favorite
(W1230-11-60) Development and Validation of Analytical Methodology by Uv-Vis Spectrophotometry for D-Limonene Quantification
Raimar Loebenberg
Favorite
Loew, Nadine

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Nadine Loew
Favorite
Loftin, Charles

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Charles Loftin
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Charles Loftin
Favorite
Lokesh, Rakshitha

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Rakshitha Lokesh
Favorite
Long, Bonnie

University of Utah
(M1430-01-01) Engineering Novel Antibody-Drug Conjugates with Dual Payloads to Improve the Incidence of Drug Resistance Associated with the Use of Antibody-Drug Conjugates in Oncology
Bonnie Long
Favorite
Longest, Worth

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Worth Longest
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Worth Longest
Favorite
Look, Jennifer

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Jennifer Look
Favorite
Losehand, Udo

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Udo Losehand
Favorite
Los, Nina

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Nina Los
Favorite
Lou, Hao

University of Kansas
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Hao Lou
Favorite
Lou, Yang

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Yang Lou
Favorite
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Yang Lou
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Yang Lou
Favorite
Lowe, Val

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Val Lowe
Favorite
Lozeau, Lindsay

MilliporeSigma
(T1130-11-61) The Role of Filtration in Maintaining HPLC Data Quality
Lindsay Lozeau
Favorite
Lozoya, Maria

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Maria Lozoya
Favorite
Luca, Lien

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Lien Luca
Favorite
Lu, Haiyan

US Food and Drug Administration
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Haiyan Lu
Favorite
Lu, Ida

St. John's University
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Ida Lu
Favorite
Lukacova, Viera

Simulations Plus, Inc.
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Viera Lukacova
Favorite
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Viera Lukacova
Favorite
(T0930-02-11) Delineating the Role of Transporters in the Absorption and Disposition of Digoxin Using the Physiologically Based Pharmacokinetic (PBPK) Modeling
Viera Lukacova
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Viera Lukacova
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Viera Lukacova
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Viera Lukacova
Favorite
Luke, Markham

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Markham Luke
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Markham Luke
Favorite
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Markham Luke
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Markham Luke
Favorite
Lulla, Mukesh

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Mukesh Lulla
Favorite
Lumay, Geoffroy

University of Liege
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Geoffroy Lumay
Favorite
Luna, Stephanie

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Stephanie Luna
Favorite
Lund, Thomas

Catalent, Inc.
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Thomas Lund
Favorite
Lu, Niannian

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Niannian Lu
Favorite
Luo, Linjie

Shenzhen University
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Linjie Luo
Favorite
Luo, Yangchao

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Yangchao Luo
Favorite
Lupo, Marco

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Marco Lupo
Favorite
Lu, Tian-Sheng

Medpace Bioanalytical Labs
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Tian-Sheng Lu
Favorite
Luxbacher, Thomas

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Thomas Luxbacher
Favorite
Lu, Xiaofeng

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Xiaofeng Lu
Favorite
Lu, Xiuling

University of Connecticut
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Xiuling Lu
Favorite
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Xiuling Lu
Favorite
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Xiuling Lu
Favorite
Lu, Yang

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Yang Lu
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Yang Lu
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Yang Lu
Favorite
Lu, Yifan

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Yifan Lu
Favorite
Lu, Yizhou

University of Mississippi
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Yizhou Lu
Favorite
Lynch, Patrick

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Patrick Lynch
Favorite
M
M. Helmy, Abdelrahman

Deraya University
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Abdelrahman M. Helmy
Favorite
Müller-Ranft, Beat

Coperion K-tron
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Beat Müller-Ranft
Favorite
Müllertz, Anette

Copenhagen University
(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity
Anette Müllertz
Favorite
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Anette Müllertz
Favorite
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Anette Müllertz
Favorite
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Anette Müllertz
Favorite
Macedo, Joana

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Joana Macedo
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Joana Macedo
Favorite
MacKay, J. Andrew

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
J. Andrew MacKay
Favorite
(M1030-07-37) GRP78 Targeting of Long-Acting Hydra-Elastin-Like Polypeptides (ELPs) Carrying Rapamycin to Breast Cancer
J. Andrew MacKay
Favorite
Magsombol-Karaan, Mary

Dow Development Laboratories, LLC
(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics
Mary Magsombol-Karaan
Favorite
(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents
Mary Magsombol-Karaan
Favorite
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Mary Magsombol-Karaan
Favorite
Mahady, Gail

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Gail Mahady
Favorite
Mahanta, Sailendra

Assam Kaziranga University
(W1030-04-19) Beyond Voltage-Gated Sodium Channel (Na_v1.7): Exploring the Dual Role of GX201 and Sulfamethoxazole in Itch Management
Sailendra Mahanta
Favorite
Mahant, Shweta

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Shweta Mahant
Favorite
Mahato, Ram

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Ram Mahato
Favorite
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Ram Mahato
Favorite
Mahato, Sohan

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Sohan Mahato
Favorite
Mahlmeister, Christian

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Christian Mahlmeister
Favorite
Mahmoudi, Morteza

Michigan State University
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Morteza Mahmoudi
Favorite
Mahmoudi, Zahra

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Zahra Mahmoudi
Favorite
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Zahra Mahmoudi
Favorite
Mahnen, Cory

Ashland Specialty Ingredients
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Cory Mahnen
Favorite
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Cory Mahnen
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Cory Mahnen
Favorite
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Cory Mahnen
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Cory Mahnen
Favorite
Mahto, Sohan

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Sohan Mahto
Favorite
Maienschein-Cline, Mark

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Mark Maienschein-Cline
Favorite
Maier, Esther

Drug Dynamics Institute
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Esther Maier
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Esther Maier
Favorite
Maisum Sarwar, Jyoti Md

Sunsho Pharmaceuticals Co; Ltd
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Jyoti Md Maisum Sarwar
Favorite
Maithania, Heena

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Heena Maithania
Favorite
Maitra, Prithwiraj

Allergan Aesthetics Skincare R&D
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Prithwiraj Maitra
Favorite
Ma, Jennifer

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Jennifer Ma
Favorite
Ma, Jian-Xing

Wake Forest University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Jian-Xing Ma
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Jian-Xing Ma
Favorite
Majima, Toshiyoi

Developing Virtue Secondary Schools
(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation
Toshiyoi Majima
Favorite
Majumdar, Soumyajit

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Soumyajit Majumdar
Favorite
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems
Soumyajit Majumdar
Favorite
(W0930-07-39) Development and Characterization of Cannabidiol and Rho Kinase Inhibitor Combination Formulations for Ophthalmic Use
Soumyajit Majumdar
Favorite
Majumder, Sushmita

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Sushmita Majumder
Favorite
Makabe, Muneyoshi

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Muneyoshi Makabe
Favorite
Makary, Moheb

US Food and Drug Administration
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Moheb Makary
Favorite
Maki, Koichiro

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Koichiro Maki
Favorite
Makishima, Takashi

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Takashi Makishima
Favorite
Malavia, Nileshkumar

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Nileshkumar Malavia
Favorite
Ma, Lisa

DigiM Solution LLC
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Lisa Ma
Favorite
(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis
Lisa Ma
Favorite
Mallik, Sanku

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Sanku Mallik
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Sanku Mallik
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Sanku Mallik
Favorite
Maloney Norcross, Sara

RTI International
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Sara Maloney Norcross
Favorite
Maloney, David

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
David Maloney
Favorite
MANCINI, VANESSA

InnoGI Technologies
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
VANESSA MANCINI
Favorite
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
VANESSA MANCINI
Favorite
Mandal, Bivash

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Bivash Mandal
Favorite
Mandavalli, Shweta

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Shweta Mandavalli
Favorite
Manickam, Devika

Duquesne University
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Devika Manickam
Favorite
Maniruzzaman, Mohammed

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Mohammed Maniruzzaman
Favorite
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Mohammed Maniruzzaman
Favorite
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Mohammed Maniruzzaman
Favorite
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Mohammed Maniruzzaman
Favorite
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Mohammed Maniruzzaman
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Mohammed Maniruzzaman
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Mohammed Maniruzzaman
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Mohammed Maniruzzaman
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Mohammed Maniruzzaman
Favorite
(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
Mohammed Maniruzzaman
Favorite
Manthena, Sweta

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Sweta Manthena
Favorite
Mao, Chen

Genentech, Inc.
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Chen Mao
Favorite
Mao, Dake

Bristol-Myers Squibb Company
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Dake Mao
Favorite
Mao, Yuxia

Pfizer Inc.
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Yuxia Mao
Favorite
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Yuxia Mao
Favorite
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Yuxia Mao
Favorite
Maqsood, Iram

University of Maryland Baltimore
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Iram Maqsood
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Iram Maqsood
Favorite
Mara, Nathan

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Nathan Mara
Favorite
Marchant, María

Pontificia Universidad Catolica de Chile de valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
María Marchant
Favorite
Mares, Pavel

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Pavel Mares
Favorite
Marino, Giorgio

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Giorgio Marino
Favorite
Markovski, Roza

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Roza Markovski
Favorite
Markus, Tiffany

Spheryx, Inc.
(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates
Tiffany Markus
Favorite
Maroney Lawrence, Yen

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Yen Maroney Lawrence
Favorite
Marques, Luís

Hovione
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Luís Marques
Favorite
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Luís Marques
Favorite
Marsh, Josh

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Josh Marsh
Favorite
Martin, Charlie

Leistritz Extrusion
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Charlie Martin
Favorite
Martinez-Acevedo, Lizbeth

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Lizbeth Martinez-Acevedo
Favorite
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Lizbeth Martinez-Acevedo
Favorite
Martin, Lawrence

Colorcon
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Lawrence Martin
Favorite
(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets
Lawrence Martin
Favorite
Martin, Stephen

University of Texas
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Stephen Martin
Favorite
Mashinson, Viktoriya

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Viktoriya Mashinson
Favorite
Masih, Shabkhaiz

Genentech, Inc
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Shabkhaiz Masih
Favorite
Masoudzadeh, Farnoush

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Farnoush Masoudzadeh
Favorite
Massard, Sebastien

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Sebastien Massard
Favorite
Masum, Zia Uddin

St. John's University
(T1330-03-17) Developing Biosustane SAIB NF as a Novel Excipient for Oral Dosage Forms
Zia Uddin Masum
Favorite
Matadh, Anusha

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Anusha Matadh
Favorite
Matahira, Yoshiharu

Sunsho Pharmaceutical Co., Ltd.
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Yoshiharu Matahira
Favorite
Mateen, Sameena

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Sameena Mateen
Favorite
Mateti, Kranthi

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Kranthi Mateti
Favorite
Mathis, Amanda

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Amanda Mathis
Favorite
Matters, Gail

Pennsylvania State University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Gail Matters
Favorite
Maul, Elise

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Elise Maul
Favorite
Maurus, Kellen

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Kellen Maurus
Favorite
Mavroudis, Panteleimon

Sanofi
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Panteleimon Mavroudis
Favorite
Maxwell, Julia

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Julia Maxwell
Favorite
Mazzola, Priscila

University of Campinas
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Priscila Mazzola
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Priscila Mazzola
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Priscila Mazzola
Favorite
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Priscila Mazzola
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Priscila Mazzola
Favorite
McAllister, Erin

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Erin McAllister
Favorite
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Erin McAllister
Favorite
McCabe, Jacob

SCIEX
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
Jacob McCabe
Favorite
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Jacob McCabe
Favorite
McCalip, Andrew

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Andrew McCalip
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Andrew McCalip
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Andrew McCalip
Favorite
McCarthy, Helen O.

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Helen O. McCarthy
Favorite
McCartt, Daniel

Lawrence Livermore National Laboratory
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Daniel McCartt
Favorite
McCorkle, Jeanette

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Jeanette McCorkle
Favorite
McCormick, Michael

Colorcon, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Michael McCormick
Favorite
McCurdy, Christopher

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Christopher McCurdy
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Christopher McCurdy
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Christopher McCurdy
Favorite
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Christopher McCurdy
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Christopher McCurdy
Favorite
McGrath, Kelly

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Kelly McGrath
Favorite
McGrath, Shannon

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Shannon McGrath
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Shannon McGrath
Favorite
McIntyre, Kevin

International Flavors and Fragrances
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Kevin McIntyre
Favorite
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Kevin McIntyre
Favorite
McSweeney, Sean

Munster Technological University
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Sean McSweeney
Favorite
Medina Monsanto, Paola

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Paola Medina Monsanto
Favorite
Mehta, Dhwani

St. John's University
(W1130-04-22) Conformational Analysis of Alkyl/Aryl-α-O-Glycosides Using Isothermal Calorimetry: Stereo-Electronic Effects vs Hydrophobic Effect
Dhwani Mehta
Favorite
Mehta, Nairuti Milan

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Nairuti Milan Mehta
Favorite
Mehta, Roshani

Lonza
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Roshani Mehta
Favorite
Meibohm, Bernd

University of Tennessee Health Sciences Center
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Bernd Meibohm
Favorite
(M1030-02-12) Investigating Differences in the Pharmacokinetics of Monoclonal Antibodies in Japanese and Non-Japanese Subjects
Bernd Meibohm
Favorite
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
Bernd Meibohm
Favorite
Mejia, Luis

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Luis Mejia
Favorite
Mekhdjian, Armen

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Armen Mekhdjian
Favorite
Mekhssian, Kevork

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Kevork Mekhssian
Favorite
Melton, Kyoka

University of Texas at Austin
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Kyoka Melton
Favorite
Mendonsa, Nicole

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Nicole Mendonsa
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Nicole Mendonsa
Favorite
Menger, Robert

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Robert Menger
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Robert Menger
Favorite
Mengesha, Abebe

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Abebe Mengesha
Favorite
Meng, Fanfei

University of Massachusetts
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Fanfei Meng
Favorite
Meng, Liping

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Liping Meng
Favorite
Meng, Min

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Min Meng
Favorite
Meng, Tuo

Virginia Commonwealth University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Tuo Meng
Favorite
Meng, Xin

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Xin Meng
Favorite
Menon, Sreejit

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
Sreejit Menon
Favorite
Menon, Sreelakshmi

Mercer University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Sreelakshmi Menon
Favorite
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Sreelakshmi Menon
Favorite
Merchant, Jumana

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Jumana Merchant
Favorite
Merritt, Jeremy

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Jeremy Merritt
Favorite
(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery
Jeremy Merritt
Favorite
Messina, Kathryn

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Kathryn Messina
Favorite
Meyer, Tony

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Tony Meyer
Favorite
Mfoafo, Kwadwo

Nova Southereastern University
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Kwadwo Mfoafo
Favorite
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Kwadwo Mfoafo
Favorite
Mhatre, Susmit

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Susmit Mhatre
Favorite
Miao, Danielle

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Danielle Miao
Favorite
Michon, Josee

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Josee Michon
Favorite
Midde, Krishna

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Krishna Midde
Favorite
Miezeiewski, Blair

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Blair Miezeiewski
Favorite
Migliore, Mattia

Massachusetts College of Pharmacy and Health Sciences
(T1530-06-33) PAR-1 Selective Antagonist, SCH-79797 Dihydrochloride, Inhibits the Proliferation and Migration of the Metastatic Human Prostate Cancer (PC-3) Cells
Mattia Migliore
Favorite
Mihailescu, Ella

Institute for Bioscience and Biotechnology Research
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Ella Mihailescu
Favorite
Miller, Dave

AustinPx
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Dave Miller
Favorite
Miller, Dustin

Eli Lilly and Company
(W0930-10-55) Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF
Dustin Miller
Favorite
Miller, Kimberly

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Kimberly Miller
Favorite
Milller, Victoria

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Victoria Milller
Favorite
Minami, Kentaro

University of Miyazaki Hospital
(M1130-04-22) DEC2 Enhancement of Gemcitabine and Oxaliplatin Sensitivity of Pancreatic Cancer Cells through Suppression of IGFBP4
Kentaro Minami
Favorite
Minatovicz, Bruna

Janssen Research & Development, LLC
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Bruna Minatovicz
Favorite
Min, Paul

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Paul Min
Favorite
Miranda, Aline

Universita Degli Studi Di Milano
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Aline Miranda
Favorite
Miranda-Calderon, Jorge Esteban

Metropolitan Autonomous University
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Jorge Esteban Miranda-Calderon
Favorite
Mirmehrabi, Mahmoud

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Mahmoud Mirmehrabi
Favorite
Mishra, Abhishek

Assam Kaziranga University
(W1030-04-19) Beyond Voltage-Gated Sodium Channel (Na_v1.7): Exploring the Dual Role of GX201 and Sulfamethoxazole in Itch Management
Abhishek Mishra
Favorite
Mishra, Gyan

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Gyan Mishra
Favorite
Mishra, Saurabh

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Saurabh Mishra
Favorite
Mishra, Shubham

Florida A&M University
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Shubham Mishra
Favorite
Misic, Zdravka

DSM-Firmenich AG
(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance
Zdravka Misic
Favorite
Misra, Bishal

West Virginia University
(M1530-09-48) Dual Adjuvanted Ionizable Lipid Nanoparticles for Vaccine Delivery
Bishal Misra
Favorite
Missaghi, Shahrzad

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Shahrzad Missaghi
Favorite
Mistilis, Jessica

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Jessica Mistilis
Favorite
Mita, Nur

Auburn University
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Nur Mita
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Nur Mita
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Nur Mita
Favorite
Mitsuhashi, Hiromi

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Hiromi Mitsuhashi
Favorite
Mittapelly, Naresh

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Naresh Mittapelly
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Naresh Mittapelly
Favorite
Mittman, Stephanie

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Stephanie Mittman
Favorite
Miyake, Taiji

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Taiji Miyake
Favorite
Miyata, Kohei

Adeka Co.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Kohei Miyata
Favorite
Mizoguchi, Ryo

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Ryo Mizoguchi
Favorite
Mizuno, Shotaro

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Shotaro Mizuno
Favorite
Modi, Dimple

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Dimple Modi
Favorite
Modi, Nisarg

Transdermal Research Pharm Laboratories LLC
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Nisarg Modi
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Nisarg Modi
Favorite
Moge, Serena

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Serena Moge
Favorite
Mogilla, Suchitra

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Suchitra Mogilla
Favorite
Mogushi, Kaoru

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Kaoru Mogushi
Favorite
Mohamed, Eman

Texas A&M University
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Eman Mohamed
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Eman Mohamed
Favorite
Mohamed, Esraa

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Esraa Mohamed
Favorite
Mohammad Gholizadeh, Amir

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Amir Mohammad Gholizadeh
Favorite
Mohammad, Jiyan

North Dakota State University
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Jiyan Mohammad
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Jiyan Mohammad
Favorite
Mohammed, Yousuf

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Yousuf Mohammed
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Yousuf Mohammed
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Yousuf Mohammed
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Yousuf Mohammed
Favorite
Mohanty, Rashmi

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Rashmi Mohanty
Favorite
Mohiti-Asli, Mahsa

BASF Corporation
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Mahsa Mohiti-Asli
Favorite
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Mahsa Mohiti-Asli
Favorite
Mohs, Aaron

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Aaron Mohs
Favorite
Mohurle, Swapnil

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Swapnil Mohurle
Favorite
Mokashi, Meghana

St. John's University
(W1030-05-28) Liposomal Amodiaquine for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC)
Meghana Mokashi
Favorite
Mok, Heeyoun

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Heeyoun Mok
Favorite
Momin, Mohammad

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Mohammad Momin
Favorite
Monirvaghefi, Atefeh sadat

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Atefeh sadat Monirvaghefi
Favorite
Monpara, Jasmin

Philadelphia College of Pharmacy
(M1430-04-20) Coarse-Grained Molecular Dynamics Simulations Evaluating Formation and Structural Stability of Nystatin-Loaded DOPC and DPPC Vesicles
Jasmin Monpara
Favorite
(M1530-06-34) Molecular Dynamics Study Using Coarse-Grained Simulation with Martini Force Field for Structural Stability and Formation of Docetaxel Loaded DOPC and DPPC Lipid Vesicle
Jasmin Monpara
Favorite
Monrreal, Luis

Universidad de Valparaiso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Luis Monrreal
Favorite
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Luis Monrreal
Favorite
Montalbano, Nick

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Nick Montalbano
Favorite
Moon, Chaeho

University of Texas at Austin
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Chaeho Moon
Favorite
Moore, Erik

Creighton University
(M1230-06-33) Evaluation of Anti-Proliferative Effect of Vorinostat (a pan-HDAC Inhibitor) on Glioblastoma Multiforme Using 3-D Cell Culture Model of T98G
Erik Moore
Favorite
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Erik Moore
Favorite
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Erik Moore
Favorite
Moore, Jodi

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Jodi Moore
Favorite
Moraga-Espinoza, Daniel

Universidad de Valparaiso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Daniel Moraga-Espinoza
Favorite
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Daniel Moraga-Espinoza
Favorite
Morales‑Cummings, Nadya

BASF Corporation
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Nadya Morales‑Cummings
Favorite
Morales-Ibarria, Marcia

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Marcia Morales-Ibarria
Favorite
Morales, Javier

Universidad de Chile
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Javier Morales
Favorite
(M1330-09-51) Synthesis and Characterization of Nanostructured Lipid Carriers (NLC) with Bile Salts: Sodium Deoxycholate (SDC), Sodium Deoxyglycholate (SDGC) and Sodium Deoxytaurocholate (SDTC)
Javier Morales
Favorite
Moravcevic, Katarina

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Katarina Moravcevic
Favorite
Moreira, Diogo

Fiocruz
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Diogo Moreira
Favorite
Moreno-Castellanos, Natalia

Universidad Industrial de Santander
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Natalia Moreno-Castellanos
Favorite
Morimoto, Yasuaki

Freund Corporation
(M1130-10-57) Evaluation of Lubricant Distribution in Tablets Using All-in-One Excipients
Yasuaki Morimoto
Favorite
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Yasuaki Morimoto
Favorite
Morita, Keiichi

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Keiichi Morita
Favorite
Morker, Krupal

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Krupal Morker
Favorite
Morrison, Ryan

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Ryan Morrison
Favorite
Mortada, Ahmed

University of Mississippi
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Ahmed Mortada
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Ahmed Mortada
Favorite
Mort, Paul

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Paul Mort
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Paul Mort
Favorite
Mosharraf, Mitra

Engimata
(M1430-11-60) Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry
Mitra Mosharraf
Favorite
(W1030-03-16) Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis
Mitra Mosharraf
Favorite
Mosley-Kellum, Keb

Florida A&M University College Of Pharmacy & Pharmaceutical Sciences - Tallahass
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Keb Mosley-Kellum
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Keb Mosley-Kellum
Favorite
Mosquera-Giraldo, Laura I.

Bristol-Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Laura I. Mosquera-Giraldo
Favorite
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Laura I. Mosquera-Giraldo
Favorite
Mostafa, Nourhan

University of Mississippi
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Nourhan Mostafa
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Nourhan Mostafa
Favorite
Mostofa, Agm

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Agm Mostofa
Favorite
Mota, Rute

Hovione PharmaScience SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Rute Mota
Favorite
Mousa, Youssef

US Food and Drug Administration
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Youssef Mousa
Favorite
Moustafa, Tarek

University of Utah
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Tarek Moustafa
Favorite
Mrsny, Randy

University of Bath
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Randy Mrsny
Favorite
M, Ruthvija

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Ruthvija M
Favorite
Mudalige, Thilak

US Food and Drug Administration
(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin
Thilak Mudalige
Favorite
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Thilak Mudalige
Favorite
(W0930-11-61) Quantitative and Qualitative Analysis of Lipids and Cholesterol Derivatives in SMOF Lipids 20% Intravenous Lipid Emulsion
Thilak Mudalige
Favorite
Muddineti, Omkara

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Omkara Muddineti
Favorite
Mueller-Albers, Jessica

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Jessica Mueller-Albers
Favorite
Muhindo, Derick

Bayer Consumer Care
(M0930-03-14) Styl’One Nano Compaction Simulation Studies and Utilization of a Digital Tableting Platform in Formulation Development
Derick Muhindo
Favorite
Mukhopadhyay, Sushobhan

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Sushobhan Mukhopadhyay
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Sushobhan Mukhopadhyay
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Sushobhan Mukhopadhyay
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Sushobhan Mukhopadhyay
Favorite
Muley, Sheetal

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Sheetal Muley
Favorite
Mulherin, Kevin

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Kevin Mulherin
Favorite
Mullin, James

Simulations Plus, Inc.
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
James Mullin
Favorite
Munasinghe, Indeewara

University of Kansas
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Indeewara Munasinghe
Favorite
Munira, Sirazum

University of Alberta
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Sirazum Munira
Favorite
Munjoma, Nyasha

Waters Corporation
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Nyasha Munjoma
Favorite
Munnangi, Siva Ram

University of Mississippi
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Siva Ram Munnangi
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Siva Ram Munnangi
Favorite
Munnangi, Sivaram

University of Mississippi
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Sivaram Munnangi
Favorite
Munoz, Eric

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Eric Munoz
Favorite
Munroe, David

Adare Pharmaceuticals, Inc.
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
David Munroe
Favorite
Munshi, Utpal

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Utpal Munshi
Favorite
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Utpal Munshi
Favorite
Munson, Eric

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Eric Munson
Favorite
(M1330-05-30) Investigating Partial Trehalose Crystallization During Lyophilization of Proteins
Eric Munson
Favorite
Munson, Eric

Kanas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Eric Munson
Favorite
Munson, Eric

Purdue University
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Eric Munson
Favorite
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Eric Munson
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Eric Munson
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Eric Munson
Favorite
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Eric Munson
Favorite
Muolokwu, Chinenye

North Dakota State University
(T1130-04-21) Plasmid ApoE2 Gene Delivery Across the Blood Brain Barrier for the Treatment of Alzheimer's Disease
Chinenye Muolokwu
Favorite
Mu, Qingxin

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Qingxin Mu
Favorite
Murazumi, Yasuhiro

Dalton Corporation
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Yasuhiro Murazumi
Favorite
Murira, Armstrong

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Armstrong Murira
Favorite
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Armstrong Murira
Favorite
Murlidharan, Nanditha

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Nanditha Murlidharan
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Nanditha Murlidharan
Favorite
Murphy, Liam

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Liam Murphy
Favorite
Murphy, Thomas

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Thomas Murphy
Favorite
Murray, Jack

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Jack Murray
Favorite
Murry, Daryl

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Daryl Murry
Favorite
Murshed, Mubtasim

University of Bath
(T1130-09-50) Biopharmaceutical Tools for De-risking Paediatric Formulation Development
Mubtasim Murshed
Favorite
Murthy, Reena

Topical Products Testing
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Reena Murthy
Favorite
Murthy, S.Narasimha

Topical Products Testing
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
S.Narasimha Murthy
Favorite
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
S.Narasimha Murthy
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
S.Narasimha Murthy
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
S.Narasimha Murthy
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
S.Narasimha Murthy
Favorite
Mustafa, Bahaa

University of Arkansas for Medical Sciences
(M1430-04-21) Anti-CD47 Peptide Combined with Oncolytic Vesiculovirus-Driven Intratumoral Immunotherapy for Colorectal Cancer
Bahaa Mustafa
Favorite
Muste, Cathy

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Cathy Muste
Favorite
Musuku, Adrien

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Adrien Musuku
Favorite
Muttavarapu, Ramesh

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Ramesh Muttavarapu
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Ramesh Muttavarapu
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Ramesh Muttavarapu
Favorite
Mutter-Rottmayer, Liz

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Liz Mutter-Rottmayer
Favorite
Muturi, Harrison

Labcorp
(M0930-10-59) Validation of a Quantitative PCR (qPCR) Assay for the Detection and Quantification of Replication Competent Lentivirus for Patient Monitoring in Lentiviral Vector-Based Cell Therapy Studies
Harrison Muturi
Favorite
Mutylo, Elizaveta

University of Chemistry and Technology
(M1030-11-61) Capsule Customization: Pioneering Automated Production of Patient-Specific Poly-Pills
Elizaveta Mutylo
Favorite
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Elizaveta Mutylo
Favorite
Muzaffar, Suhail

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Suhail Muzaffar
Favorite
Myratgeldiyev, Gadam

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Gadam Myratgeldiyev
Favorite
Myslitska, Daria

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Daria Myslitska
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Daria Myslitska
Favorite
Myung, Ja Hye

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Ja Hye Myung
Favorite
N
Nadwodny, Kimberly

GlaxoSmithKline plc
(T1330-02-07) Translational PK/PD Modeling to Predict Human PK and Treg Depletion of a Monoclonal Antibody Based on Preclinical Data
Kimberly Nadwodny
Favorite
Nagarajan, Venkatraman

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Venkatraman Nagarajan
Favorite
Nagaraj, Harini

University of Massachusetts
(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation
Harini Nagaraj
Favorite
Nagarsenkar, Mangal

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Mangal Nagarsenkar
Favorite
Nagata, Masashi

Institute of Science Tokyo
(T1030-04-24) Oren-gedoku-to, a Traditional Chinese Medicine, Prevents the Hyperglycemia Caused by Chronic Olanzapine Administration via Hypothalamic AMP-Activated Protein Kinase Activity
Masashi Nagata
Favorite
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Masashi Nagata
Favorite
Nagata, Takako

NT Biologics
(M1130-06-35) Maintaining Pristine Structure for High-Purity Isolates: A Combined Method for Nuclei and Mitochondria
Takako Nagata
Favorite
Naguboyina, Tejaswini

University of Mississippi
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Tejaswini Naguboyina
Favorite
Nagy, Eniko

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Eniko Nagy
Favorite
Nail, Steven

Simtra BioPharma Solutions
(M0930-01-01) Graphical Design Space for the Primary Drying Phase of Freeze Drying: Factors Affecting the Dried Product Layer Resistance
Steven Nail
Favorite
Naing, Marvin

Merck & Co., Inc.
(W1130-02-10) The Advantage and Disadvantage of In Vivo Predictive Dissolution Profiles of BCS Class II Drugs Generated by a Transfer Method and Compendial Method with Different Buffer Species
Marvin Naing
Favorite
Nair, Anil

US Food and Drug Administration
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Anil Nair
Favorite
Nair, Shrikanth

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement
Shrikanth Nair
Favorite
Najafi, Ana

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ana Najafi
Favorite
Najafian, Saeed

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Saeed Najafian
Favorite
Najafi, Ron

Emery Pharma
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Ron Najafi
Favorite
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Ron Najafi
Favorite
Nakagawa, Yoshiyuki

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Yoshiyuki Nakagawa
Favorite
Nakai, Takashi

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Takashi Nakai
Favorite
Nakhla, David

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
David Nakhla
Favorite
Nakhla, Nardin

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Nardin Nakhla
Favorite
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Nardin Nakhla
Favorite
Nalajala, Navya

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Navya Nalajala
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Navya Nalajala
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Navya Nalajala
Favorite
Naldrett, Hannah

University of Michigan
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Hannah Naldrett
Favorite
Namba, Chitaka

Nagoya City University
(M0930-04-24) Role of FLVCR2 in the Intestinal Choline Uptake in the Rat Model
Chitaka Namba
Favorite
Nantz, Michael

University of Louisville
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Michael Nantz
Favorite
Nappier Cherup, William

Charles River Laboratories
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
William Nappier Cherup
Favorite
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
William Nappier Cherup
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
William Nappier Cherup
Favorite
Narala, Nagarjuna

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Nagarjuna Narala
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Nagarjuna Narala
Favorite
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Nagarjuna Narala
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Nagarjuna Narala
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Nagarjuna Narala
Favorite
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Nagarjuna Narala
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Nagarjuna Narala
Favorite
Narkhede, Rajkiran

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Rajkiran Narkhede
Favorite
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Rajkiran Narkhede
Favorite
Narula, Akshay

University of Connecticut
(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations
Akshay Narula
Favorite
Narwankar, Pravin

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Pravin Narwankar
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Pravin Narwankar
Favorite
Nascimento, Andre

University of Copenhagen
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Andre Nascimento
Favorite
Nasim, Md Talat

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Md Talat Nasim
Favorite
Natarajan, Karthika

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Karthika Natarajan
Favorite
Nathani, Aakash

Florida A&M University
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Aakash Nathani
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Aakash Nathani
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Aakash Nathani
Favorite
Nayar, Rajiv

HTD Biosystems Inc.
(M1430-11-60) Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry
Rajiv Nayar
Favorite
(W1030-03-16) Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis
Rajiv Nayar
Favorite
Negash, Beth

Catalent Pharma Solutions
(M1430-10-58) Rapid Material-Sparing Approach to Address Hairline Fractures in Low Drug Load Tablets via Compaction Simulation
Beth Negash
Favorite
Neill, Sterling

Mercer University
(T1230-06-34) PEGylated Nanoparticles Conjugated with LHRH Receptor Binding Peptide for Treatment of Lung Cancer
Sterling Neill
Favorite
Nejadnik, Reza

University of Iowa
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Reza Nejadnik
Favorite
(W1130-11-61) Forced Degradation of Cell-Based Therapeutic Products Using Various Stresses and Use of Flow Imaging Microscopy for Identification of Damaged Cells and Cell Debris
Reza Nejadnik
Favorite
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Reza Nejadnik
Favorite
Nejely, Arianna

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Arianna Nejely
Favorite
Nellore, Bhanuchandar

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Bhanuchandar Nellore
Favorite
Nelson, Amy J.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Amy J. Nelson
Favorite
Nesbitt, Daniel

University of Wisconsin Madison
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Daniel Nesbitt
Favorite
Nethercott, Matthew

Kansas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Matthew Nethercott
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Matthew Nethercott
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Matthew Nethercott
Favorite
Neu, Heather

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Heather Neu
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Heather Neu
Favorite
Neupane, Yub Raj

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Yub Raj Neupane
Favorite
Neusaenger, Amy

Merck & Co., Inc.
(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition
Amy Neusaenger
Favorite
Nevelos, Jim

Rayner Surgical
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Jim Nevelos
Favorite
Neveu, Aurelien

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Aurelien Neveu
Favorite
Newman, Bryan

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Bryan Newman
Favorite
Ng, Chee Meng

NewGround Pharm Consulting LLC
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Chee Meng Ng
Favorite
Ng, Ivan

Marching Pharmaceutical Limited
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Ivan Ng
Favorite
Ngo, Albert Nguessan

Florida A & M University
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Albert Nguessan Ngo
Favorite
Ngo, Hai

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Hai Ngo
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Hai Ngo
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Hai Ngo
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Hai Ngo
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Hai Ngo
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Hai Ngo
Favorite
Ngo, Teri

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Teri Ngo
Favorite
Nguyen, Duyen

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Duyen Nguyen
Favorite
Nguyen, Hiep

Center for Innovation and Science
(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation
Hiep Nguyen
Favorite
Nguyen, Hy

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Hy Nguyen
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Hy Nguyen
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Hy Nguyen
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Hy Nguyen
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Hy Nguyen
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Hy Nguyen
Favorite
Nguyen, Ivy

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Ivy Nguyen
Favorite
Nguyen, Jessica

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Jessica Nguyen
Favorite
Nguyen, Viet

Cytiva
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Viet Nguyen
Favorite
Nickel, Nils P.

Texas Tech University Health Science Center
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Nils P. Nickel
Favorite
Nickerson, Jessica

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Jessica Nickerson
Favorite
Niederquell, Andreas

University of Applied Sciences and Arts Northwestern Switzerland
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Andreas Niederquell
Favorite
Nie, Haichen

Teva Branded Pharmaceutical Products R&D, Inc.
(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility
Haichen Nie
Favorite
Nieto, Susana

Patheon, part of Thermo Fisher Scientific
(W0930-05-27) Compaction Simulation as a Risk Mitigation Strategy for Dual Sourcing on Commercial Drug Products
Susana Nieto
Favorite
Nikopour, Aryo

Nelson Labs
(M1530-11-62) Method Development and Validation for Leachable Silicone Oil in Pharmaceutical Drug Products by Graphite Furnace AAS
Aryo Nikopour
Favorite
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Aryo Nikopour
Favorite
Ning, Xin

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Xin Ning
Favorite
Nissley, Becky

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Becky Nissley
Favorite
Niu, Mengmeng

US Food and Drug Administration
(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products
Mengmeng Niu
Favorite
Niyangoda, Sayuri

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Sayuri Niyangoda
Favorite
Noda, Tsubura

Tokyo Medial and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Tsubura Noda
Favorite
Noel, Jean-Francois

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Jean-Francois Noel
Favorite
Nofsinger, Rebecca

Eli Lilly and Company
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Rebecca Nofsinger
Favorite
Nomoto, Yasuhiro

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Yasuhiro Nomoto
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Yasuhiro Nomoto
Favorite
Norford, Madelyn

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Madelyn Norford
Favorite
North, Jeffery

Creighton University
(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
Jeffery North
Favorite
Nounou, Malak

Hall High School
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Malak Nounou
Favorite
Nounou, Mohamed

Alexandria University
(M1130-10-56) Near-Infrared Assessment: A Potential Rapid Screening Tool for Pharmaceutical Quality Assessment
Mohamed Nounou
Favorite
Novakovic, Jasmina

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Jasmina Novakovic
Favorite
Nurunnabi, Md

University of Texas at El Paso
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Md Nurunnabi
Favorite
Nybond, Susanna

Mercodia AB
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Susanna Nybond
Favorite
Nyholm, Karen

Waters Corporation
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Karen Nyholm
Favorite
O
O’Croinin, Conor

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Conor O’Croinin
Favorite
O’Reilly Beringhs, Andre

US Food and Drug Administration
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Andre O’Reilly Beringhs
Favorite
Ҫelik, Metin

Pharmaceutical Technologies International, Inc.
(M1330-10-57) Enhancing Tablet Manufacturing Flexibility: Design Space Determination with Compaction Simulator
Metin Ҫelik
Favorite
O
Oakes, Robert

University of Maryland
(M1230-10-54) 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance
Robert Oakes
Favorite
Oberoi, Hardeep

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Hardeep Oberoi
Favorite
OBrien, Shona

Ashland Specialty Ingredients
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Shona OBrien
Favorite
O'Connor, Thomas

US Food and Drug Administration
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Thomas O'Connor
Favorite
O'Dwyer, Patrick

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Patrick O'Dwyer
Favorite
O'Farrell, Connor

InnoGI Technologies
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
Connor O'Farrell
Favorite
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
Connor O'Farrell
Favorite
Ognibene, Ted

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
Ted Ognibene
Favorite
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Ted Ognibene
Favorite
Ogueri, Kenneth

Pfizer Inc.
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Kenneth Ogueri
Favorite
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Kenneth Ogueri
Favorite
O'Hara, Karen

Eisai Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Karen O'Hara
Favorite
Ohhashi, Ryo

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Ryo Ohhashi
Favorite
Oh, Kyung Taek

Chung-Ang University
(M1130-01-05) Novel Cell-Penetrating Peptide-Based Therapy for Treating Atopic Dermatitis
Kyung Taek Oh
Favorite
Okada, Yuka

Tomita Pharmaceutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Yuka Okada
Favorite
Okado, Toshiaki

Nippon Soda Co., Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Toshiaki Okado
Favorite
Okawara, Masaki

Sunsho Pharmaceutical Co., Ltd.
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Masaki Okawara
Favorite
Okezue, Mercy

University of Michigan
(W0930-11-64) Developing an Assessment Framework, Items, and Expert Reviews for an Educational Instrument for the Proper Use of the USP/NF Pharmacopeia
Mercy Okezue
Favorite
Okuda, Hiroki

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Hiroki Okuda
Favorite
Olajubutu, Oluwabukunmi

Howard University
(M1530-01-03) Targeted Cell-Penetrating Peptide-Drug Conjugates for the Treatment of Pancreatic Cancer
Oluwabukunmi Olajubutu
Favorite
Oldenhof, John

BioPharma Services Inc.
(M0930-02-12) Sex, Racial, and Ethnic Representation in COVID-19 Vaccine Clinical Trials Conducted in US - A Systematic Review Compared to 2020 US Census Data
John Oldenhof
Favorite
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
John Oldenhof
Favorite
Oliveira, Lucas

Federal University of Rio Grande do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
Lucas Oliveira
Favorite
Oliveira, Wogenes

Federal University of Rio Grande do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
Wogenes Oliveira
Favorite
Oliver, Lee

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Lee Oliver
Favorite
Omar, Spozhmai

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Spozhmai Omar
Favorite
Omidian, Hossein

Nova Southeastern University
(M0930-07-38) Evaluating Mucoadhesion of Polymer Films Using Wax Substrates with Mucin Coating
Hossein Omidian
Favorite
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Hossein Omidian
Favorite
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Hossein Omidian
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Hossein Omidian
Favorite
O'Neill, Sean

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Sean O'Neill
Favorite
Ong, Jun Jie

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Jun Jie Ong
Favorite
Ong, Whitney

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Whitney Ong
Favorite
Onoue, Satomi

University of Shizuoka
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Satomi Onoue
Favorite
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Satomi Onoue
Favorite
Ooashi, Tatsuya

Nissor Pharmaceuticals Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Tatsuya Ooashi
Favorite
Oottamasathein, Siam

Harvard Medical School
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Siam Oottamasathein
Favorite
Opere, Catherine

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Catherine Opere
Favorite
Oppong, Edwina

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Edwina Oppong
Favorite
Orozco-Castellanos, Luis Manuel

Universidad de Guanajuato
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Luis Manuel Orozco-Castellanos
Favorite
Orr, Natalie

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Natalie Orr
Favorite
Orsi, Daniela

University of Brasilia
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Daniela Orsi
Favorite
Orth, Dave

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Dave Orth
Favorite
Ortiz, Jairo

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Jairo Ortiz
Favorite
O'Shea, Joseph

University College Cork
(W1030-04-21) Computational Pharmaceutics Approaches to Guide Lipid Based Formulation Development: How Data Mining Can Improve the Process
Joseph O'Shea
Favorite
Otavalo, Gabriela

Universidad de Chile
(M1330-09-51) Synthesis and Characterization of Nanostructured Lipid Carriers (NLC) with Bile Salts: Sodium Deoxycholate (SDC), Sodium Deoxyglycholate (SDGC) and Sodium Deoxytaurocholate (SDTC)
Gabriela Otavalo
Favorite
Otieno, Monicah

Bill & Melinda Gates Medical Research Institute
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Monicah Otieno
Favorite
Ou, Mingxi

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Mingxi Ou
Favorite
Oupicky, David

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
David Oupicky
Favorite
(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)
David Oupicky
Favorite
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
David Oupicky
Favorite
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
David Oupicky
Favorite
(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
David Oupicky
Favorite
Ovacik, Meric

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Meric Ovacik
Favorite
Overfield, Jeffrey

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Jeffrey Overfield
Favorite
Owens, Donald

TFF Pharmaceuticals, Inc.
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Donald Owens
Favorite
Oza, Kamlesh

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Kamlesh Oza
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Kamlesh Oza
Favorite
Ozoude, Chukwuebuka

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Chukwuebuka Ozoude
Favorite
P
Paguigan, Joel

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Joel Paguigan
Favorite
Paisana, Maria

Hovione
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Maria Paisana
Favorite
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Maria Paisana
Favorite
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Maria Paisana
Favorite
Paiva Santos, Ana Claudia

University of Coimbra
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Ana Claudia Paiva Santos
Favorite
Paiva, Mafalda

Hovione
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Mafalda Paiva
Favorite
Palakurthi, Srinath

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Srinath Palakurthi
Favorite
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Srinath Palakurthi
Favorite
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Srinath Palakurthi
Favorite
Palakurthi, Sushesh Srivatsa

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Sushesh Srivatsa Palakurthi
Favorite
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Sushesh Srivatsa Palakurthi
Favorite
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Sushesh Srivatsa Palakurthi
Favorite
Pal, Arindom

US Food and Drug Administration
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Arindom Pal
Favorite
Palekar, Siddhant

Aprecia Pharmaceuticals LLC
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Siddhant Palekar
Favorite
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Siddhant Palekar
Favorite
Palsgrove, Kelsey

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Kelsey Palsgrove
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Kelsey Palsgrove
Favorite
Panagiotou, Thomai "Mimi"

Delphi Scientific, LLC
(M1030-07-40) Drug Release Rate Characterization of Double Nanoemulsions (W1/O/W)
Thomai "Mimi" Panagiotou
Favorite
Panchal, Priyanka

St. John's University
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Priyanka Panchal
Favorite
(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity
Priyanka Panchal
Favorite
Pandey, Pawan Kumar

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Pawan Kumar Pandey
Favorite
Pandey, Prajita

Emery Pharma
(T1330-06-34) LC-MS/MS Method for the Quantitation of Each Monoclonal Antibody (from a 6-Components Antibody Cocktail Drug Product) in Human Serum Matrix
Prajita Pandey
Favorite
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Prajita Pandey
Favorite
Pandey, Prashant

University of Mississippi
(T1530-10-55) 3D Printed Container System for Delayed Release
Prashant Pandey
Favorite
Pandey, Prashant

University of Alberta
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Prashant Pandey
Favorite
Pandhare, Prajal

IMCD
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Prajal Pandhare
Favorite
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Prajal Pandhare
Favorite
Pandya, Anjali Kiran

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Anjali Kiran Pandya
Favorite
Pangeni, Rudra

Virginia Commonwealth University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Rudra Pangeni
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Rudra Pangeni
Favorite
Pang, Eric

US Food and Drug Administration
(M1330-02-08) In Vitro Assays for the Evaluation of Innate Immunogenicity in Generic Peptide Drug Products
Eric Pang
Favorite
Panigrahi, Abhiram

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Abhiram Panigrahi
Favorite
Panigrahi, Sanjali

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Sanjali Panigrahi
Favorite
Panja, Sudipta

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Sudipta Panja
Favorite
Pansare, Swaroop

Irma Lerma Rangel School of Pharmacy
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Swaroop Pansare
Favorite
Pant, Amit

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Amit Pant
Favorite
Pant, Ashruti

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Ashruti Pant
Favorite
Pan, Yuting

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Yuting Pan
Favorite
Papandreou, Konstantinos

National and Kapodistrian University of Athens
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Konstantinos Papandreou
Favorite
Papinska, Anna

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Anna Papinska
Favorite
Paquette, Jay

Cytiva
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Jay Paquette
Favorite
Paredes, Alejandro

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Alejandro Paredes
Favorite
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Alejandro Paredes
Favorite
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Alejandro Paredes
Favorite
(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease
Alejandro Paredes
Favorite
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Alejandro Paredes
Favorite
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Alejandro Paredes
Favorite
Parent, Stephan

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Stephan Parent
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Stephan Parent
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Stephan Parent
Favorite
Parhizkar, Maryam

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Maryam Parhizkar
Favorite
Parikh, Kuntal

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Kuntal Parikh
Favorite
Parish, Craig

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Craig Parish
Favorite
Park, Chun-Woong

Chungbuk National University
(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers
Chun-Woong Park
Favorite
(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)
Chun-Woong Park
Favorite
Park, Daeui

Korea Institute of Toxicology
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Daeui Park
Favorite
Park, Hyeryeong

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Hyeryeong Park
Favorite
Park, Jenny

AbbVie Inc.
(M1030-02-07) Review of First-in-Human Trials for Gene Therapy in Ocular Diseases
Jenny Park
Favorite
Park, Ji-Min

Ajou University
(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug
Ji-Min Park
Favorite
(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity
Ji-Min Park
Favorite
(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery
Ji-Min Park
Favorite
(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle
Ji-Min Park
Favorite
(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate
Ji-Min Park
Favorite
(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers
Ji-Min Park
Favorite
Park, Juhwan

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Juhwan Park
Favorite
Park, Jungmi

University of Massachusetts
(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
Jungmi Park
Favorite
Park, Junwoo

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Junwoo Park
Favorite
Park, Sang Yeob

Samyang Holdings Corporation
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Sang Yeob Park
Favorite
Park, Shawn

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Shawn Park
Favorite
Parlane, Maurice

Centre for Biopharmaceutical Excellence Pty Ltd
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Maurice Parlane
Favorite
Parr, Josh

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Josh Parr
Favorite
Parrot, Madison

University of Utah
(T1030-02-07) Pediatric Oral Cavity PBPK Model to Predict Pharmacokinetics of Mucoadhesive Atropine Gel to Treat Sialorrhea
Madison Parrot
Favorite
Pashikanti, Srinath

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Srinath Pashikanti
Favorite
Pasika, Shashank Reddy

St. John's University
(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules
Shashank Reddy Pasika
Favorite
Pasqua, Anthony J. Di

Massachusetts College of Pharmacy and Health Science
(W1230-09-50) Preparation and Characterization of an Ultraflexible Liposomal Gel for Transdermal Delivery of a Novel Pan-RAS Inhibitor for Melanoma
Anthony J. Di Pasqua
Favorite
Pasupuleti, Dedeepya

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Dedeepya Pasupuleti
Favorite
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Dedeepya Pasupuleti
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Dedeepya Pasupuleti
Favorite
(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration
Dedeepya Pasupuleti
Favorite
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Dedeepya Pasupuleti
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Dedeepya Pasupuleti
Favorite
Paszkowska, Jadwiga

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Jadwiga Paszkowska
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Jadwiga Paszkowska
Favorite
Patel, Akanksha

St. John's University
(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer
Akanksha Patel
Favorite
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Akanksha Patel
Favorite
(T0930-03-18) Targeting Multiple Oncogenic Drivers in NSCLC: Therapeutic Potential of ARV-825 and Gefitinib-Based PROTAC-3 Protein Degraders
Akanksha Patel
Favorite
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Akanksha Patel
Favorite
Patel, Ashish

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Ashish Patel
Favorite
Patel, Dakshesh

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Dakshesh Patel
Favorite
Patel, Devang

Colorcon, Inc.
(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity
Devang Patel
Favorite
Patel, Henis

St. John's University
(M0930-05-30) Sotorasib Nanosuspension: A Patient-Centric Approach to Improve Oral Absorption and Overcome Limitations Associated with Current Treatment
Henis Patel
Favorite
(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer
Henis Patel
Favorite
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Henis Patel
Favorite
(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules
Henis Patel
Favorite
Patel, Henis

St. John's University
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Henis Patel
Favorite
(T1430-02-10) Modified Dissolution-Permeation Assembly Mimicking In Vivo Condition: An Ideal Method to Test Dissolution Profile of Nanosuspension Formulation
Henis Patel
Favorite
Patel, Himaxi

St. John's University
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Himaxi Patel
Favorite
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Himaxi Patel
Favorite
Patel, Hiren

US Food and Drug Administration
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Hiren Patel
Favorite
Patel, Ketan

St. John's University
(M0930-05-30) Sotorasib Nanosuspension: A Patient-Centric Approach to Improve Oral Absorption and Overcome Limitations Associated with Current Treatment
Ketan Patel
Favorite
(M0930-09-48) Data-Driven Prediction of Translational Formulation Strategies for Poorly Water-Soluble Drug Molecules: Machine Learning to Minimize Trial and Error in Early Formulation Development
Ketan Patel
Favorite
(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis
Ketan Patel
Favorite
(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer
Ketan Patel
Favorite
(T0930-03-18) Targeting Multiple Oncogenic Drivers in NSCLC: Therapeutic Potential of ARV-825 and Gefitinib-Based PROTAC-3 Protein Degraders
Ketan Patel
Favorite
(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules
Ketan Patel
Favorite
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Ketan Patel
Favorite
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Ketan Patel
Favorite
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Ketan Patel
Favorite
(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity
Ketan Patel
Favorite
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Ketan Patel
Favorite
(T1430-02-10) Modified Dissolution-Permeation Assembly Mimicking In Vivo Condition: An Ideal Method to Test Dissolution Profile of Nanosuspension Formulation
Ketan Patel
Favorite
(W1230-03-18) Harnessing Albumin-Anchored BRD4 PROTAC Nanoliposomes for Selective and Targeted Degradation in Pancreatic Ductal Adenocarcinoma
Ketan Patel
Favorite
Patel, Rachana

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Rachana Patel
Favorite
Patel, Shitalben

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Shitalben Patel
Favorite
Patel, Vishal

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Vishal Patel
Favorite
Patel, Vivek

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Vivek Patel
Favorite
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Vivek Patel
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Vivek Patel
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Vivek Patel
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Vivek Patel
Favorite
Paterson, Clare

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Clare Paterson
Favorite
Paterson, Daniel

Certara UK (Simcyp Division)
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Daniel Paterson
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Daniel Paterson
Favorite
Pathak, Divya

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Divya Pathak
Favorite
Pathak, Shriram

Eisai Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Shriram Pathak
Favorite
Patil, Karishma

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Karishma Patil
Favorite
Patil, Smital Rajan

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Smital Rajan Patil
Favorite
Patil, Tanvi

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Tanvi Patil
Favorite
Patterson, Jared

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Jared Patterson
Favorite
Patterson-Orazem, Athena

RNAimmune Inc
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Athena Patterson-Orazem
Favorite
Patwardhan, Ketaki

Roquette America Inc.
(M1530-06-32) How the Physical Form of Mannitol Affects Tablet Ejection Force
Ketaki Patwardhan
Favorite
Pauletti, Giovanni

St. Louis College of Pharmacy
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Giovanni Pauletti
Favorite
(M1030-03-17) Bioresponsive Hydrogel Compositions Designed to Fortify Natural Contraceptive Barrier Properties of the Cervicovaginal Environment in Humans
Giovanni Pauletti
Favorite
Pauletti, Giovanni M.

University of Health Science and Pharmacy in Saint Louis
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Giovanni M. Pauletti
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Giovanni M. Pauletti
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Giovanni M. Pauletti
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Giovanni M. Pauletti
Favorite
Paul, Shubhajit

Boehringer Ingelheim Pharmaceuticals, Inc.
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Shubhajit Paul
Favorite
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Shubhajit Paul
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Shubhajit Paul
Favorite
Paulvannan, Kumar

Prosetta Biosciences, Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Kumar Paulvannan
Favorite
Paulvia, Samuel-RK

Roquette America Inc.
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Samuel-RK Paulvia
Favorite
Pavon, Alexander

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Alexander Pavon
Favorite
Pavurala, Naresh

US Food and Drug Administration
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Naresh Pavurala
Favorite
Pdss, Prakash

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Prakash Pdss
Favorite
Peabody, Sarah

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Sarah Peabody
Favorite
Pearson, Kendall

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Kendall Pearson
Favorite
Pearson, Ryan

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Ryan Pearson
Favorite
Pecriaux, Angélique

Patheon, part of Thermo Fisher Scientific
(W0930-05-27) Compaction Simulation as a Risk Mitigation Strategy for Dual Sourcing on Commercial Drug Products
Angélique Pecriaux
Favorite
Peddapatla, Raghu Vamshi Goud

Alkermes Inc
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Raghu Vamshi Goud Peddapatla
Favorite
Peiter, Erik

Merck Life Science KGaA
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Erik Peiter
Favorite
Pena Perez, Lissette

Dow Development Laboratories, LLC
(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations
Lissette Pena Perez
Favorite
Peng, Tao

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Tao Peng
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Tao Peng
Favorite
Pennell, Page

University of Pittsburgh
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Page Pennell
Favorite
Pennington, Alexander

Aliri Bioanalysis
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Alexander Pennington
Favorite
Pepin, Xavier

Simulations Plus, Inc.
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Xavier Pepin
Favorite
Perdikoulias, John

Compuplast
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
John Perdikoulias
Favorite
Pereira, Tony

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Tony Pereira
Favorite
Peretz, Yoav

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Yoav Peretz
Favorite
Perez-Ibarbia, Leire

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Leire Perez-Ibarbia
Favorite
Perez-Olivares, Mercedes

Abzena
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Mercedes Perez-Olivares
Favorite
Peri, Ravi

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Ravi Peri
Favorite
Peri, Ravi Vamsi

St. Joseph's University
(T1430-09-48) Exploring Mannitol's Influence on Protein Stability: Spray-Dried rHGH Formulations
Ravi Vamsi Peri
Favorite
Perrin, Simon

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Simon Perrin
Favorite
Persoons, Tim

Trinity College Dublin
(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis
Tim Persoons
Favorite
Petermann, Oliver

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Oliver Petermann
Favorite
Peterson, John

Glyscend Therapeutics
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
John Peterson
Favorite
Peterson, Noah

Thermo Fisher Scientific
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Noah Peterson
Favorite
Petraglia, Lauren

LCI Corporation
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Lauren Petraglia
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Lauren Petraglia
Favorite
Petrovic, Mirko

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Mirko Petrovic
Favorite
Pezzillo, Michael

University of Pittsburgh
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Michael Pezzillo
Favorite
Pfaffenbach, Magnus

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Magnus Pfaffenbach
Favorite
Pham, Nicky

SRI international
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Nicky Pham
Favorite
Phan, Khanh

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Khanh Phan
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Khanh Phan
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Khanh Phan
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Khanh Phan
Favorite
Phan, Philana

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Philana Phan
Favorite
Pheap, Peti

Moderna Therapeutics
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Peti Pheap
Favorite
Philips, Laura

Spheryx, Inc.
(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates
Laura Philips
Favorite
Phillips, Brian

Evonik Corporation
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Brian Phillips
Favorite
Phillips, Kelli

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Kelli Phillips
Favorite
Phillips, Oludotun

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Oludotun Phillips
Favorite
Phillips, Sarea Recarde

Texas A&M University
(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis
Sarea Recarde Phillips
Favorite
Phoo, May

University of Michigan
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
May Phoo
Favorite
Phung, Abraham

University of California San Diego
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Abraham Phung
Favorite
Piao, Longzhu

Medpace
(W1030-02-07) Determination of the Concentration of Monoclonal Antibodies (Mab) Drug in Human Serum Using an Enzyme-Linked Immunosorbent Assay (ELISA)
Longzhu Piao
Favorite
Piazza, Gary

Auburn University
(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer
Gary Piazza
Favorite
(W1230-09-50) Preparation and Characterization of an Ultraflexible Liposomal Gel for Transdermal Delivery of a Novel Pan-RAS Inhibitor for Melanoma
Gary Piazza
Favorite
Picchio, Matias

University of the Basque Country
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Matias Picchio
Favorite
Picco, Camila

Queen's University Belfast
(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants
Camila Picco
Favorite
Picco, Sandrine

Lonza Capsules & Health Ingredients
(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C
Sandrine Picco
Favorite
Pillai, Nikhil

Sanofi
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Nikhil Pillai
Favorite
Pineiro-Llanes, Janny

University of Florida
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Janny Pineiro-Llanes
Favorite
Pinheiro, Carolina

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Carolina Pinheiro
Favorite
Pinton, Philippe

Ferring Pharmaceuticals A/S
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Philippe Pinton
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Philippe Pinton
Favorite
Pinto, Sara

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Sara Pinto
Favorite
Pistilli, Barbara

Gustave Roussy Cancer Campus
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Barbara Pistilli
Favorite
Pitaksuteepong, Tasana

Aresuan University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Tasana Pitaksuteepong
Favorite
Pivetta, Rhannanda Copetti

Applied Pharmaceutical Innovation
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Rhannanda Copetti Pivetta
Favorite
Plait, Fiona

Simulations Plus, Inc.
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Fiona Plait
Favorite
Plas, David

University of Cincinnati
(W0930-10-58) Translational Research to Facilitate Development of Novel Therapeutic Combination of Letrozole with a CDK 4/6 Inhibitor Ribociclib for the Treatment of Glioblastoma
David Plas
Favorite
Plumb, Robert

Waters Corporation
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Robert Plumb
Favorite
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Robert Plumb
Favorite
Plummer, Chelsea

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Chelsea Plummer
Favorite
Poddar, Aditi

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Aditi Poddar
Favorite
Polak, Sebastian

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Sebastian Polak
Favorite
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Sebastian Polak
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Sebastian Polak
Favorite
Polak, Sebastian

Jagiellonian University
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Sebastian Polak
Favorite
Polak, Sebastian

Certara UK Ltd
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Sebastian Polak
Favorite
Poloni, Ester-Sophie

University of Greifswald
(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?
Ester-Sophie Poloni
Favorite
Polyzois, Hector

Purdue University
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Hector Polyzois
Favorite
Poojary, Sannidhi

Creighton University
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Sannidhi Poojary
Favorite
Poole, Jill A.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Jill A. Poole
Favorite
Poon, Tin Wai

ZSHK Laboratories Ltd.
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Tin Wai Poon
Favorite
Poozesh, Sadegh

AstraZeneca
(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies
Sadegh Poozesh
Favorite
Popescu, Carmen

Roquette Pharmaceutical Innovation Center
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Carmen Popescu
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Carmen Popescu
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Carmen Popescu
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Carmen Popescu
Favorite
Post, Steve

Leistritz Extrusion
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Steve Post
Favorite
Pothupitiya, Jinal

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Jinal Pothupitiya
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Jinal Pothupitiya
Favorite
Poudel, Ishwor

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Ishwor Poudel
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Ishwor Poudel
Favorite
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Ishwor Poudel
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Ishwor Poudel
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Ishwor Poudel
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Ishwor Poudel
Favorite
Poudel, Sagun

Virginia Commonwealth University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Sagun Poudel
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Sagun Poudel
Favorite
Poudel, Surendra

Virginia Commonwealth University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Surendra Poudel
Favorite
Powers, David

US Food and Drug Administration
(T0930-11-64) Evaluation of CQA Outcomes in Cell Line Changes in Upstream Biomanufacturing
David Powers
Favorite
Pozy, Ethan

US Food and Drug Administration
(M1330-11-61) Performance Verification Variations Within Mechanical Calibration Allowance of Paddle Apparatus with Standard and Apex Vessels
Ethan Pozy
Favorite
Pradhan, Adwait

University of Texas at Austin
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Adwait Pradhan
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Adwait Pradhan
Favorite
Prakash, Manikwar

AstraZeneca
(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies
Manikwar Prakash
Favorite
Prakash, Sangeeta

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Sangeeta Prakash
Favorite
Preddie, Denise

Secant Group
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Denise Preddie
Favorite
Priest, Chad

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Chad Priest
Favorite
Prieto, Nathalia

Anton Paar USA, Inc.
(M0930-11-64) Low Surface Area Measurements of Excipients, Replacing Krypton with Nitrogen
Nathalia Prieto
Favorite
Primack, Ronya

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Ronya Primack
Favorite
Prinn, Kristin

Allergan Aesthetics Skincare R&D
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Kristin Prinn
Favorite
Priscilla, Lia

Hanyang University
(M1030-03-14) Enhancing Glycyrrhizin Delivery to White Adipose Tissue: A Promising Approach for Safe and Effective Obesity Treatment
Lia Priscilla
Favorite
Priya, Harini

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Harini Priya
Favorite
Prohens, Rafel

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Rafel Prohens
Favorite
Prokofyeva, Anastasia

University of Utah
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Anastasia Prokofyeva
Favorite
Prorok, Monika

Wuxi Biologics
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Monika Prorok
Favorite
Psarellis, Yorgos

Sanofi
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Yorgos Psarellis
Favorite
Pucell, Dale

Chemical Microscopy LLC
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Dale Pucell
Favorite
Pugh, Jonathan

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Jonathan Pugh
Favorite
Pulsipher, Abigail

University of Utah
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Abigail Pulsipher
Favorite
Punia, Ashish

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Ashish Punia
Favorite
(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions
Ashish Punia
Favorite
Punnoose, Santhosh

BASF Corporation
(W0930-07-41) Evaluation of Plasticizer and Stabilizer Effect on Drug Release Profiles of Taste-Masked Vardenafil MUPS ODT
Santhosh Punnoose
Favorite
Purcell, Dale

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Dale Purcell
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Dale Purcell
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Dale Purcell
Favorite
Puri, Ashana

East Tennessee State University
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
Ashana Puri
Favorite
(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation
Ashana Puri
Favorite
Purohit, Hitesh

AbbVie Inc.
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Hitesh Purohit
Favorite
Putans, Becca

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Becca Putans
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Becca Putans
Favorite
Puzan, Marissa

Pfizer Inc.
(T0930-07-38) Understanding Dibasic Calcium Phosphate Impact on Chemical Stability - Trends in Immediate Release Tablet Formulations
Marissa Puzan
Favorite
Q
Qaddoumi, Mohammad

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Mohammad Qaddoumi
Favorite
Qian, Jie

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Jie Qian
Favorite
Qi, Luqing

Dow Chemical Company
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Luqing Qi
Favorite
Qin, Bin

US Food and Drug Administration
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Bin Qin
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Bin Qin
Favorite
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Bin Qin
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Bin Qin
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Bin Qin
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Bin Qin
Favorite
Qi, Qingqing

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Qingqing Qi
Favorite
Qiu, Yihong

QPD Solutions LLC.
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Yihong Qiu
Favorite
Qi, Wenzhu

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Wenzhu Qi
Favorite
Quadros, Mural

St. John's University
(W1130-01-06) DoE-Enabled Development of Osimertinib-Encapsulated PLGA Nanoparticles for the Treatment of Non-Small Cell Lung Cancer
Mural Quadros
Favorite
Quadry, Zahara

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Zahara Quadry
Favorite
Qu, Li

WuXi AppTec
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Li Qu
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Li Qu
Favorite
R
R Alles, Sascha

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Sascha R Alles
Favorite
Rades, Thomas

Copenhagen University
(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity
Thomas Rades
Favorite
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Thomas Rades
Favorite
Radmard, Ariana

Mercer University
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Ariana Radmard
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Ariana Radmard
Favorite
Radocea, Adrian

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Adrian Radocea
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Adrian Radocea
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Adrian Radocea
Favorite
Rafols, Clara

University of Barcelona
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Clara Rafols
Favorite
Rahimi, Shahnaz

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Shahnaz Rahimi
Favorite
Rahman, Aevelina

Regeneron Pharmaceuticals
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Aevelina Rahman
Favorite
Rahman, Fahad Imtiaz

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Fahad Imtiaz Rahman
Favorite
Rahman, Mahbubur

North South University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mahbubur Rahman
Favorite
Rahman, Md Moshikur

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Md Moshikur Rahman
Favorite
Rahman, Md Nawabur

Square Pharmaceuticals Ltd.
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Md Nawabur Rahman
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Md Nawabur Rahman
Favorite
Rahman, Mohammad Asikur

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Mohammad Asikur Rahman
Favorite
Rahman, Mohammad Atiqur

University of Houston
(T1130-04-19) Thioredoxin Interacting Protein (TXNIP) Inhibitor Protects Against Nicotine-Induced Podocyte Injury and Glomerular Sclerosis
Mohammad Atiqur Rahman
Favorite
(T1130-04-22) Membrane Raft Redox Signalling Pathway Mediates Gut Microbial Metabolite TMAO-Induced NLRP3 Inflammasome Activation and Endothelial Dysfunction
Mohammad Atiqur Rahman
Favorite
Rahman, Omar

Enable Injections
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Omar Rahman
Favorite
Rahman, Taufiq

University of Cambridge
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Taufiq Rahman
Favorite
Rahman, Ziyaur

Texas A&M University
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Ziyaur Rahman
Favorite
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Ziyaur Rahman
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Ziyaur Rahman
Favorite
(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing
Ziyaur Rahman
Favorite
Rai, Anjali

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Anjali Rai
Favorite
Rainey, Trevor

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Trevor Rainey
Favorite
Rainville, Paul D.

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Paul D. Rainville
Favorite
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Paul D. Rainville
Favorite
Raitsin, Sofia

Biopharma Services Inc.
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
Sofia Raitsin
Favorite
Rajaii, Fatemeh

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Fatemeh Rajaii
Favorite
Rajapaksha, Ruwini

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Ruwini Rajapaksha
Favorite
Raje, Vishvesh

St. John's University
(M0930-09-48) Data-Driven Prediction of Translational Formulation Strategies for Poorly Water-Soluble Drug Molecules: Machine Learning to Minimize Trial and Error in Early Formulation Development
Vishvesh Raje
Favorite
(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel
Vishvesh Raje
Favorite
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Vishvesh Raje
Favorite
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Vishvesh Raje
Favorite
Ramakrishnan, Abira

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Abira Ramakrishnan
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Abira Ramakrishnan
Favorite
Ramakrishnan, Radha

Bristol Myers Squibb
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Radha Ramakrishnan
Favorite
Ramakrishnan, Yogaraj

North Dakota State University
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Yogaraj Ramakrishnan
Favorite
Ramani, Ashish

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Ashish Ramani
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Ashish Ramani
Favorite
Ramezanli, Tannaz

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Tannaz Ramezanli
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Tannaz Ramezanli
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Tannaz Ramezanli
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Tannaz Ramezanli
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Tannaz Ramezanli
Favorite
Ramisetty, Bhargavi Srija

University of Kansas
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Bhargavi Srija Ramisetty
Favorite
Ramos, Corinne

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
Corinne Ramos
Favorite
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Corinne Ramos
Favorite
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Corinne Ramos
Favorite
(T1030-02-12) Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing
Corinne Ramos
Favorite
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Corinne Ramos
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Corinne Ramos
Favorite
Ramos, Ines

Hovione
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Ines Ramos
Favorite
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Ines Ramos
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Ines Ramos
Favorite
Rana, Sohel

Jahangirnagar University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Sohel Rana
Favorite
Ranathunga, Dineli

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Dineli Ranathunga
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Dineli Ranathunga
Favorite
Rane, Manish

Evonik Corporation
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Manish Rane
Favorite
(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications
Manish Rane
Favorite
Rane, Rahul

SOPAT
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Rahul Rane
Favorite
Raney, Sam

US Food and Drug Administration
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Sam Raney
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Sam Raney
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Sam Raney
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Sam Raney
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Sam Raney
Favorite
Rangappa, Srinath

Topical Products Testing
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Product Testing LLC
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Products Testing
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Srinath Rangappa
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Srinath Rangappa
Favorite
Rangappa, Srinath

Topical Product Testing LLC
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Srinath Rangappa
Favorite
Rangari, Vijaya

Tuskegee University
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Vijaya Rangari
Favorite
Ranjbar, Sheyda

University of Connecticut
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Sheyda Ranjbar
Favorite
Ransdell-Green, Eleanor

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Eleanor Ransdell-Green
Favorite
Rasamoelisolo, Michele

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Michele Rasamoelisolo
Favorite
Rascon, Adriana

Lovelace Biomedical Research Institute
(T1430-06-35) Comparative Analysis of High-Throughput RNA Extraction Kits in Naïve Non-Human Primate Tissues for Downstream Applications Utilizing Xeno Internal Positive Control (IPC)
Adriana Rascon
Favorite
Rasmussen, Quinn

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Quinn Rasmussen
Favorite
Rasulo, Nick

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Nick Rasulo
Favorite
Rathod, Drishti

St. John's University
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Drishti Rathod
Favorite
(W1230-03-18) Harnessing Albumin-Anchored BRD4 PROTAC Nanoliposomes for Selective and Targeted Degradation in Pancreatic Ductal Adenocarcinoma
Drishti Rathod
Favorite
Rathore, Anurag

Indian Institute of Technology
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Anurag Rathore
Favorite
Rath, Seeprarani

Rutgers, The State University of New Jersey
(T1230-02-10) Revisiting Potency Classification of Topical Corticosteroids Using a Standardized Approach Involving Vasoconstrictor Assay (VCA)
Seeprarani Rath
Favorite
Rautenberg, Annika

University of Bonn
(W1030-11-63) Crystalline Craftsmanship: Controlling Surface Roughness of Spray-Freeze-Dried Particles
Annika Rautenberg
Favorite
Raut, Nishikant

Rashtrasant Tukadoji Maharaj Nagpur University
(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer
Nishikant Raut
Favorite
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Nishikant Raut
Favorite
Ravenhill, Dannielle

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Dannielle Ravenhill
Favorite
Ravikumar, Tarini

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Tarini Ravikumar
Favorite
Rawal, Saurin

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Saurin Rawal
Favorite
Rawa, Susan

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Susan Rawa
Favorite
Rayaprolu, Bindhu

Regeneron Pharmaceuticals
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Bindhu Rayaprolu
Favorite
Ray, Michael

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Michael Ray
Favorite
Razack, Nihala

Fairleigh Dickinson University
(M1230-05-25) A Molecular Dynamics Study of the Impact of Water Content on Pre-nucleation Aggregates in Amorphous 2-Phenylamino Nicotinic Acid
Nihala Razack
Favorite
Rebola, Teresa

Hovione
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Teresa Rebola
Favorite
Reddy, Sravani

St. John's University
(M1030-09-52) Development of a Self-Emulsifying Drug Delivery System (SEDDS) of Fenofibrate Using ZoomLab^TM
Sravani Reddy
Favorite
Reese, Kimberly

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Kimberly Reese
Favorite
Refaat, Hesham

University of Iowa
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Hesham Refaat
Favorite
Rege, Bhagwant

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Bhagwant Rege
Favorite
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Bhagwant Rege
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Bhagwant Rege
Favorite
Reginauld, Bianca

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Bianca Reginauld
Favorite
Reichel, Felix

Heinrich Heine University Düsseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Felix Reichel
Favorite
(T1230-02-09) Examination of the Diffusion Properties of Hydrogels as Optimized Preclinical In Vitro Models for the Human Vitreous Body
Felix Reichel
Favorite
Reich, Jeffrey

Sparian Biosciences
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Jeffrey Reich
Favorite
Reil, Eric

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Eric Reil
Favorite
Reines, Scott

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Scott Reines
Favorite
Ren, Angela

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Angela Ren
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Angela Ren
Favorite
Ren, Ke

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Ke Ren
Favorite
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Ke Ren
Favorite
(M1430-02-11) Common Bioequivalence (BE) Deficiencies Identified in ANDAs Associated with Solid Oral Extended-Release Drugs in Various Therapeutic Areas: A Retrospective Survey of BE Study Data Submitted to the FDA
Ke Ren
Favorite
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Ke Ren
Favorite
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Ke Ren
Favorite
(T1430-02-09) Evaluation of Methods for Assessing Pre-Dose Steady-State Drug Concentration Attainment in Bioequivalence Studies in Abbreviated New Drug Application (ANDA) Submissions
Ke Ren
Favorite
Rennier, Keith

LabCorp
(M0930-10-59) Validation of a Quantitative PCR (qPCR) Assay for the Detection and Quantification of Replication Competent Lentivirus for Patient Monitoring in Lentiviral Vector-Based Cell Therapy Studies
Keith Rennier
Favorite
Ren, Ning

WuXi AppTec Co., Ltd./ DMPK (NJ, USA)
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Ning Ren
Favorite
Ren, Yi

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Yi Ren
Favorite
Ren, Zhongjie

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Zhongjie Ren
Favorite
Repka, Michael

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Michael Repka
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Michael Repka
Favorite
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Michael Repka
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Michael Repka
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Michael Repka
Favorite
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Michael Repka
Favorite
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Michael Repka
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Michael Repka
Favorite
(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques
Michael Repka
Favorite
Reppas, Christos

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Christos Reppas
Favorite
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Christos Reppas
Favorite
Reumer, Ank

Nelson Labs
(T1530-11-62) The Necessity of Using LC-MS/MS Technology to Investigate the Presence of N-Nitrosamines Impurities in Pharmaceutical Drug Products
Ank Reumer
Favorite
Reynolds, Thomas

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Thomas Reynolds
Favorite
(M1130-10-59) Prediction of Maximum Drug Loading in a Tablet Using Percolation Theory
Thomas Reynolds
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Thomas Reynolds
Favorite
Rezhdo, Oljora

Northeastern University
(T1330-04-23) Concurrent Effect of Lipids and Surfactants on Intestinal Drug Absorption: A Modeling Approach
Oljora Rezhdo
Favorite
Reznik, Sandra

St. John's University
(T1130-02-12) Idasanutlin-Ionizable Lipid Nanocomplex (IDLIN) for Enhanced Solubility, Stability, and Anticancer Activity in p53 Sensitive Lung Cancer
Sandra Reznik
Favorite
Richardson, Norman

BASF Corporation
(M1230-09-51) Formulating Sustainable Solid Oral Tablets by Employing Digital Tools and Co-Processed Excipients
Norman Richardson
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Norman Richardson
Favorite
Richards, Terjahna

St. John's University
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Terjahna Richards
Favorite
Ridgway, Jake

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jake Ridgway
Favorite
Riemann, Bernadette

University of Bonn
(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles
Bernadette Riemann
Favorite
Rieutord, André

Gustave Roussy Cancer Campus
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
André Rieutord
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
André Rieutord
Favorite
Rios-Alegre, Adriana

Universidad Autonoma Del Estado De Morelos
(M1330-04-22) In Silico Evaluation of Coumarin Derivatives as Potential Antioxidant Agents on Psoriasis Treatment
Adriana Rios-Alegre
Favorite
Rioux, Nathalie

Certara UK Ltd
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Nathalie Rioux
Favorite
Ritchie, Stuart

Adare Pharma Solutions
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Stuart Ritchie
Favorite
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
Stuart Ritchie
Favorite
Rivera-Islas, Jesus

Universidad Autonoma Del Estado De Morelos
(M1330-04-22) In Silico Evaluation of Coumarin Derivatives as Potential Antioxidant Agents on Psoriasis Treatment
Jesus Rivera-Islas
Favorite
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Jesus Rivera-Islas
Favorite
Rivera-Leyva, Julio Cesar

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Julio Cesar Rivera-Leyva
Favorite
Rivera, Shannon

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Shannon Rivera
Favorite
Robart, Stephanie

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Stephanie Robart
Favorite
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Stephanie Robart
Favorite
Roberts, Frederick

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Frederick Roberts
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Frederick Roberts
Favorite
Roberts, Michael

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Michael Roberts
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Michael Roberts
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Michael Roberts
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Michael Roberts
Favorite
Robin, Marianne

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Marianne Robin
Favorite
Robinson, Lindsay

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Lindsay Robinson
Favorite
Robinson, Morgan

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Morgan Robinson
Favorite
Robota, Miriam

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Miriam Robota
Favorite
Rochet, Jean

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Jean Rochet
Favorite
Rodriguez Maciñeiras, Xela

FABRX Ltd
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Xela Rodriguez Maciñeiras
Favorite
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Xela Rodriguez Maciñeiras
Favorite
Rodrigues, Liliana

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Liliana Rodrigues
Favorite
Rodriguez, Alexander

PPD, a part of Thermo Fisher Scientific
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Alexander Rodriguez
Favorite
Rodriguez-Cruz, Vivian

Eli Lilly and Company
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Vivian Rodriguez-Cruz
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Vivian Rodriguez-Cruz
Favorite
Rogers, True

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
True Rogers
Favorite
Rojas, Sofia

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Sofia Rojas
Favorite
Romanova, Svetlana

University of Nebraska Medical Center
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
Svetlana Romanova
Favorite
Romanski, Michal

Poznan University of Medical Sciences
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Michal Romanski
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Michal Romanski
Favorite
Ronaldson, Patrick

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Patrick Ronaldson
Favorite
Rooney, Melissa

DigiM Solution LLC
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Melissa Rooney
Favorite
Rosalas Soto, Jesus

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Jesus Rosalas Soto
Favorite
Roscoe, Ben

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Ben Roscoe
Favorite
Rostami-Hodjegan, Amin

Certara UK Ltd.
(W1130-02-12) Virtual Bioequivalence (VBE) Outcome May Depend on Choice of Dissolution Inputs in Physiologically Based Pharmacokinetic Modelling
Amin Rostami-Hodjegan
Favorite
Rotello, Vincent

University of Massachusetts
(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation
Vincent Rotello
Favorite
(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
Vincent Rotello
Favorite
Roundtree, Imani

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Imani Roundtree
Favorite
Rowe, Blake

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Blake Rowe
Favorite
Roy, Mckenzie

University of Connecticut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Mckenzie Roy
Favorite
Roy, Sourav

University of Texas El Paso
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Sourav Roy
Favorite
Ruhn, Peggy

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Peggy Ruhn
Favorite
Ruiz, Rebeca

Pion Inc. (UK) Ltd
(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions
Rebeca Ruiz
Favorite
Rumbelow, Stephen

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
Stephen Rumbelow
Favorite
Russo, Jackson

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Jackson Russo
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Jackson Russo
Favorite
Ryan, Callum

University College Cork
(W1030-04-21) Computational Pharmaceutics Approaches to Guide Lipid Based Formulation Development: How Data Mining Can Improve the Process
Callum Ryan
Favorite
Ryman, Josiah

EMD Serono
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
Josiah Ryman
Favorite
S
S. Ascenso, Osvaldo

Hovione
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Osvaldo S. Ascenso
Favorite
Sa Barreto, Livia

University of Brasilia
(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion
Livia Sa Barreto
Favorite
Sa Barreto, Livia Cristina

University of Brasilia
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Livia Cristina Sa Barreto
Favorite
Sa Couto, Clara

HOVIONE FARMACIENCIA S.A.
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Clara Sa Couto
Favorite
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Clara Sa Couto
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Clara Sa Couto
Favorite
Sá Couto, Clara

Hovione PharmaScience SA
(M1330-10-59) Dissolution Method Development for Amorphous Solid Dispersions-Based Oral Drug Products
Clara Sá Couto
Favorite
Sabouni, Adam

Sophrosyne Pharmaceuticals Limited
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Adam Sabouni
Favorite
Sabri, Akmal

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Akmal Sabri
Favorite
Sabri, Akmal

Nottingham University
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Akmal Sabri
Favorite
Sabri, Akmal

Queen's University Belfast
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Akmal Sabri
Favorite
Sacha, Gregory

Simtra BioPharma Solutions
(M0930-01-01) Graphical Design Space for the Primary Drying Phase of Freeze Drying: Factors Affecting the Dried Product Layer Resistance
Gregory Sacha
Favorite
(M0930-11-63) The Effect of Annealing Temperature and Composition on Lyophilized Sucrose / Glycine Formulations
Gregory Sacha
Favorite
(M1230-11-60) The Effect of Conventional Cooling Versus Controlled Ice Nucleation on Primary Drying Time
Gregory Sacha
Favorite
Sadat, Sams

Cytiva
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Sams Sadat
Favorite
Sadykov, Marat

University of Nebraska Medical Center
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
Marat Sadykov
Favorite
Saganich, Michael

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Michael Saganich
Favorite
Sagun, James

University of Texas at Austin
(T1030-05-28) Characterizing the Effects of a Novel Surfactant on Growth Inhibition and Preservation of Different Bacterial Species
James Sagun
Favorite
Sahai, Pulkit

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Pulkit Sahai
Favorite
Saha, Sanjib

University of Iowa
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Sanjib Saha
Favorite
Saha, Sumit Kumar

Jamia Hamdard University
(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment
Sumit Kumar Saha
Favorite
Saha, Sushanto Kumar

University of Utah
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Sushanto Kumar Saha
Favorite
Sahoo, Kaustuv

Thermo Fisher Scientific
(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments
Kaustuv Sahoo
Favorite
Sahoo, Sangrama

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Sangrama Sahoo
Favorite
Saini, Bhawna

Pennsylvania State University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Bhawna Saini
Favorite
Sakai, Hidetoshi

Shin-Etsu Chemical Co., Ltd.
(T1030-09-51) Simplification Study of Feed System in HPMCAS Dry Coating
Hidetoshi Sakai
Favorite
Sakamoto, Chihiro

Osaka Medical and Pharmaceutical University
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Chihiro Sakamoto
Favorite
Sakuma, Shinji

Setsunan University
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Shinji Sakuma
Favorite
Sala, Javier

Nutraresearch
(T1530-01-01) Proven New Sustainable Eco-Friendly Packaging for Challenging Formulation Compositions
Javier Sala
Favorite
Saldanha, Susana

Hovione PharmaScience SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Susana Saldanha
Favorite
Salem, Aliasger

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Aliasger Salem
Favorite
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Aliasger Salem
Favorite
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Aliasger Salem
Favorite
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Aliasger Salem
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Aliasger Salem
Favorite
Salha, Danielle

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Danielle Salha
Favorite
Salian, Vrishali

University of Minnesota, Department of Pharmaceutics
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Vrishali Salian
Favorite
Salomon, Claudio

Universidad Nacional de Rosario
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Claudio Salomon
Favorite
Samatar, Elwaad

Arizona State University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Elwaad Samatar
Favorite
Sanderson, Brian

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Brian Sanderson
Favorite
Sandhu, Mimi

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Mimi Sandhu
Favorite
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Mimi Sandhu
Favorite
Sandoval, Plinio

Colorcon, Inc.
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Plinio Sandoval
Favorite
Sangalli, Martina

Queen's University Belfast
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Martina Sangalli
Favorite
Sanhueza, Carlos A.

St. John's University
(W1130-04-22) Conformational Analysis of Alkyl/Aryl-α-O-Glycosides Using Isothermal Calorimetry: Stereo-Electronic Effects vs Hydrophobic Effect
Carlos A. Sanhueza
Favorite
Sanil, Kavish

University of Mississippi
(M1230-05-29) Employing Hot Melt Extrusion and Vacuum Compression Molding to Develop Cannabidiol Solid Sedds for Improved Solubility
Kavish Sanil
Favorite
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Kavish Sanil
Favorite
Santana de Freitas Blanco, Veronica

Croda Inc.
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Veronica Santana de Freitas Blanco
Favorite
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
Veronica Santana de Freitas Blanco
Favorite
Santana, Emerson

Federal University of Rio Grande do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
Emerson Santana
Favorite
Santi, Celia

Washington University School of Medicine in Saint Louis
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Celia Santi
Favorite
Santos, Joyce

Ferderal University of UFABC
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Joyce Santos
Favorite
Sapkota, Rachana

Purdue University
(M1330-05-30) Investigating Partial Trehalose Crystallization During Lyophilization of Proteins
Rachana Sapkota
Favorite
Saraf, Poonam

US Food and Drug Administration
(M1030-06-32) Analytical Considerations of Drug Products Containing Isomeric Active Pharmaceutical Ingredients in Abbreviated New Drug Application (ANDA) Submissions
Poonam Saraf
Favorite
Sarmah, Bhaskarjyoti

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Bhaskarjyoti Sarmah
Favorite
Sato, Ayaka

Freund Corporation
(M1130-10-57) Evaluation of Lubricant Distribution in Tablets Using All-in-One Excipients
Ayaka Sato
Favorite
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Ayaka Sato
Favorite
Sato, Hideyuki

University of Shizuoka
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Hideyuki Sato
Favorite
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Hideyuki Sato
Favorite
Saudan, Philippe

Kuros Biosciences AG
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Philippe Saudan
Favorite
Sauer, Andreas

SE Tylose GmbH & Co. KG
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Andreas Sauer
Favorite
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Andreas Sauer
Favorite
Saurer, Eric

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Eric Saurer
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Eric Saurer
Favorite
Sawant, Atish

BASF Corporation
(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient
Atish Sawant
Favorite
Sayeed, Vilayat

US Food and Drug Administration
(T1430-05-29) Critical System Suitability Test Established in Regulatory Analytical Procedures for Testing Organic Impurities in Drug Substance and Drug Product and Relevant Changes in Recently Revised USP < 621 >
Vilayat Sayeed
Favorite
Sayer, Chris

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Chris Sayer
Favorite
Sborov, Douglas

University of Utah
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Douglas Sborov
Favorite
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Douglas Sborov
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Douglas Sborov
Favorite
Scapin, Giovana

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Giovana Scapin
Favorite
Schaefer, BJ

Avadel
(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
BJ Schaefer
Favorite
(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM
BJ Schaefer
Favorite
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
BJ Schaefer
Favorite
Schaefer, Joachim

Boehringer Ingelheim
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
Joachim Schaefer
Favorite
Schatzlein, Andreas

University College London
(T1230-04-20) Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Andreas Schatzlein
Favorite
Schenck, Luke

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Luke Schenck
Favorite
Scherzer, Michael

Huntsman Cancer Institute
(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma
Michael Scherzer
Favorite
Schiavone, Carmine

University of Naples Federico II
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Carmine Schiavone
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Carmine Schiavone
Favorite
Schilling, Michelle

Aprecia Pharmaceuticals LLC
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Michelle Schilling
Favorite
(T1430-10-57) Envisioning New Concepts for 3D Printing and Solubility Enhancement: Tablet Manufacturing of Loaded Parteck^® SLC through Z-Form Binder Jetting Technology
Michelle Schilling
Favorite
Schinzinger, Oliver

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Oliver Schinzinger
Favorite
Schiwy, Jakob

University of Bonn
(M1130-11-63) Synthesis of Novel Surfactant for Formulating Cationic Nanoparticles
Jakob Schiwy
Favorite
Schlesinger, Erica

Serán Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Erica Schlesinger
Favorite
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Erica Schlesinger
Favorite
Schmid, Alexander

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Alexander Schmid
Favorite
Schmidt, Gregory

Iowa Lions Eye Bank
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Gregory Schmidt
Favorite
Schmidt, Maike

23andMe Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Maike Schmidt
Favorite
Schulte, Marvin

Idaho State University
(W1230-04-19) Explainable Artificial Intelligence (XAI) for Generation of Library of Novel Potential Acetylcholinesterase Inhibitors
Marvin Schulte
Favorite
Schulze, Nicolee

Rayner Surgical
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Nicolee Schulze
Favorite
Schupp, Jon

InfraTrac
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Jon Schupp
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Jon Schupp
Favorite
Schwabe, robert

Boehringer Ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
robert Schwabe
Favorite
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
robert Schwabe
Favorite
Schweiggert, Christiane

DSM-Firmenich AG
(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance
Christiane Schweiggert
Favorite
Schwendeman, Anna

University of Michigan
(M1430-10-57) Development of a Single-Vial Drug Release Assay Utilizing Bio-Beads SM-2 Resin to Evaluate Doxorubicin Liposomes
Anna Schwendeman
Favorite
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Anna Schwendeman
Favorite
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
Anna Schwendeman
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Anna Schwendeman
Favorite
Schwendeman, Steve

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Steve Schwendeman
Favorite
Schwendman, Steven

University of Michigan
(M1430-09-49) Remote Encapsulation of Exenatide in PLGA Microspheres Using Cationic Excipients
Steven Schwendman
Favorite
(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions
Steven Schwendman
Favorite
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Steven Schwendman
Favorite
Schwing, Quyen

Ashland Specialty Ingredients
(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages
Quyen Schwing
Favorite
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Quyen Schwing
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Quyen Schwing
Favorite
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Quyen Schwing
Favorite
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Quyen Schwing
Favorite
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Quyen Schwing
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Quyen Schwing
Favorite
Schwintner, Carole

MaaT Pharma
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Carole Schwintner
Favorite
Scumaci, Angela

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Angela Scumaci
Favorite
Sczodrok, Jaroslaw

Physiolution GmbH
(M1530-03-15) Biopredictive Dissolution of Budesonide Enteric Pellets under Simulated Fasted Intake Conditions
Jaroslaw Sczodrok
Favorite
Seabra, Maria

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Maria Seabra
Favorite
Seidler, Paul

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Paul Seidler
Favorite
Seidlitz, Anne

Heinrich-Heine-University Dusseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Anne Seidlitz
Favorite
(T1230-02-09) Examination of the Diffusion Properties of Hydrogels as Optimized Preclinical In Vitro Models for the Human Vitreous Body
Anne Seidlitz
Favorite
Sei, Shunsuke

Sunsho Pharmaceutical Co., Ltd.
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Shunsuke Sei
Favorite
Selen, Ebru

SCIEX
(T1130-04-24) Automated Workflow for Targeted Protein Degrader (TPD) Metabolite Identification Using Collision-Induced Dissociation (CID) and Electron-Activated Dissociation (EAD)
Ebru Selen
Favorite
Selmin, Francesca

Universita Degli Studi Di Milano
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Francesca Selmin
Favorite
Selvaraj, Karthikeyan

Lonza
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Karthikeyan Selvaraj
Favorite
Semenov, Alexander

Croda Inc.
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Alexander Semenov
Favorite
Senechal, Victor

Aliri Bioanalysis
(M1430-02-12) Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients
Victor Senechal
Favorite
Senetra, Alexandria

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Alexandria Senetra
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Alexandria Senetra
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Alexandria Senetra
Favorite
Sen, Koyel

Boehringer Ingelheim Pharmaceuticals, Inc.
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Koyel Sen
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Koyel Sen
Favorite
Sen, Ramkrishna

University of Iowa
(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed
Ramkrishna Sen
Favorite
(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer
Ramkrishna Sen
Favorite
(W1130-04-21) Identification of Potential Drug Combinations against BRAF V600E,p53 R273H HT-29 Colon Cancer Cells With and Without BRCA1 Knocked Down
Ramkrishna Sen
Favorite
Seo, Sungman

Korea Institue of Geoscience and Mineral Resources
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Sungman Seo
Favorite
Seo, Won-Gyun

Chungju Weedahm Integrative Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Won-Gyun Seo
Favorite
Serajuddin, Abu

St. John's University
(M1030-01-06) Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by Applying Acid-Base Supersolubilization (ABS) Principle
Abu Serajuddin
Favorite
(M1330-05-28) Application of Acid-Base Supersolubilization Principle to Telmisartan, a Weakly Acidic, High Melting, and Low Solubility Drug, to Lower Hot Melt Extrusion Temperature and Increase Drug Dissolution
Abu Serajuddin
Favorite
(M1430-05-28) Development of 3D Printed Tablets of Weakly Acidic Drug-Flurbiprofen by Acid-Base Super-Solubilization at Lower Extrusion Temperature and Improved Printability
Abu Serajuddin
Favorite
Serajuddin, Abu T.M

St. John's University
(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections
Abu T.M Serajuddin
Favorite
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Abu T.M Serajuddin
Favorite
(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose
Abu T.M Serajuddin
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Abu T.M Serajuddin
Favorite
(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion
Abu T.M Serajuddin
Favorite
Serrano-Mora, Luis Eduardo

National Autonomous University of Mexico
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Luis Eduardo Serrano-Mora
Favorite
Serra, Vanda

Instituto Superior Tecnico de Lisboa
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Vanda Serra
Favorite
Servant, Guy

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Guy Servant
Favorite
Setlow, Barry

University of Florida
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Barry Setlow
Favorite
Setta, Hiroko

University of Shizuoka
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Hiroko Setta
Favorite
Sevim, Kevser

Quotient Sciences
(M1530-02-10) Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model
Kevser Sevim
Favorite
Sewell, David

AstraZeneca
(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies
David Sewell
Favorite
Sfeir, Charles

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Charles Sfeir
Favorite
SG, pragathi

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
pragathi SG
Favorite
Shah, Aashma

Contract Pharmaceuticals Limited
(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management
Aashma Shah
Favorite
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Aashma Shah
Favorite
Shah, Devanshi

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Devanshi Shah
Favorite
Shah, Gopit

BioAgilytix
(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System
Gopit Shah
Favorite
Shah, Harsh

BASF Corporation
(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion
Harsh Shah
Favorite
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Harsh Shah
Favorite
Shah, Heeshma

Signet Excipients
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Heeshma Shah
Favorite
Shah, Jaimin

Genzum Life Sciences
(M1130-10-54) Advancing Treatment for Metastatic Triple Negative Breast Cancer: Liposomal Oncolytic Adenovirus as a Novel Neoadjuvant Therapy
Jaimin Shah
Favorite
Shah, Jaymin

Pfizer Inc.
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Jaymin Shah
Favorite
Shah, Samarth

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Samarth Shah
Favorite
Shah, Sarthak

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Sarthak Shah
Favorite
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Sarthak Shah
Favorite
(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers
Sarthak Shah
Favorite
Shah, Shrey

University of Maryland
(M1230-10-54) 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance
Shrey Shah
Favorite
Shaikat, Mahdi Mubin

Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Mahdi Mubin Shaikat
Favorite
Shaikh, Rizwan

Irma Lerma Rangel School of Pharmacy
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Rizwan Shaikh
Favorite
Shakleya, Diaa

US Food and Drug Administration
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Diaa Shakleya
Favorite
Shameem, Mohammed

Regeneron Pharmaceuticals, Inc.
(M1030-11-64) Thaw Time Prediction for Partially-Filled Bottles of Antibody Solution in Varying Environments – Predictive Statistical Model on CFD-Generated Datasets
Mohammed Shameem
Favorite
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Mohammed Shameem
Favorite
(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics
Mohammed Shameem
Favorite
Shamilov, Roman

Alexion Pharmaceuticals, Inc.
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Roman Shamilov
Favorite
Shamsaei, Nima

Auburn University
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Nima Shamsaei
Favorite
Shang, Jun

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Jun Shang
Favorite
Shang, Linyue

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Linyue Shang
Favorite
Shankar, Gita

SRI Internatioanl
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Gita Shankar
Favorite
Shanks, Elaine

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Elaine Shanks
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Elaine Shanks
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Elaine Shanks
Favorite
Shariare, Mohammad Hossain

North South University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mohammad Hossain Shariare
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Mohammad Hossain Shariare
Favorite
Sharifi, Leila

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Leila Sharifi
Favorite
(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments
Leila Sharifi
Favorite
Sharifi, Shahriar

Michigan State University
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Shahriar Sharifi
Favorite
Sharma, Abhisheak

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Abhisheak Sharma
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Abhisheak Sharma
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Abhisheak Sharma
Favorite
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Abhisheak Sharma
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Abhisheak Sharma
Favorite
Sharma, Reena

NIPER
(W1030-01-02) Harnessing the Potential of Self-Assembled Hyaluronic Acid Nanoparticles for Tumor Targeted Co-Delivery of Betulinic Acid and Paclitaxel
Reena Sharma
Favorite
Sharma, Ruchi

Cytiva
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Ruchi Sharma
Favorite
Sharma, Sejal

Texas Tech University Health Sciences Center
(M0930-04-21) Evaluation of the Blood-Brain Barrier Protective Effects of Metformin after Mixed Exposures to Cigarette Smoke, e-Cigarette Vapor, and Stroke Conditions
Sejal Sharma
Favorite
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Sejal Sharma
Favorite
Sharma, Shruti

Colorcon, Inc.
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Shruti Sharma
Favorite
Sharma, Sonia

Long Island University
(T1330-02-11) A PBPK Model for Acetaminophen: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure in Pediatric Patient Populations
Sonia Sharma
Favorite
Sharpe, Sally

UK Health Security Agency
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Sally Sharpe
Favorite
Shawkat, Sanjana

North South University
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Sanjana Shawkat
Favorite
Shaw, Pang Chui

Chinese University of Hong Kong, The
(M1430-04-24) Gut Microbiota-Based Bioassay for the Quality Control of Dendrobium from Different Sources
Pang Chui Shaw
Favorite
(M1530-04-24) Isolation and Biological Activity Evaluations of Exosome-Like Nanovesicles Derived from Dendrobium officinale
Pang Chui Shaw
Favorite
Shehabeldin, Mostafa

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Mostafa Shehabeldin
Favorite
Shen, Ben-Quan

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Ben-Quan Shen
Favorite
Shen, Guolin

Chinese Academy of Inspection and Quarantine
(W0930-04-24) Kidney Metabolomics Demonstrated the Energy Supply Upregulation by Radix Aconiti Lateralis Preparations in Rats
Guolin Shen
Favorite
Shen, Honglue

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Honglue Shen
Favorite
Shen, Jie

Northeastern University
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Jie Shen
Favorite
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Jie Shen
Favorite
Shen, Liang

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Liang Shen
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Liang Shen
Favorite
Shen, Mike

DigiM Solution LLC
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Mike Shen
Favorite
sherck, Nicholas

BASF Corporation
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Nicholas sherck
Favorite
Sherwin, Catherine

Differentia Bio
(T1530-02-11) Prediction of Lacosamide Concentrations to Optimize Dosing during Pregnancy
Catherine Sherwin
Favorite
Shet, Manjuath

Imbrium Therapeutics
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Manjuath Shet
Favorite
Shevalye, Hanna

Iowa Lions Eye Bank
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Hanna Shevalye
Favorite
Shibazaki, Ikki

Hoshi University
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Ikki Shibazaki
Favorite
Shibuya, Yuichi

Nippon Soda Co., Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Yuichi Shibuya
Favorite
Shidhaye, Supriya

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Supriya Shidhaye
Favorite
Shigeno, Koichi

Adeka Co.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Koichi Shigeno
Favorite
Shii, Hisaaki

University of Miyazaki Hospital
(M1130-04-22) DEC2 Enhancement of Gemcitabine and Oxaliplatin Sensitivity of Pancreatic Cancer Cells through Suppression of IGFBP4
Hisaaki Shii
Favorite
Shimoboji, Tsuyoshi

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Tsuyoshi Shimoboji
Favorite
Shin, Beom Soo

Sungkyunkwan University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Beom Soo Shin
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Beom Soo Shin
Favorite
Shin, Changyell

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Changyell Shin
Favorite
Shin, Soyoung

Chung-Ang University
(M1530-06-33) Development of 3D-Printed Expandable Gastroretentive Drug Delivery System by Applying the Design of Experiment Approach
Soyoung Shin
Favorite
(T1430-04-22) Novel PBPK-IVIVC Model to Predict Human Pharmacokinetics of Ruxolitinib Sustained-Release Formulations
Soyoung Shin
Favorite
Shipkova, Petia

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Petia Shipkova
Favorite
Shirahama, Akane

Physio Mckina Co., Ltd.
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Akane Shirahama
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Akane Shirahama
Favorite
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Akane Shirahama
Favorite
Shi, Shi

23andMe, Inc.
(W1030-06-33) Development of Sensitive Free and Total Assays for the Quantification of Soluble CD200R1 in Human Plasma Samples to Assess Drug-Target Engagement
Shi Shi
Favorite
Shivva, Vittal

Genentech, Inc
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Vittal Shivva
Favorite
Shi, Xiangqian

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Xiangqian Shi
Favorite
Shi, Zhenqi

Genentech, Inc.
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Zhenqi Shi
Favorite
Shomin, Carolyn

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Carolyn Shomin
Favorite
Shrestha, Nisha

Mercer University
(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib
Nisha Shrestha
Favorite
(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles
Nisha Shrestha
Favorite
(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis
Nisha Shrestha
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Nisha Shrestha
Favorite
Shrestha, Sama

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Sama Shrestha
Favorite
Shukla, Sagar

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Sagar Shukla
Favorite
Shukla, Snehal

Pfizer Inc.
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Snehal Shukla
Favorite
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Snehal Shukla
Favorite
Shukla, Surabhi

Creighton University
(M1230-06-33) Evaluation of Anti-Proliferative Effect of Vorinostat (a pan-HDAC Inhibitor) on Glioblastoma Multiforme Using 3-D Cell Culture Model of T98G
Surabhi Shukla
Favorite
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Surabhi Shukla
Favorite
Shunje, Kelly

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Kelly Shunje
Favorite
Shvetz, Julia

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Julia Shvetz
Favorite
Siahboomi, Ali Rajabi

Colorcon, Inc.
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Ali Rajabi Siahboomi
Favorite
(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity
Ali Rajabi Siahboomi
Favorite
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Ali Rajabi Siahboomi
Favorite
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Ali Rajabi Siahboomi
Favorite
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Ali Rajabi Siahboomi
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Ali Rajabi Siahboomi
Favorite
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Ali Rajabi Siahboomi
Favorite
(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets
Ali Rajabi Siahboomi
Favorite
Siddhanta, Kasturi

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Kasturi Siddhanta
Favorite
Siegel, Ronald

University of Minnesota
(W1230-10-57) Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
Ronald Siegel
Favorite
Siepser, Natasha

Catalent, Inc.
(M1330-10-54) DSC vs. DVS: Determining the Moisture-Induced Tg vs. RH of Hygroscopic Materials
Natasha Siepser
Favorite
Sigal, George

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
George Sigal
Favorite
Sikka, Pragya

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Pragya Sikka
Favorite
Siler, Scott

Simulations Plus, Inc.
(W0930-10-57) Orforglipron Weight Loss and Nausea Accurately Simulated with OBESITYsym
Scott Siler
Favorite
Silva, Daniela

Simulations Plus, Inc.
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Daniela Silva
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Daniela Silva
Favorite
Silva, Izabel

University of Brasilia
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Izabel Silva
Favorite
Silva, Vânia

Universidade Federal de Sao Paulo
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Vânia Silva
Favorite
Silverio, Luiza

Unicamp
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Luiza Silverio
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Luiza Silverio
Favorite
Silvestre, Rafaela

Hovione
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Rafaela Silvestre
Favorite
Sima, Monica

University of Utah
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Monica Sima
Favorite
Simon, Nimi

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Nimi Simon
Favorite
Singaraju, Aditya

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Aditya Singaraju
Favorite
Singh, Abhiranjan

BioAgilytix
(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System
Abhiranjan Singh
Favorite
Singh, Amar B

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Amar B Singh
Favorite
Singh, Amarinder

University of Tennessee Health Sciences Center
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Amarinder Singh
Favorite
Singh, Jagdish

North Dakota State University
(M1430-03-17) Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)
Jagdish Singh
Favorite
(T1030-04-19) Cannabidiol and BDNF-Encapsulated Brain-Targeted Lipid Nanoparticles Reduce Inflammation, Lower Pathological Amyloid and Tau Levels, and Improve Cognition in Transgenic Models of Alzheimer’s disease
Jagdish Singh
Favorite
(T1130-04-21) Plasmid ApoE2 Gene Delivery Across the Blood Brain Barrier for the Treatment of Alzheimer's Disease
Jagdish Singh
Favorite
(T1230-04-21) Synthesis and Characterization of Multi-Functionalized Chitosan Polymeric Micelles for Intranasal Delivery of pApoE2 to PS19 Tauopathy Mice
Jagdish Singh
Favorite
(T1230-05-30) Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
Jagdish Singh
Favorite
Singh, Mandip

Florida A&M University
(M0930-04-19) Genetically Engineered PD-L1 Targeted Exosomes for Immunotherapy of Doxorubicin Resistant Triple Negative Breast Cancers
Mandip Singh
Favorite
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Mandip Singh
Favorite
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Mandip Singh
Favorite
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Mandip Singh
Favorite
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Mandip Singh
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Mandip Singh
Favorite
Singh, Rashim

University of Houston
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Rashim Singh
Favorite
Singh, Revanth

Mercer University
(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19
Revanth Singh
Favorite
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Revanth Singh
Favorite
Singh, Romi

Sun Pharmaceutical Industries Limited
(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment
Romi Singh
Favorite
Singh, Shubhadra

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Shubhadra Singh
Favorite
Singh, Somnath

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Somnath Singh
Favorite
Singh, Sonam

Shin-Etsu Chemical Tylose India Pvt., Ltd.
(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement
Sonam Singh
Favorite
(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate
Sonam Singh
Favorite
Sinko, Balint

Pion Inc.
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Balint Sinko
Favorite
Sintes, Rachel

AP-HP
(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C
Rachel Sintes
Favorite
Siva Sankara, Chenikkayala

University of Florida
(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Chenikkayala Siva Sankara
Favorite
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Chenikkayala Siva Sankara
Favorite
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Chenikkayala Siva Sankara
Favorite
Sivanesapillai, Rakulan

Bayer AG
(M0930-03-14) Styl’One Nano Compaction Simulation Studies and Utilization of a Digital Tableting Platform in Formulation Development
Rakulan Sivanesapillai
Favorite
Sivaraman, Lakshmi

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Lakshmi Sivaraman
Favorite
Skeie, Jessica

University of Iowa
(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy
Jessica Skeie
Favorite
Skillman, Mikayla

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Mikayla Skillman
Favorite
Skinner, Samantha

University of Southern California
(T0930-02-09) Development of Dihydromyricetin for Effective Oral Dosing
Samantha Skinner
Favorite
Slaybaugh, Casie

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Casie Slaybaugh
Favorite
Sleczka, Bogdan

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Bogdan Sleczka
Favorite
Sluggett, Gregory

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Gregory Sluggett
Favorite
Smith, Andrew

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Andrew Smith
Favorite
Smith, Brian

Serán Bioscience
(W1130-11-65) Engineering Spray Dried Protein Particles to Enable Subcutaneous Injection of High Concentration Protein Suspensions
Brian Smith
Favorite
Smith, Daniel

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Daniel Smith
Favorite
Smith, Daniel

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Daniel Smith
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Daniel Smith
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Daniel Smith
Favorite
Smith, Pamela

Improved Pharma
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Pamela Smith
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Pamela Smith
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Pamela Smith
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Pamela Smith
Favorite
Smith, Steven

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Steven Smith
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Steven Smith
Favorite
Smith, William

US Food and Drug Administration
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
William Smith
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
William Smith
Favorite
Smolenski, Michal

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Michal Smolenski
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Michal Smolenski
Favorite
Smyth, Hugh

University of Texas at Austin
(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration
Hugh Smyth
Favorite
Sofa, Cait

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Cait Sofa
Favorite
Solomos, Marina

Merck & Co., Inc.
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Marina Solomos
Favorite
Somayaji, Vijay

Drug Development and Innovation Centre
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Vijay Somayaji
Favorite
Song, Chang-Woo

Korea Institute of Toxicology
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Chang-Woo Song
Favorite
Song, Qianbo

Chinese University of Hong Kong, The
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Qianbo Song
Favorite
(M1430-04-24) Gut Microbiota-Based Bioassay for the Quality Control of Dendrobium from Different Sources
Qianbo Song
Favorite
(M1530-04-24) Isolation and Biological Activity Evaluations of Exosome-Like Nanovesicles Derived from Dendrobium officinale
Qianbo Song
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Qianbo Song
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Qianbo Song
Favorite
Song, SeungEun

Yonsei University
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
SeungEun Song
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
SeungEun Song
Favorite
Song, Sichen

University of Minnesota
(W1230-10-57) Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
Sichen Song
Favorite
Song, Zifeng

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Zifeng Song
Favorite
Soni, Ankitkumar

Colorcon, Inc.
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Ankitkumar Soni
Favorite
Soni, Viren

Thomas Jefferson University
(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome
Viren Soni
Favorite
Sonntag, Erik

University of Chemistry and Technology
(M1030-11-61) Capsule Customization: Pioneering Automated Production of Patient-Specific Poly-Pills
Erik Sonntag
Favorite
Sonsalla, Tina-Sophie

Rottendorf Pharma GmbH
(M0930-11-65) Optimization of a Mini-Tablet Compression Process
Tina-Sophie Sonsalla
Favorite
Soto, Marcus

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Marcus Soto
Favorite
Soto, Melissa

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Melissa Soto
Favorite
Sousa, Caroline

Queen's University Belfast
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Caroline Sousa
Favorite
Southard, Benjamin

University of Texas at Austin
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Benjamin Southard
Favorite
Soza, Claudia

Universidad de Valparaiso
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Claudia Soza
Favorite
Spano, Giacomo

University of North Texas Health Science Center
(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle
Giacomo Spano
Favorite
Sperger, Diana

Gilead Sciences, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Diana Sperger
Favorite
Spiratos, Adelia

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Adelia Spiratos
Favorite
Spires, Jessica

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Jessica Spires
Favorite
Spotten, Dee

Lonza
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Dee Spotten
Favorite
Spurgin, Nathan

Thermo Fisher Scientific
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Nathan Spurgin
Favorite
Squillante, Emilio

St. John's University
(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer
Emilio Squillante
Favorite
Srinivasan, Jayasree

Simtra BioPharma Solutions
(M0930-01-01) Graphical Design Space for the Primary Drying Phase of Freeze Drying: Factors Affecting the Dried Product Layer Resistance
Jayasree Srinivasan
Favorite
(M0930-11-63) The Effect of Annealing Temperature and Composition on Lyophilized Sucrose / Glycine Formulations
Jayasree Srinivasan
Favorite
Srinivasan, Priyanka

US Food and Drug Administration
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Priyanka Srinivasan
Favorite
Srinivas, Nuggehally

Kenox Holdings Corp
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Nuggehally Srinivas
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Nuggehally Srinivas
Favorite
Sriram, Nandhini

Catalent, Inc.
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Nandhini Sriram
Favorite
Srivastava, Ritesh

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Ritesh Srivastava
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Ritesh Srivastava
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Ritesh Srivastava
Favorite
(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH
Ritesh Srivastava
Favorite
St Ignac, Tovau

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Tovau St Ignac
Favorite
Staal, Bastiaan

BASF SE
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Bastiaan Staal
Favorite
Stadermann, David

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
David Stadermann
Favorite
Staller, Dalton

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Dalton Staller
Favorite
Staniszewska, Marcela

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Marcela Staniszewska
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Marcela Staniszewska
Favorite
Stanojevic, Dusan

Avantgarde Molecular, LLC
(M1030-07-40) Drug Release Rate Characterization of Double Nanoemulsions (W1/O/W)
Dusan Stanojevic
Favorite
Starkie, Victoria

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Victoria Starkie
Favorite
Steckl, Andrew

University of Cincinnati
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Andrew Steckl
Favorite
Stefanski, Kevin

Bristol-Myers Squibb Company
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Kevin Stefanski
Favorite
Stella, Aaron

Sciex
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Aaron Stella
Favorite
Stepanek, Frantisek

University of Chemistry and Technology
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Frantisek Stepanek
Favorite
(M1030-11-61) Capsule Customization: Pioneering Automated Production of Patient-Specific Poly-Pills
Frantisek Stepanek
Favorite
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Frantisek Stepanek
Favorite
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Frantisek Stepanek
Favorite
Stephens, James

Korsch America
(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation
James Stephens
Favorite
Sternebring, Ola

Ferring Pharmaceuticals A/S
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Ola Sternebring
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Ola Sternebring
Favorite
Stevens, Lewis

University of Iowa
(M1130-09-51) Engineered Cocrystals to Improve Solution Behavior of Poorly Soluble NAR
Lewis Stevens
Favorite
Stevenson, Joseph

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Joseph Stevenson
Favorite
Stewart, Benjamin

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
Benjamin Stewart
Favorite
Stewart, Madeline

Merck & Co., Inc.
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Madeline Stewart
Favorite
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Madeline Stewart
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Madeline Stewart
Favorite
Stinchcomb, Audra

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Audra Stinchcomb
Favorite
St-Jean, Olivier

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Olivier St-Jean
Favorite
Stoyanov, Edmont

Nisso Chemical Europe
(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential
Edmont Stoyanov
Favorite
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Edmont Stoyanov
Favorite
(M1430-10-59) High Drug Load Metformin ER 1000 mg Tablets Processed via Roller Compaction in Combination with High Molecular Weight HPC
Edmont Stoyanov
Favorite
Strab, Robert

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Robert Strab
Favorite
Strassburger, Kenneth

Adare Pharmaceuticals, Inc.
(T1330-11-62) Laboratory Study in Gastric Nitrosamine Formation
Kenneth Strassburger
Favorite
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
Kenneth Strassburger
Favorite
Strecker, Claas

Croda Inc.
(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning
Claas Strecker
Favorite
Strickler, Sarah

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Sarah Strickler
Favorite
Strongrich, Andrew

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Andrew Strongrich
Favorite
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Andrew Strongrich
Favorite
Strotman, Neil

Merck & Co., Inc.
(T1130-10-56) Understanding Friability Performance in Titanium-Free Film Coated Tablets as a Function of Tablet Shape and Core Composition
Neil Strotman
Favorite
Strozyk, Malgorzata

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Malgorzata Strozyk
Favorite
Struckhoff, Katie

Anton Paar USA, Inc.
(M0930-11-64) Low Surface Area Measurements of Excipients, Replacing Krypton with Nitrogen
Katie Struckhoff
Favorite
Subelzu, Natalia

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Natalia Subelzu
Favorite
Subick, Stacia

University of Pittsburgh
(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity
Stacia Subick
Favorite
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Stacia Subick
Favorite
Su, Dan

BeiGene
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Dan Su
Favorite
Sueiro, Ana Claudia

Unicamp
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Ana Claudia Sueiro
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Ana Claudia Sueiro
Favorite
Sugandhi, Vrashabh

St. John's University
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Vrashabh Sugandhi
Favorite
(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin
Vrashabh Sugandhi
Favorite
Sullivan, Kyle

WuXi AppTec Co., Ltd.
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Kyle Sullivan
Favorite
Sultana, Tasmin Ara

US Food and Drug Administration
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Tasmin Ara Sultana
Favorite
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Tasmin Ara Sultana
Favorite
Sun, Calvin

University of Minnesota
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Calvin Sun
Favorite
Sun, Changquan

University of Minnesota
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Changquan Sun
Favorite
(M1130-11-64) Decreased Crystal Plasticity by Solvation-The Case of Levofloxacin Acesulfame
Changquan Sun
Favorite
(M1330-05-25) Generalization of the Tabletability Equation for Describing Powder Properties as a Function of Compaction Pressure
Changquan Sun
Favorite
(T0930-05-25) Impact of Excipient Types and Drug Loadings on the Tabletability Flip Phenomenon
Changquan Sun
Favorite
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Changquan Sun
Favorite
(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery
Changquan Sun
Favorite
(W0930-01-01) Are Amorphous Drugs More Compressible Than Their Crystalline Counterparts?
Changquan Sun
Favorite
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Changquan Sun
Favorite
(W1230-10-57) Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
Changquan Sun
Favorite
Sundaram, Soumya

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Soumya Sundaram
Favorite
Sun, Duxin

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Duxin Sun
Favorite
sung, Si Woo

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Si Woo sung
Favorite
Sun, Li

Florida State University
(M0930-06-35) Harnessing Camel Milk-Derived Exosomes to Enhance Oral Bioavailability of Anticancer Agents with Poor Solubility and Permeability (ARV-825 and CBD) and Revealing the Mechanism of Improved Absorption
Li Sun
Favorite
Sun, Li

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Li Sun
Favorite
Sun, Li

Florida State University
(W0930-04-21) Combination Therapy with Carboplatin and miR-5193/149-5p Mimics Against PD-L1 and FOXM1 Axes Loaded in NK-EVs Show Synergistic Effects in Two EGFR-TKI-Resistant (PDX and H1975R) Lung Tumor Models
Li Sun
Favorite
Sun, Ling

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Ling Sun
Favorite
Sun, Weixing

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Weixing Sun
Favorite
Suresh, Sarasija

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Sarasija Suresh
Favorite
Suryanarayanan, Raj

University of Minnesota
(T1030-11-60) Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies
Raj Suryanarayanan
Favorite
Sutar, Yogesh

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Yogesh Sutar
Favorite
(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections
Yogesh Sutar
Favorite
Su, Xiaolan

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Xiaolan Su
Favorite
Su, Yongchao

Merck & Co., Inc.
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Yongchao Su
Favorite
Suzali, Sorfina

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Sorfina Suzali
Favorite
Suzuki, Shintaro

University of Shizuoka
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Shintaro Suzuki
Favorite
Svay, Maranny

Catalent Pharma Solutions
(M1430-10-58) Rapid Material-Sparing Approach to Address Hairline Fractures in Low Drug Load Tablets via Compaction Simulation
Maranny Svay
Favorite
Swaminathan, Shrikant

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Shrikant Swaminathan
Favorite
Swarnakar, Nitin

BASF Corp
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Nitin Swarnakar
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Nitin Swarnakar
Favorite
(M1030-09-52) Development of a Self-Emulsifying Drug Delivery System (SEDDS) of Fenofibrate Using ZoomLab^TM
Nitin Swarnakar
Favorite
(M1230-09-51) Formulating Sustainable Solid Oral Tablets by Employing Digital Tools and Co-Processed Excipients
Nitin Swarnakar
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Nitin Swarnakar
Favorite
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Nitin Swarnakar
Favorite
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Nitin Swarnakar
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Nitin Swarnakar
Favorite
(T1430-02-11) Alcohol Dose Dumping in Modified Release Formulations: Critical Considerations for Regulatory Guidance(s)
Nitin Swarnakar
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Nitin Swarnakar
Favorite
(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets
Nitin Swarnakar
Favorite
(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation
Nitin Swarnakar
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Nitin Swarnakar
Favorite
Syed, Amber

St. John's University
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Amber Syed
Favorite
Syed, Irfan

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Irfan Syed
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Irfan Syed
Favorite
Syed, Mohammed

Evonik Corporation/ St. Johns University
(M1030-01-06) Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by Applying Acid-Base Supersolubilization (ABS) Principle
Mohammed Syed
Favorite
(M1330-05-28) Application of Acid-Base Supersolubilization Principle to Telmisartan, a Weakly Acidic, High Melting, and Low Solubility Drug, to Lower Hot Melt Extrusion Temperature and Increase Drug Dissolution
Mohammed Syed
Favorite
(M1430-05-28) Development of 3D Printed Tablets of Weakly Acidic Drug-Flurbiprofen by Acid-Base Super-Solubilization at Lower Extrusion Temperature and Improved Printability
Mohammed Syed
Favorite
T
Tabatabaeian Nimavardi, Ali

Certara UK (Simcyp Division)
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Ali Tabatabaeian Nimavardi
Favorite
Tachibana, Tatsuhiko

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Tatsuhiko Tachibana
Favorite
Tadjiki, Soheyl

Postnova Analytics
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Soheyl Tadjiki
Favorite
Taft, David

Long Island University
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
David Taft
Favorite
(T1330-02-11) A PBPK Model for Acetaminophen: Incorporation of SULT Enzyme Ontogeny to Predict Age-Dependent Metabolism and Systemic Exposure in Pediatric Patient Populations
David Taft
Favorite
Taha, Iman

University of Mississippi
(T0930-04-20) Effect of Processing Method on Release Profile of Fenofibrate Amorphous Solid Dispersion Prepared by Hot Melt Extrusion and 3D Printing
Iman Taha
Favorite
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Iman Taha
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Iman Taha
Favorite
Tahara, Kohei

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Kohei Tahara
Favorite
Taherian, Elham

University of Iowa
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Elham Taherian
Favorite
Tajarobi, Pirjo

AstraZeneca
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Pirjo Tajarobi
Favorite
Takagi, Ayaka

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Ayaka Takagi
Favorite
Takechi-Haraya, Yuki

National Institute of Health Sciences
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Yuki Takechi-Haraya
Favorite
Takeda, Hideo

Physio Mckina Co., Ltd.
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Hideo Takeda
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Hideo Takeda
Favorite
(T1430-05-25) Monitoring the Dissolution Behavior of Dissolving Microneedles by UV-Vis Imaging System
Hideo Takeda
Favorite
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Hideo Takeda
Favorite
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Hideo Takeda
Favorite
Takeuchi, Katsuyuki

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Katsuyuki Takeuchi
Favorite
Talluri, Sesha Rajeswari

Rutgers, The State University of New Jersey
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Sesha Rajeswari Talluri
Favorite
(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch
Sesha Rajeswari Talluri
Favorite
Talmadge, James E.

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
James E. Talmadge
Favorite
Tamam, Hassan

Purdue University
(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer
Hassan Tamam
Favorite
Tamanna, Tasmi

North South University
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Tasmi Tamanna
Favorite
Tamashiro, Shintaro

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Shintaro Tamashiro
Favorite
Tamhane, Mitalee

AbbVie Inc.
(M1030-02-07) Review of First-in-Human Trials for Gene Therapy in Ocular Diseases
Mitalee Tamhane
Favorite
Tanai, Ikuo

Freund Corporation
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Ikuo Tanai
Favorite
Tanaka, Mayuko

Physio Mckina Co., Ltd.
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Mayuko Tanaka
Favorite
Tanaka, Yurika

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Yurika Tanaka
Favorite
Tang, Andrew

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Andrew Tang
Favorite
Tang, Michelle

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Michelle Tang
Favorite
Tang, Tiffany

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Tiffany Tang
Favorite
Tang, Xiaojia

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Xiaojia Tang
Favorite
Tang, Yongan

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Yongan Tang
Favorite
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Yongan Tang
Favorite
Tank, Shivali

Vivekanand Education Society’s College of Pharmacy
(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib
Shivali Tank
Favorite
Tanna, Nikunj

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Nikunj Tanna
Favorite
Tanner, Eden

University of Mississippi
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Eden Tanner
Favorite
Tao, Xun

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Xun Tao
Favorite
Tao, Yi

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Yi Tao
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Yi Tao
Favorite
Tao, Yushi

Queen's University Belfast
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Yushi Tao
Favorite
Tarczynski, Frank

Alcami Corporation
(M1230-04-19) Guaifenesin: Discovery and Attributes of Novel Racemic Compound
Frank Tarczynski
Favorite
(W0930-11-62) Quantification of Novel Racemic Compound of Guaifenesin in Commercial Conglomerate Material Using Powder X-ray Diffraction
Frank Tarczynski
Favorite
Ta, Stephan

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Stephan Ta
Favorite
Tatum, Wesley

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Wesley Tatum
Favorite
Tavares, Francisco

Hovione
(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability
Francisco Tavares
Favorite
(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking
Francisco Tavares
Favorite
Tawde, Salonee

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Salonee Tawde
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Salonee Tawde
Favorite
Tawde, Suprita

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Suprita Tawde
Favorite
Tayade, Nitin

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Nitin Tayade
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Nitin Tayade
Favorite
Taylor, Lynne

Purdue University
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Lynne Taylor
Favorite
(M1330-07-38) Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance
Lynne Taylor
Favorite
Taylor, Melissa

Moderna Therapeutics
(T0930-06-33) Troubleshooting the Lack of Neutralizing Antibody Activity during Development of an Enzyme-Based nAb Assay
Melissa Taylor
Favorite
Taylor, Nicole

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Nicole Taylor
Favorite
Telaprolu, Krishna Chaitanya

Certara UK (Simcyp Division)
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Krishna Chaitanya Telaprolu
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Krishna Chaitanya Telaprolu
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Krishna Chaitanya Telaprolu
Favorite
Teleshova, Natalia

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Natalia Teleshova
Favorite
Temkitthawon, Prapapan

Naresuan University
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Prapapan Temkitthawon
Favorite
Tennimier, David

SCIEX
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
David Tennimier
Favorite
Terao, Kimio

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Kimio Terao
Favorite
Terpak, Nicole

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Nicole Terpak
Favorite
Terry, David

Foghorn Therapeutics
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
David Terry
Favorite
Teska, Jordan

Freund Inc.
(M1430-10-54) Designing Spray Dried Particles with a Pressure Nozzle at Small Scale
Jordan Teska
Favorite
Thakker, Prashant

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Prashant Thakker
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Prashant Thakker
Favorite
Thakur, Kanika

Certara UK (Simcyp Division)
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Kanika Thakur
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Kanika Thakur
Favorite
Theisen, Robert

Colorcon, Inc.
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Robert Theisen
Favorite
Thomas, Anitha

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Anitha Thomas
Favorite
(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles
Anitha Thomas
Favorite
Thomas, Heath

Aclairo
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Heath Thomas
Favorite
Thomas, Sherin

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Sherin Thomas
Favorite
Thomas, Vidhya

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Vidhya Thomas
Favorite
Thombre, Ruchi

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Ruchi Thombre
Favorite
Thompson, Kevin

Mayo Clinic
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Kevin Thompson
Favorite
Thompson, Walter

Eastman
(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate
Walter Thompson
Favorite
Thongsukmak, Atsawin

J-Star Research Inc.
(T1330-10-57) Material Sparing Approaches for Preparation of Amorphous Solid Dispersions
Atsawin Thongsukmak
Favorite
Thorne, Christopher

Thermo Fisher Scientific
(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale
Christopher Thorne
Favorite
(T1530-11-64) A Rational Approach to Scaling-Up Lubrication in Pharmaceutical Tablet Manufacturing
Christopher Thorne
Favorite
(W0930-11-60) Case Study Approach of an Excipient Compaction Assessment to Support Dual Sourcing
Christopher Thorne
Favorite
Thorne, Pascal

Thermo Fisher Scientific
(T1230-11-64) Roller Compaction Simulation Reproducible Milling Technologies Between Lab Scale and Pilote Scale
Pascal Thorne
Favorite
(W0930-11-60) Case Study Approach of an Excipient Compaction Assessment to Support Dual Sourcing
Pascal Thorne
Favorite
Thorne, Peter

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Peter Thorne
Favorite
Thorsteinsson, Thorsteinn

Avadel
(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Thorsteinn Thorsteinsson
Favorite
(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM
Thorsteinn Thorsteinsson
Favorite
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Thorsteinn Thorsteinsson
Favorite
Thota, Sunil kumar

Irma Lerma Rangel School of Pharmacy
(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate
Sunil kumar Thota
Favorite
Tian, Lei

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Lei Tian
Favorite
Tian, Li

US Food and Drug Administration
(M1330-11-61) Performance Verification Variations Within Mechanical Calibration Allowance of Paddle Apparatus with Standard and Apex Vessels
Li Tian
Favorite
Tian, Shiying

Adare Pharma Solutions
(W1030-10-57) The Effect of Food Vehicle on In Vitro Performance of Mini-Tablets Formulation
Shiying Tian
Favorite
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Shiying Tian
Favorite
Tian, Wei

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Wei Tian
Favorite
Tiesman, Daniel

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Daniel Tiesman
Favorite
Tijani, Akeemat

East Tennessee State University
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
Akeemat Tijani
Favorite
(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation
Akeemat Tijani
Favorite
Titus, Celene

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Celene Titus
Favorite
Tiwari, Deo

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Deo Tiwari
Favorite
Tiwari, Sandip

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Sandip Tiwari
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Sandip Tiwari
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Sandip Tiwari
Favorite
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Sandip Tiwari
Favorite
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Sandip Tiwari
Favorite
(T1330-04-19) Non-Gelatin Film Coatings for Formulating Easy-to-Swallow Tablets
Sandip Tiwari
Favorite
(T1430-02-11) Alcohol Dose Dumping in Modified Release Formulations: Critical Considerations for Regulatory Guidance(s)
Sandip Tiwari
Favorite
(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency
Sandip Tiwari
Favorite
(W1030-10-55) Optimizing Tablet Formulation through Integrated Use of Digital Formulation Tools and Compaction Simulation
Sandip Tiwari
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Sandip Tiwari
Favorite
Tobin, Kevin

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Kevin Tobin
Favorite
Tocce, Elizabeth

International Flavors and Fragrances
(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature
Elizabeth Tocce
Favorite
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Elizabeth Tocce
Favorite
To, Daniel

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Daniel To
Favorite
(T1330-11-65) Considerations for Drug layering of Sitagliptin on Placebo Tablets to Manufacture Fixed Dose Combination Drug Products
Daniel To
Favorite
Todd, Paula

International Flavors and Fragrances
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Paula Todd
Favorite
To, Kenneth K.W.

Chinese University of Hong Kong, The
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
Kenneth K.W. To
Favorite
Tomarchio, Aaron

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Aaron Tomarchio
Favorite
Tomassen, Peter

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Peter Tomassen
Favorite
Tomezyk, Aurore

Aliri Bioanalysis
(M1330-06-32) Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development
Aurore Tomezyk
Favorite
Tomita, Dianne

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Dianne Tomita
Favorite
Tomono, Takumi

Setsunan University
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Takumi Tomono
Favorite
Tong, Anqi

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Anqi Tong
Favorite
Tong, Rong

Virginia Polytechnic Institute and State University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Rong Tong
Favorite
Tong, Sharon

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Sharon Tong
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Sharon Tong
Favorite
Topp, Elizabeth

Purdue University
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Elizabeth Topp
Favorite
Torchilin, Vladimir P.

Northeastern University
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Vladimir P. Torchilin
Favorite
Torres, Alex

Evonik Canada, Inc.
(M0930-09-51) Improvements in Liposomal Manufacturing Technology
Alex Torres
Favorite
Torre, Sandra Dela

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Sandra Dela Torre
Favorite
Torres, Pedro

Universidad de Chile
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Pedro Torres
Favorite
Tortoles, Daphne

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Daphne Tortoles
Favorite
Tounge, Brett

Mebias Discovery, Inc.
(T1230-02-11) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Rats in a 28-Day Oral Toxicity Study
Brett Tounge
Favorite
(W0930-02-09) Toxicokinetics of MEB-1170, a mu-Opioid Receptor Agonist, in Dogs in a 28-Day Oral Toxicity Study
Brett Tounge
Favorite
Tousi, Fatemeh

Sanofi
(T0930-11-62) Strategic Optimization and Evaluation of Stress Conditions for IgG4 Antibodies
Fatemeh Tousi
Favorite
Tower, Cole

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Cole Tower
Favorite
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Cole Tower
Favorite
Tozuka, Yuichi

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Yuichi Tozuka
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Yuichi Tozuka
Favorite
Trampont, Paul

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Paul Trampont
Favorite
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Paul Trampont
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Paul Trampont
Favorite
Trapa, Patrick

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Patrick Trapa
Favorite
Treffer, Daniel

MeltPrep GmbH
(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans
Daniel Treffer
Favorite
(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation
Daniel Treffer
Favorite
Trinh, Duong N.

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Duong N. Trinh
Favorite
Trinh, Jamie

University of Connecticut
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Jamie Trinh
Favorite
Trippier, Paul

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Paul Trippier
Favorite
Trivedi, Maitri Chetan

Mercer University
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Maitri Chetan Trivedi
Favorite
(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid
Maitri Chetan Trivedi
Favorite
Trivedi, Meghana

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Meghana Trivedi
Favorite
Trivedi, Riddhi

North Dakota State University
(M1430-03-17) Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)
Riddhi Trivedi
Favorite
(T1230-05-30) Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder
Riddhi Trivedi
Favorite
Trommeshauser, dirk

Boehringer Ingelheim
(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug
dirk Trommeshauser
Favorite
Troth, Emma

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Emma Troth
Favorite
Trudeau, Mary

Waters Corporation
(T1230-04-24) SPE-LC/MS Bioanalytical Quantification of the Biotherapeutic Peptide, Semaglutide from Plasma
Mary Trudeau
Favorite
Trujeque, Damien

University of Colorado
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Damien Trujeque
Favorite
Trujillo, Adriana

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Adriana Trujillo
Favorite
Tsakalozou, Eleftheria

US Food and Drug Administration
(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability
Eleftheria Tsakalozou
Favorite
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
Eleftheria Tsakalozou
Favorite
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Eleftheria Tsakalozou
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Eleftheria Tsakalozou
Favorite
(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa
Eleftheria Tsakalozou
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Eleftheria Tsakalozou
Favorite
Tseng, Chien-Te Kent

University of Texas Medical Branch
(M1430-04-22) Discovery and Development of a New Therapeutic Product for the Treatment Long Covid
Chien-Te Kent Tseng
Favorite
Tseng, Yin-Chao

Boehringer Ingelheim Pharmaceuticals, Inc.
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Yin-Chao Tseng
Favorite
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Yin-Chao Tseng
Favorite
(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons
Yin-Chao Tseng
Favorite
Tsinman, Oksana

Pion Inc.
(T0930-10-59) In Vitro and In Vivo Correlations of Danazol-SEDDS Formulations Using MacroFLUX^TM and miniFLUX™
Oksana Tsinman
Favorite
Tsuji, Takanobu

Dalton Corporation
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Takanobu Tsuji
Favorite
Tsume, Yasuhiro

Merck & Co., Inc.
(W1130-02-10) The Advantage and Disadvantage of In Vivo Predictive Dissolution Profiles of BCS Class II Drugs Generated by a Transfer Method and Compendial Method with Different Buffer Species
Yasuhiro Tsume
Favorite
Tsuru, Kyosuke

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Kyosuke Tsuru
Favorite
Tsutsumi-Ogawa, Shiho

University of Tsukuba
(T1530-04-23) Constitution of a Helical Peptide on Exosome-Mimetic Vesicles
Shiho Tsutsumi-Ogawa
Favorite
Tsutsumi, Yasuhiro

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Yasuhiro Tsutsumi
Favorite
Tubbs, Josiah

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Josiah Tubbs
Favorite
Tu, Buu

Saint Joseph's University
(W1030-03-17) Amorphous Stabilization of BCS II Drugs Using Mesoporous Silica
Buu Tu
Favorite
Tuhin, Md Tariqul Haque

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Md Tariqul Haque Tuhin
Favorite
Tuliani, Vinod

Roquette America Inc.
(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder
Vinod Tuliani
Favorite
(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing
Vinod Tuliani
Favorite
(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets
Vinod Tuliani
Favorite
(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets
Vinod Tuliani
Favorite
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Vinod Tuliani
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Vinod Tuliani
Favorite
Tunc, Cansu

University of Utah
(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer
Cansu Tunc
Favorite
(T0930-02-08) The Influence of Silica Nanoparticles with Varied Physicochemical Properties on the Immune Function of RAW 264.7 Macrophages
Cansu Tunc
Favorite
Turin, Rachel

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Rachel Turin
Favorite
Turner, Brenden

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Brenden Turner
Favorite
Turner, David

Certara UK Ltd.
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
David Turner
Favorite
(W1130-02-12) Virtual Bioequivalence (VBE) Outcome May Depend on Choice of Dissolution Inputs in Physiologically Based Pharmacokinetic Modelling
David Turner
Favorite
Tushakiran, Mallika

Contract Pharmaceuticals Limited
(T1430-11-65) Unraveling the Impact of Polymeric Material Attributes in Semisolid Products: Paving the Way for Consistent Viscosity Profile Across Commercial Batches
Mallika Tushakiran
Favorite
Tuvin, Daniel

Sanford Health
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Daniel Tuvin
Favorite
Tzul, Franco

Regeneron Pharmaceuticals
(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations
Franco Tzul
Favorite
U
Uchegbu, Ijeoma

University College London
(T1230-04-20) Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Ijeoma Uchegbu
Favorite
Uchida, Atsushi

University of Yamanashi Hospital
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Atsushi Uchida
Favorite
Uchida, Haruka

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Haruka Uchida
Favorite
Uchida, Shinichi

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Shinichi Uchida
Favorite
Uchiyama, Hiromasa

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Hiromasa Uchiyama
Favorite
(M1530-11-65) Investigation of Dissolution and Permeation Properties of Amorphous Drug Particles Dispersed in Wax-Based Formulations
Hiromasa Uchiyama
Favorite
Uddin, Mohammad Nasir

Mercer University
(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study
Mohammad Nasir Uddin
Favorite
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Mohammad Nasir Uddin
Favorite
(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study
Mohammad Nasir Uddin
Favorite
Ueno, Takashi

Eisai Co. Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Takashi Ueno
Favorite
Uner, Burcu

St. Louis College of Pharmacy
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Burcu Uner
Favorite
(M1030-03-17) Bioresponsive Hydrogel Compositions Designed to Fortify Natural Contraceptive Barrier Properties of the Cervicovaginal Environment in Humans
Burcu Uner
Favorite
Usciak, Adam

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Adam Usciak
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Adam Usciak
Favorite
Uth, Leonie-Lara Dorothea

Heinrich Heine University Düsseldorf
(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films
Leonie-Lara Dorothea Uth
Favorite
(M1230-11-63) Prediction Model for the Dry Film Thickness in the Continuous Manufacturing of Oral Films
Leonie-Lara Dorothea Uth
Favorite
Uttreja, Prateek

University of Mississippi
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Prateek Uttreja
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Prateek Uttreja
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Prateek Uttreja
Favorite
Uyeda, Craig

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Craig Uyeda
Favorite
V
V.Makabenta, Jessa Marie

Avient
(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control
Jessa Marie V.Makabenta
Favorite
Vadgama, Jaydutt

Charles Drew University of Medicine and Science
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Jaydutt Vadgama
Favorite
Vagnerova, Barbora

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Barbora Vagnerova
Favorite
Valadian, Roozbeh

Granutools
(M1230-11-64) A New Insight into the Effect of the Process Conditions on the Permeability of Powders
Roozbeh Valadian
Favorite
Valdivia-Berroeta, Gabriel

Boehringer Ingelheim Pharmaceuticals, Inc.
(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities
Gabriel Valdivia-Berroeta
Favorite
Valdivia, Patrick

FourFront
(T1230-02-12) Gaps in Non-Binary Populations in Clinical Trial Participation: A Comparative Analysis of Cardiovascular and Solid Tumor Studies
Patrick Valdivia
Favorite
Valdivia, Rodney

Larkin University
(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment
Rodney Valdivia
Favorite
Valekar, Pradeep

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Pradeep Valekar
Favorite
Valladares Mendez, Adriana

Universidad Autonoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Adriana Valladares Mendez
Favorite
Vallejo, Celeste

Simulations Plus, Inc.
(W0930-10-57) Orforglipron Weight Loss and Nausea Accurately Simulated with OBESITYsym
Celeste Vallejo
Favorite
van den Elsen, Lieke

InnoGI Technologies
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
Lieke van den Elsen
Favorite
Van Der Gucht, Filip

ProCepT
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Filip Van Der Gucht
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Filip Van Der Gucht
Favorite
Van Der Lee, Saskia

Genmab
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Saskia Van Der Lee
Favorite
van der linden, Marcel

Genmab
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Marcel van der linden
Favorite
van der Meijden, Jannes

Genmab
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Jannes van der Meijden
Favorite
Van Osdol, William

Simulations Plus, Inc.
(M1530-02-09) Dermal PBPK Model for Psoriatic Skin: Clobetasol Propionate Case Study
William Van Osdol
Favorite
van Soest, Remco

SCIEX
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
Remco van Soest
Favorite
Vandevivere, Lise

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Lise Vandevivere
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Lise Vandevivere
Favorite
Vanhoorne, Valerie

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Valerie Vanhoorne
Favorite
Vargas Michelena, Lina

Universidad Nacional de Rosario
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Lina Vargas Michelena
Favorite
Vargas-Castillo, Sofía

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Sofía Vargas-Castillo
Favorite
Varner, Corinne

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Corinne Varner
Favorite
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems
Corinne Varner
Favorite
(W0930-07-39) Development and Characterization of Cannabidiol and Rho Kinase Inhibitor Combination Formulations for Ophthalmic Use
Corinne Varner
Favorite
Vasisht, Niraj

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Niraj Vasisht
Favorite
Vats, Mukti

St. John's University
(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation
Mukti Vats
Favorite
(T0930-03-18) Targeting Multiple Oncogenic Drivers in NSCLC: Therapeutic Potential of ARV-825 and Gefitinib-Based PROTAC-3 Protein Degraders
Mukti Vats
Favorite
(W1230-03-18) Harnessing Albumin-Anchored BRD4 PROTAC Nanoliposomes for Selective and Targeted Degradation in Pancreatic Ductal Adenocarcinoma
Mukti Vats
Favorite
Vaughn, Jason

Avadel
(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Jason Vaughn
Favorite
(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM
Jason Vaughn
Favorite
(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)
Jason Vaughn
Favorite
Vaz-Luis, Inès

Gustave Roussy Cancer Campus
(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital
Inès Vaz-Luis
Favorite
Veerareddy, Vaishnavi

University of Minnesota
(M1030-04-22) Amyloid Beta Peptides Inhibit Insulin Trafficking at the Blood-Brain-Barrier in Alzheimer's disease Brain
Vaishnavi Veerareddy
Favorite
(T1130-04-23) Regulation of VCAM-1 Expression by the Gut Microbial Metabolite Butyrate: Insights into Molecular Mechanisms
Vaishnavi Veerareddy
Favorite
(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium
Vaishnavi Veerareddy
Favorite
Veerubhotla, Krishna

Pfizer Inc.
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Krishna Veerubhotla
Favorite
Veettil, Shalini

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Shalini Veettil
Favorite
Velaga, Sitaram

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Sitaram Velaga
Favorite
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Sitaram Velaga
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Sitaram Velaga
Favorite
Velez, Ricardo

Hovione FarmaCiencia SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Ricardo Velez
Favorite
Velhal, Mrudul

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Mrudul Velhal
Favorite
Velingkar, Neha

Colorcon Asia Pvt Ltd
(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations
Neha Velingkar
Favorite
(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms
Neha Velingkar
Favorite
Vemula, Sateesh Kumar

University of Mississippi
(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion
Sateesh Kumar Vemula
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Sateesh Kumar Vemula
Favorite
(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends
Sateesh Kumar Vemula
Favorite
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Sateesh Kumar Vemula
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Sateesh Kumar Vemula
Favorite
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Sateesh Kumar Vemula
Favorite
(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG
Sateesh Kumar Vemula
Favorite
(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer
Sateesh Kumar Vemula
Favorite
Venkatachalem, Sathish

North Dakota State University
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Sathish Venkatachalem
Favorite
Vera, Matthew

US Food and Drug Administration
(T1430-05-29) Critical System Suitability Test Established in Regulatory Analytical Procedures for Testing Organic Impurities in Drug Substance and Drug Product and Relevant Changes in Recently Revised USP < 621 >
Matthew Vera
Favorite
Verbic, Tatjana Z.

University of Belgrade
(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle
Tatjana Z. Verbic
Favorite
(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride
Tatjana Z. Verbic
Favorite
Verma, Pratishtha

University of Iowa
(M1130-03-18) Model-Informed Approach for Formulation Development of Extended-Release Phenserine Tablets to Mitigate pH-Dependent Degradation
Pratishtha Verma
Favorite
Vernillet, Laurent

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Laurent Vernillet
Favorite
Vert, Katya

Nostopharma
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Katya Vert
Favorite
Vertzoni, Maria

National and Kapodistrian University of Athens
(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed
Maria Vertzoni
Favorite
(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis
Maria Vertzoni
Favorite
Vervaet, Chris

Ghent University
(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers
Chris Vervaet
Favorite
Verzijl, Dennis

Genmab
(T1430-06-36) Addressing Target Interference During the Development of a Neutralizing Anti-Drug Antibody Assay for the Clinical Support of a Bispecific Therapeutic Antibody
Dennis Verzijl
Favorite
Viglietta, Vissia

Nido Biosciences, Inc.
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Vissia Viglietta
Favorite
Vijayanand, Sharon

US Food and Drug Administration
(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System
Sharon Vijayanand
Favorite
Viramontes, Jose

Dow Development Laboratories, LLC
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Jose Viramontes
Favorite
Viswaroopan, Nethra

Mercer University
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Nethra Viswaroopan
Favorite
(T1130-06-34) In Vitro Topical and Transdermal Delivery of 4-Phenylbutyric Acid Emulsome Loaded Foam Formulation for the Treatment of Chemical Warfare Agent-Induced Skin Injury
Nethra Viswaroopan
Favorite
(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Nethra Viswaroopan
Favorite
Vivian, Diana

US Food and Drug Administration
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Diana Vivian
Favorite
Voelker, Troy

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Troy Voelker
Favorite
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Troy Voelker
Favorite
Vogt, Andrew

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Andrew Vogt
Favorite
Voleti, Rao

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Rao Voleti
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Rao Voleti
Favorite
Vollenbröker, Marc

Farco-Pharma
(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder
Marc Vollenbröker
Favorite
Volpe-Zanutto, Fabiana

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Fabiana Volpe-Zanutto
Favorite
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Fabiana Volpe-Zanutto
Favorite
(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria
Fabiana Volpe-Zanutto
Favorite
Von Raumer, Markus

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Markus Von Raumer
Favorite
Vora, Akshay

Massachusetts College of Pharmacy and Health Sciences
(T1530-06-33) PAR-1 Selective Antagonist, SCH-79797 Dihydrochloride, Inhibits the Proliferation and Migration of the Metastatic Human Prostate Cancer (PC-3) Cells
Akshay Vora
Favorite
Vora, Lalitkumar

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Lalitkumar Vora
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Lalitkumar Vora
Favorite
Vo, Trinh

AstraZeneca
(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies
Trinh Vo
Favorite
Vreeman, Gerrit

University of Minnesota
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Gerrit Vreeman
Favorite
(M1330-05-25) Generalization of the Tabletability Equation for Describing Powder Properties as a Function of Compaction Pressure
Gerrit Vreeman
Favorite
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Gerrit Vreeman
Favorite
Vu Trieu, Isabelle

Waters Corporation
(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector
Isabelle Vu Trieu
Favorite
(M1430-11-63) Going Greener with the USP 621 Globally Harmonized Pharmacopeial Guidance for Liquid Chromatography
Isabelle Vu Trieu
Favorite
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Isabelle Vu Trieu
Favorite
Vu, Kelly

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Kelly Vu
Favorite
Vyas, Zankrut

Rutgers University
(T0930-11-65) Quantitative Prediction of Segregation Risk in Multicomponent Pharmaceutical Blends
Zankrut Vyas
Favorite
Vyshkina, Tamara

BASF Corporation
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Tamara Vyshkina
Favorite
W
Wada, David (Russ)

QuanTx Consulting
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
David (Russ) Wada
Favorite
Wade, Jonathan

Eli Lilly and Company
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Jonathan Wade
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Jonathan Wade
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Jonathan Wade
Favorite
Wadi, Ahmed

University of Mississippi
(T1530-10-55) 3D Printed Container System for Delayed Release
Ahmed Wadi
Favorite
Wagner, Karl

University Bonn
(M1430-10-59) High Drug Load Metformin ER 1000 mg Tablets Processed via Roller Compaction in Combination with High Molecular Weight HPC
Karl Wagner
Favorite
Wahab, Abiodun

University of Alabama
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Abiodun Wahab
Favorite
Wahab, S M Riajul

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
S M Riajul Wahab
Favorite
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
S M Riajul Wahab
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
S M Riajul Wahab
Favorite
Walenga, Ross

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Ross Walenga
Favorite
Waller, Mark

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Mark Waller
Favorite
Walsh, Andrew

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Andrew Walsh
Favorite
Walsh, Taylor

Eurofins Lancaster Laboratories Professional Scientific Services
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Taylor Walsh
Favorite
Wan, Bo

University of Connecticut
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Bo Wan
Favorite
Wan, Bo

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Bo Wan
Favorite
Wan, Boyong

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Boyong Wan
Favorite
Wang, Ching-Chiung

Taipei Medical University
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Ching-Chiung Wang
Favorite
Wang, Dong

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Dong Wang
Favorite
Wang, Fei

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Fei Wang
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Fei Wang
Favorite
Wang, Fengqiang

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Fengqiang Wang
Favorite
Wang, Honghe

University of Mississippi
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Honghe Wang
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Honghe Wang
Favorite
Wang, Hongmei

WuXi AppTec (Shanghai) Co., Ltd.
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Hongmei Wang
Favorite
Wang, Jennie

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Jennie Wang
Favorite
Wang, Jessica (Zheng)

Regeneron Pharmaceuticals
(M0930-06-36) 1-Tiered Approach for Anti-drug Antibody Testing in Clinical Study
Jessica (Zheng) Wang
Favorite
Wang, Jiang

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Jiang Wang
Favorite
Wang, Jianxin (Jason)

Resolian
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
Jianxin (Jason) Wang
Favorite
Wang, Jiawen

Queen's University Belfast
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Jiawen Wang
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Jiawen Wang
Favorite
Wang, Jiefei

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Jiefei Wang
Favorite
Wang, Kaikai

University of Michigan
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Kaikai Wang
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Kaikai Wang
Favorite
Wang, Kelin

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Kelin Wang
Favorite
Wang, Lushan

Johnson & Johnson
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Lushan Wang
Favorite
Wang, Miaojun

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Miaojun Wang
Favorite
Wang, Michael Zhuo

University of Kansas
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Michael Zhuo Wang
Favorite
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Michael Zhuo Wang
Favorite
Wang, Pinger

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Pinger Wang
Favorite
Wang, Qi

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Qi Wang
Favorite
Wang, Rong

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Rong Wang
Favorite
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Rong Wang
Favorite
Wang, Rui

WuXi AppTec (Shanghai) Co., Ltd.
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Rui Wang
Favorite
Wang, Ruifeng

University of Connecticut
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Ruifeng Wang
Favorite
wang, Serena

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Serena wang
Favorite
Wang, Shuying

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Shuying Wang
Favorite
Wang, Sihong

City College of New York
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Sihong Wang
Favorite
Wang, Viola

WuXi AppTec Co., Ltd.
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Viola Wang
Favorite
Wang, Wei

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Wei Wang
Favorite
Wang, Xiaoyi

University of Connecticut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Xiaoyi Wang
Favorite
Wang, Xinning

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Xinning Wang
Favorite
Wang, Xinyao

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Xinyao Wang
Favorite
Wang, Xinye

University of Michigan
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
Xinye Wang
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Xinye Wang
Favorite
Wang, Xuechun

AbbVie Inc.
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Xuechun Wang
Favorite
Wang, Xuefang

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Xuefang Wang
Favorite
Wang, Xuejing Aimee

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Xuejing Aimee Wang
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Xuejing Aimee Wang
Favorite
Wang, Yan

US Food and Drug Administration
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Yan Wang
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Yan Wang
Favorite
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Yan Wang
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Yan Wang
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Yan Wang
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Yan Wang
Favorite
Wang, Yi

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Yi Wang
Favorite
Wang, Yifan

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Yifan Wang
Favorite
Wang, Yihan

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Yihan Wang
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Yihan Wang
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Yihan Wang
Favorite
Wang, ying

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
ying Wang
Favorite
Wang, Yinghe

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Yinghe Wang
Favorite
Wang, Zhaoxian (George)

Bristol-Myers Squibb Company
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Zhaoxian (George) Wang
Favorite
Wang, Zhengqiang

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Zhengqiang Wang
Favorite
Wang, Zhihui

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Zhihui Wang
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Zhihui Wang
Favorite
Wang, Zijian

University of Minnesota
(T0930-05-25) Impact of Excipient Types and Drug Loadings on the Tabletability Flip Phenomenon
Zijian Wang
Favorite
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Zijian Wang
Favorite
Wani, Shweta

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Shweta Wani
Favorite
Waranuch, Neti

Naresuan University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Neti Waranuch
Favorite
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Neti Waranuch
Favorite
Warren, Brandon

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Brandon Warren
Favorite
Warunek, Jordan

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Jordan Warunek
Favorite
Wasalathanthri, Dhanuka

Bristol Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Dhanuka Wasalathanthri
Favorite
Watson, Thomas

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Thomas Watson
Favorite
Watson, Tom

International Flavors and Fragrances
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Tom Watson
Favorite
Watt, Kevin

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Kevin Watt
Favorite
Watts, Alan

Catalent, Inc.
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Alan Watts
Favorite
Weaver, Lauren

i2Vision
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Lauren Weaver
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Lauren Weaver
Favorite
Webster, Jarom

Thermo Fisher Scientific
(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments
Jarom Webster
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Jarom Webster
Favorite
Webster, Thomas M.

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Thomas M. Webster
Favorite
Wei, Huimei

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Huimei Wei
Favorite
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Huimei Wei
Favorite
Wei, Kevin

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Kevin Wei
Favorite
Weissig, Volkmar

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Volkmar Weissig
Favorite
Welch, Jonathan

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Jonathan Welch
Favorite
Welch, Katie

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Katie Welch
Favorite
Wen, Xinxin

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Xinxin Wen
Favorite
Westlund, Karin N

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Karin N Westlund
Favorite
Wetzel, Stefan

IntiQuan AG
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Stefan Wetzel
Favorite
Whang, Dakyung

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Dakyung Whang
Favorite
Whelihan, Matt

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Matt Whelihan
Favorite
White, Andrew

UK Health Security Agency
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Andrew White
Favorite
White, Brianna

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Brianna White
Favorite
Wijewantha, Nisitha

US Food and Drug Administration
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Nisitha Wijewantha
Favorite
Wilcock, Brandon

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brandon Wilcock
Favorite
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Brandon Wilcock
Favorite
Wildfong, Peter L.D.

Duquesne University
(M1530-07-39) Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions
Peter L.D. Wildfong
Favorite
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Peter L.D. Wildfong
Favorite
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Peter L.D. Wildfong
Favorite
Wilkie, Emma

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Emma Wilkie
Favorite
Willett, Daniel

US Food and Drug Administration
(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets
Daniel Willett
Favorite
Williams, Mark

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Mark Williams
Favorite
Williams, Michael

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Michael Williams
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Michael Williams
Favorite
Williamson, Jeff

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Jeff Williamson
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Jeff Williamson
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Jeff Williamson
Favorite
Williams, Robert

The University of Texas at Austin
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Robert Williams
Favorite
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Robert Williams
Favorite
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Robert Williams
Favorite
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Robert Williams
Favorite
Williams, Steve

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Steve Williams
Favorite
Williams, Steve

Centre for Biopharmaceutical Excellence Pty Ltd
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Steve Williams
Favorite
Williard, Clark

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Clark Williard
Favorite
Wilson, Ian

Imperial College London
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Ian Wilson
Favorite
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Ian Wilson
Favorite
Wilson, Peter

Queen's University Belfast
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Peter Wilson
Favorite
Wilson, Renae

Nova Southeastern University
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Renae Wilson
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Renae Wilson
Favorite
Winiarski, Maciej

Institute of Low Temperature and Structure Research
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Maciej Winiarski
Favorite
Wisniewski, Steven

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Steven Wisniewski
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Steven Wisniewski
Favorite
Wi, Sungsool

National High Magnetic Field Laboratory
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Sungsool Wi
Favorite
Wohlstadter, Jacob

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Jacob Wohlstadter
Favorite
Won, Donghan

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Donghan Won
Favorite
Wong, Li Chin

Eli Lilly and Company
(W0930-10-55) Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF
Li Chin Wong
Favorite
Wong, Melissa

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Melissa Wong
Favorite
Wong, Norris

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Norris Wong
Favorite
(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration
Norris Wong
Favorite
Wong, Siu Ming Raymond

Prince of Wales Hospital, Hospital Authority
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Siu Ming Raymond Wong
Favorite
Wong, Timothy

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Timothy Wong
Favorite
Wongumpornpinit, Vorawut

Naresuan University
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Vorawut Wongumpornpinit
Favorite
Wood, Brent

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Brent Wood
Favorite
Wood, Jason

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Jason Wood
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Jason Wood
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Jason Wood
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Jason Wood
Favorite
Woods, Adam

BASF Corporation
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Adam Woods
Favorite
Wood, Sharla

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Sharla Wood
Favorite
Wood, Tim

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Tim Wood
Favorite
Woo, Mi Ran

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Mi Ran Woo
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Mi Ran Woo
Favorite
Woo, Sanghyun

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sanghyun Woo
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sanghyun Woo
Favorite
Woo, Sukyung

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Sukyung Woo
Favorite
Worrest, Hannah

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Hannah Worrest
Favorite
Wo, Siu Kwan

Chinese University of Hong Kong, The
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Siu Kwan Wo
Favorite
Wrona, Mark

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Mark Wrona
Favorite
Wu, Fang

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Fang Wu
Favorite
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Fang Wu
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Fang Wu
Favorite
Wu, Jiewei

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Jiewei Wu
Favorite
Wu, Jincao

Eisai Inc.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Jincao Wu
Favorite
Wu, Qi

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Qi Wu
Favorite
Wu, Xiangmeng

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Xiangmeng Wu
Favorite
Wu, Xiaohuan

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Xiaohuan Wu
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Xiaohuan Wu
Favorite
Wu, Yanyuan

Charles Drew University of Medicine and Science
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Yanyuan Wu
Favorite
Wu, Yue

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Yue Wu
Favorite
X
Xiang, Tianyi

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Tianyi Xiang
Favorite
(W1230-10-57) Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion
Tianyi Xiang
Favorite
Xiao, Yingwen

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Yingwen Xiao
Favorite
Xiaoyu, Ji

Chinese University of Hong Kong, The
(W0930-04-24) Kidney Metabolomics Demonstrated the Energy Supply Upregulation by Radix Aconiti Lateralis Preparations in Rats
Ji Xiaoyu
Favorite
Xia, Qiang

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Qiang Xia
Favorite
Xie, Huan

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Huan Xie
Favorite
Xie, Jiashu

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Jiashu Xie
Favorite
Xie, Lingxiao

US Food and Drug Administration
(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories
Lingxiao Xie
Favorite
(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin
Lingxiao Xie
Favorite
Xie, Zuoxu

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Zuoxu Xie
Favorite
Xin, Benjamin

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Benjamin Xin
Favorite
Xing, Kuiyi

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Kuiyi Xing
Favorite
Xing, Lili

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Lili Xing
Favorite
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Lili Xing
Favorite
Xin, Lun

Wuxi Biologics
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Lun Xin
Favorite
Xi, Zhangjie

Bayer Consumer Care
(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules
Zhangjie Xi
Favorite
(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays
Zhangjie Xi
Favorite
(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel
Zhangjie Xi
Favorite
(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations
Zhangjie Xi
Favorite
Xue, Liang

University of the Pacific
(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles
Liang Xue
Favorite
Xue, Zheng

University of Minnesota
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Zheng Xue
Favorite
Xu, Guo

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Guo Xu
Favorite
Xu, Haiyue

University of Texas at Austin
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Haiyue Xu
Favorite
Xu, Jianchao

Purdue University
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Jianchao Xu
Favorite
Xu, Miao

Chinese University of Hong Kong, The
(M1230-01-05) Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants
Miao Xu
Favorite
Xu, Qingguo

Virginia Commonwealth University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Qingguo Xu
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Qingguo Xu
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Qingguo Xu
Favorite
Xu, Shuyu

Ashland Specialty Ingredients
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Shuyu Xu
Favorite
Xu, Weifeng

Merck & Co., Inc.
(M1030-06-31) Utilizing LC-MS to Support of PABAD-Based Detection of Neutralizing Antibodies
Weifeng Xu
Favorite
Xu, Wenqin

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Wenqin Xu
Favorite
Xu, Xiaolin

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Xiaolin Xu
Favorite
Xu, Xiaoming

US Food and Drug Administration
(T1530-11-60) Evaluation of Near Infrared (NIR) for the Quantitation of Low Dose Drugs
Xiaoming Xu
Favorite
Xu, Yueqiang

ICE Bioscience
(M1030-04-19) Integrated Screening Platform of PDE for Lung Fibrosis Drug Discovery
Yueqiang Xu
Favorite
Xu, Yunming

US Food and Drug Administration
(M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
Yunming Xu
Favorite
(T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
Yunming Xu
Favorite
Xu, Zijing

University of Florida College of Pharmacy
(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Zijing Xu
Favorite
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Zijing Xu
Favorite
Xu, Zizhao

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Zizhao Xu
Favorite
Y
Yabuuchi, Kohei

Asahi Kasei Corporation
(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs
Kohei Yabuuchi
Favorite
Yadav, Anjali

St. John's University
(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment
Anjali Yadav
Favorite
Yadav, Balaji

Creighton University
(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis
Balaji Yadav
Favorite
Yadav, Vivek

NIPER
(W1030-01-02) Harnessing the Potential of Self-Assembled Hyaluronic Acid Nanoparticles for Tumor Targeted Co-Delivery of Betulinic Acid and Paclitaxel
Vivek Yadav
Favorite
Yadwad, Veerarajendra

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Veerarajendra Yadwad
Favorite
Yagi, Haruya

Setsunan University
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Haruya Yagi
Favorite
Yalamarty, Satya Siva Kishan

Northeastern University
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Satya Siva Kishan Yalamarty
Favorite
Yamada, Kohei

University of Shizuoka
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Kohei Yamada
Favorite
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Kohei Yamada
Favorite
Yamagata, Marie

Tomita Pharmaceutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Marie Yamagata
Favorite
Yamaguchi, Katsutoshi

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Katsutoshi Yamaguchi
Favorite
Yamamoto, Hidemi

Harvard Medical School
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Hidemi Yamamoto
Favorite
Yamashiro, Takahiro

Nagoya City University
(M0930-04-24) Role of FLVCR2 in the Intestinal Choline Uptake in the Rat Model
Takahiro Yamashiro
Favorite
Yamashita, Shogo

Hoshi University
(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery
Shogo Yamashita
Favorite
Yamato, Mana

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Mana Yamato
Favorite
Yamauchi, Yuta

Nissor Pharmaceuticals Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Yuta Yamauchi
Favorite
Yamazoe, Eriko

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Eriko Yamazoe
Favorite
Yang, Fengyuan

Ashland Specialty Ingredients
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Fengyuan Yang
Favorite
Yang, Jay

Alexion Pharmaceuticals, Inc.
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Jay Yang
Favorite
Yang, Jerry

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Jerry Yang
Favorite
Yang, Jesse

Gilead Sciences, Inc.
(M0930-02-07) Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling
Jesse Yang
Favorite
Yang, Jiyuan

University of Utah
(M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
Jiyuan Yang
Favorite
(M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
Jiyuan Yang
Favorite
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Jiyuan Yang
Favorite
(T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
Jiyuan Yang
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Jiyuan Yang
Favorite
(T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
Jiyuan Yang
Favorite
(W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
Jiyuan Yang
Favorite
Yang, Mengbi

Drug Safety Testing Center, Hong Kong Science and Technology Parks
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Mengbi Yang
Favorite
Yang, Mengbi

Chinese University of Hong Kong, The
(W0930-04-24) Kidney Metabolomics Demonstrated the Energy Supply Upregulation by Radix Aconiti Lateralis Preparations in Rats
Mengbi Yang
Favorite
Yang, Rong-Sheng

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Rong-Sheng Yang
Favorite
Yang, Suhui

Charles Drew University of Medicine and Science
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Suhui Yang
Favorite
Yang, Sung-Don

Chungju Weedahm Integrative Hospital
(T1330-02-09) Examining PDGFRA Gene Downregulation in the Peripheral Blood of Patients with Functional Dyspepsia
Sung-Don Yang
Favorite
Yang, Yagai

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Yagai Yang
Favorite
Yang, Yang

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Yang Yang
Favorite
Yang, Yejin

Adare Pharma Solutions
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Yejin Yang
Favorite
Yang, Zhiyong

FZata
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Zhiyong Yang
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Zhiyong Yang
Favorite
Yanwinitchai, Sorawee

University of Texas at Austin
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Sorawee Yanwinitchai
Favorite
Yasuda, Sanae

Eisai Inc.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Sanae Yasuda
Favorite
Yasujima, Tomoya

Nagoya City University
(M0930-04-24) Role of FLVCR2 in the Intestinal Choline Uptake in the Rat Model
Tomoya Yasujima
Favorite
Yearley, Jennifer

Merck & Co., Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Jennifer Yearley
Favorite
Yee, Leanna

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Leanna Yee
Favorite
Yellepeddi, Venkata

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Venkata Yellepeddi
Favorite
(T1030-02-07) Pediatric Oral Cavity PBPK Model to Predict Pharmacokinetics of Mucoadhesive Atropine Gel to Treat Sialorrhea
Venkata Yellepeddi
Favorite
Yeoh, Thean

Pfizer Inc.
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Thean Yeoh
Favorite
Yeo, Sooho

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Sooho Yeo
Favorite
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
Sooho Yeo
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Sooho Yeo
Favorite
Yeo, Yoon

Purdue University
(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer
Yoon Yeo
Favorite
(T1130-07-37) Albumin Corona Improves Colloidal Stability of Nanosac, a Non-Cationic Polyphenol Gene Carrier
Yoon Yeo
Favorite
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Yoon Yeo
Favorite
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Yoon Yeo
Favorite
(T1530-06-36) DoE-Based Optimization of RNA Nanosac Lyophilization for Cold-Chain-Free Storage and Transportation
Yoon Yeo
Favorite
(W0930-07-37) Nanoparticle Development for Systemic Delivery of Resiquimod to Reactivate Immunosuppressive Tumor Microenvironment
Yoon Yeo
Favorite
Yesilyurt, Volkan

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Volkan Yesilyurt
Favorite
Yetsko, Kyle

St. Joseph's University
(T1430-04-24) Method Optimization to Reduce Leakage of Encapsulated Protein from Ethylcellulose Microcapsules Using Bovine Serum Albumin as a Model Protein
Kyle Yetsko
Favorite
Ye, Zhuqiu

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Zhuqiu Ye
Favorite
Yi, Bofang

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Bofang Yi
Favorite
Yilmaz, Huzeyfe

US Food and Drug Administration
(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets
Huzeyfe Yilmaz
Favorite
Yin, Weimin

fuxing company
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Weimin Yin
Favorite
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Weimin Yin
Favorite
Yip, Victor

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Victor Yip
Favorite
Yonet-Tanyeri, Nihan

University of Pittsburgh
(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics
Nihan Yonet-Tanyeri
Favorite
Yong, Hong

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Hong Yong
Favorite
Yoo, Chaerim

Hanyang University
(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation
Chaerim Yoo
Favorite
Yoon, Hongjun

Dankook University
(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability
Hongjun Yoon
Favorite
(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability
Hongjun Yoon
Favorite
(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability
Hongjun Yoon
Favorite
(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability
Hongjun Yoon
Favorite
Yoo, Seunghyun

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Seunghyun Yoo
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Seunghyun Yoo
Favorite
Yoshida, Ayumi

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Ayumi Yoshida
Favorite
Yoshikawa, Etsushi

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Etsushi Yoshikawa
Favorite
Young, Daniel

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Daniel Young
Favorite
Young, Valerie

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Valerie Young
Favorite
Yousef, Malaz

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Malaz Yousef
Favorite
Youssef, Ahmed

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Ahmed Youssef
Favorite
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems
Ahmed Youssef
Favorite
You, Youngjae

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Youngjae You
Favorite
Yu, Andy

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Andy Yu
Favorite
Yuan, Zhongyue

Purdue University
(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain
Zhongyue Yuan
Favorite
Yuasa, Hiroaki

Nagoya City University
(M0930-04-24) Role of FLVCR2 in the Intestinal Choline Uptake in the Rat Model
Hiroaki Yuasa
Favorite
Yu, Dongyue

Bristol-Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Dongyue Yu
Favorite
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Dongyue Yu
Favorite
Yue, Hongfei

US Food and Drug Administration
(T1430-05-29) Critical System Suitability Test Established in Regulatory Analytical Procedures for Testing Organic Impurities in Drug Substance and Drug Product and Relevant Changes in Recently Revised USP < 621 >
Hongfei Yue
Favorite
Yuen, Eunice

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Eunice Yuen
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Eunice Yuen
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Eunice Yuen
Favorite
Yue, Weizhou

Northeastern University
(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging
Weizhou Yue
Favorite
Yu, Hua

FZata
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Hua Yu
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Hua Yu
Favorite
Yu, Jesse

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Jesse Yu
Favorite
Yu, Mengqi

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Mengqi Yu
Favorite
yun, Chun Hee

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Chun Hee yun
Favorite
Yun-Lin, Mei

Foghorn Therapeutics
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Mei Yun-Lin
Favorite
Yu, Ruth

Dow Development Laboratories, LLC
(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics
Ruth Yu
Favorite
Yu, Weidong (David)

BioPharma Services Inc.
(M0930-02-12) Sex, Racial, and Ethnic Representation in COVID-19 Vaccine Clinical Trials Conducted in US - A Systematic Review Compared to 2020 US Census Data
Weidong (David) Yu
Favorite
Z
Zaczek, Adam

AbbVie Inc.
(T1430-10-54) Drug Particle Size Change of a Hydrophobic Drug and Its Impact on Dissolution after Twin-Screw Wet Granulation
Adam Zaczek
Favorite
Zadrazil, Ales

University of Chemistry and Technology
(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem
Ales Zadrazil
Favorite
Zahid, Md Ikhtiar

University of Texas at El Paso
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Md Ikhtiar Zahid
Favorite
Zakarian, Joseph

Anton Paar USA, Inc.
(M1530-11-61) Evaluating Zeta Potential's Role in Monoclonal Antibody Manufacturing and Medical Application
Joseph Zakarian
Favorite
(T1530-11-61) Advanced Characterization of COVID-19 mRNA Vaccines Using Litesizer DLS Instruments
Joseph Zakarian
Favorite
Zaker, Yeakub

U S Food and Drug Administration
(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets
Yeakub Zaker
Favorite
Zamora, Agustín

Pontificia Universidad Catolica de Chile de Valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Agustín Zamora
Favorite
Zangle, Thomas

University of Utah
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Thomas Zangle
Favorite
Zelesky, Todd

Pfizer Inc.
(T0930-07-38) Understanding Dibasic Calcium Phosphate Impact on Chemical Stability - Trends in Immediate Release Tablet Formulations
Todd Zelesky
Favorite
Zemlyanov, Dmitry

Purdue University
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Dmitry Zemlyanov
Favorite
Zeng, Chaowang

University of Minnesota
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Chaowang Zeng
Favorite
Zeng, Wei

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Wei Zeng
Favorite
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Wei Zeng
Favorite
Zeng, Yang

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Yang Zeng
Favorite
Zerin, Farzana

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Farzana Zerin
Favorite
Zhan, Chang-Guo

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Chang-Guo Zhan
Favorite
Zhang, Ariel

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Ariel Zhang
Favorite
Zhang, Chenpu

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Chenpu Zhang
Favorite
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Chenpu Zhang
Favorite
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Chenpu Zhang
Favorite
Zhang, Chu

Auburn University
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Chu Zhang
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Chu Zhang
Favorite
Zhang, Endong

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Endong Zhang
Favorite
Zhang, Fan

University of Florida
(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Fan Zhang
Favorite
(T1430-04-20) In Situ Engineering of Tumor-Infiltrating Myeloid Cells Through Dendrimer-Based Lipid Nanoparticles
Fan Zhang
Favorite
(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor
Fan Zhang
Favorite
Zhang, Feng

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Feng Zhang
Favorite
(M1230-11-65) Local Heat Generation at Kneading Zone in Continuous Twin-Screw Melt Granulation: Exploring the Interplay of Processing Parameters and Binder Level for a Novel Thermal Binder
Feng Zhang
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Feng Zhang
Favorite
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Feng Zhang
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Feng Zhang
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Feng Zhang
Favorite
(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant
Feng Zhang
Favorite
Zhang, Ge

Hong Kong Baptist University
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Ge Zhang
Favorite
Zhang, Hailong

Roquette Asia Pacific Pte. Ltd.
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Hailong Zhang
Favorite
Zhang, Han

Mainline Scientific
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Han Zhang
Favorite
Zhang, Hang

Chinese University of Hong Kong, The
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
Hang Zhang
Favorite
Zhang, Hongling

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Hongling Zhang
Favorite
(W1230-02-10) Post-Complete Response Letter Scientific Meeting Requests: Key Takeaways from Case Studies
Hongling Zhang
Favorite
Zhang, Hongyu

Umabs Therapeutics
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Hongyu Zhang
Favorite
Zhang, Jessica

Univar Solutions
(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000
Jessica Zhang
Favorite
Zhang, Jiantao

Ningbo CIxi Institute of Biomedical Engineering
(T1230-01-03) A High Oral Bioavailable Berberine-Lornoxicam Cocrystal with Improved Caco-2 Permeability, Tunable Dissolution, and Improved Taste
Jiantao Zhang
Favorite
Zhang, Jilin

ARx, LLC
(T1030-09-52) Weekly Apixaban Transdermal Delivery System
Jilin Zhang
Favorite
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Jilin Zhang
Favorite
Zhang, Jun

Chinese University of Hong Kong, The
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Jun Zhang
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Jun Zhang
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Jun Zhang
Favorite
Zhang, Lan

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Lan Zhang
Favorite
Zhang, Lei

US Food and Drug Administration
(M0930-11-61) Investigating Impact of Food Induced Fluid Viscosity on Immediate Release Tablet Disintegration and Drug Dissolution
Lei Zhang
Favorite
(M1130-11-60) Effect of Medium Viscosity on Swelling and Disintegration of Immediate Release Solid Oral Tablet
Lei Zhang
Favorite
Zhang, Lei

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Lei Zhang
Favorite
Zhang, Luchen

University of Michigan
(T1130-06-35) Leveraging Machine Learning to Predict Clinical Adverse Events Driven by Target-Specific and Off-Target Binding
Luchen Zhang
Favorite
Zhang, Nan

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Nan Zhang
Favorite
Zhang, Pei

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Pei Zhang
Favorite
Zhang, Peilun

US Food and Drug Administration
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Peilun Zhang
Favorite
Zhang, Qi

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Qi Zhang
Favorite
Zhang, Qian

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Qian Zhang
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Qian Zhang
Favorite
Zhang, Qiangnan

US Food and Drug Administration
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Qiangnan Zhang
Favorite
Zhang, Qing-yu

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Qing-yu Zhang
Favorite
Zhang, Shawn

DigiM Solution LLC
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Shawn Zhang
Favorite
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Shawn Zhang
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Shawn Zhang
Favorite
Zhang, Shimin

Population Council
(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation
Shimin Zhang
Favorite
Zhang, Shuo

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Shuo Zhang
Favorite
Zhang, Stephanie

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Stephanie Zhang
Favorite
Zhang, Tao

Boehringer Ingelheim
(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying
Tao Zhang
Favorite
Zhang, Tao

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Tao Zhang
Favorite
(T1330-02-08) Machine Learning Approaches for Assessing Medication Transfer to Human Breast Milk: Estimating Milk/Plasma Drug Ratios
Tao Zhang
Favorite
Zhang, Xianwei

Boehringer-Ingelheim
(T1430-02-12) Ocular Pharmacokinetic Model for Intravitreal Antibody Injection
Xianwei Zhang
Favorite
Zhang, Yeli

International Flavors and Fragrances
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Yeli Zhang
Favorite
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Yeli Zhang
Favorite
Zhang, Yilu

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Yilu Zhang
Favorite
Zhang, Yong

Texas Tech University Health Sciences Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Yong Zhang
Favorite
Zhang, Yu

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Yu Zhang
Favorite
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Yu Zhang
Favorite
Zhang, Yu-E
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Yu-E Zhang
Favorite
Zhang, Yufeng

Chinese University of Hong Kong, The
(M1130-11-62) Network Analysis of Pharmaceutical Products from Hong Kong PIC/S GMP Manufacturers
Yufeng Zhang
Favorite
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Yufeng Zhang
Favorite
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Yufeng Zhang
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Yufeng Zhang
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Yufeng Zhang
Favorite
Zhang, Zhe

Wuxi Biologics
(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies
Zhe Zhang
Favorite
Zhang, Zhen

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Zhen Zhang
Favorite
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Zhen Zhang
Favorite
Zhao, Eric

Frontage Laboratories
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Eric Zhao
Favorite
Zhao, Gang

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Gang Zhao
Favorite
Zhao, Jin

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Jin Zhao
Favorite
Zhao, Juan

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Juan Zhao
Favorite
(W1030-02-12) Comparative Detection of Pre-existing Anti‑AAV8 Antibodies in Normal Human Serum by a Total Antibody Assay Versus a Transduction Inhibition Assay
Juan Zhao
Favorite
Zhao, Liang

US Food and Drug Administration
(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel
Liang Zhao
Favorite
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Liang Zhao
Favorite
Zhao, Min

Moderna Therapeutics
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Min Zhao
Favorite
Zhao, Shen

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Shen Zhao
Favorite
Zhao, Shengnan

University of Alberta
(W1030-11-60) Canada and the World: A Comparative Global Regulatory and Quality Variability Study of Melatonin Health Products
Shengnan Zhao
Favorite
Zhao, Xiaofeng

Adare Pharma Solutions
(W1030-10-59) Optimization of Assay Method for a Drug with Two pKa
Xiaofeng Zhao
Favorite
zhao, Yan

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Yan zhao
Favorite
Zhao, Yongzhong

Frontage Laboratories, Inc.
(T1230-06-36) Quantitative Assessment of mRNA Drug Biological Activity by Cell-Based Assays
Yongzhong Zhao
Favorite
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Yongzhong Zhao
Favorite
Zhao, Yuxiang

Bristol Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Yuxiang Zhao
Favorite
Zhao, Zhongyuan

Binghamton University
(M1430-02-09) A PBPK Model for Prediction of Apixaban and Rivaroxaban Secretion into Milk
Zhongyuan Zhao
Favorite
(T1330-02-08) Machine Learning Approaches for Assessing Medication Transfer to Human Breast Milk: Estimating Milk/Plasma Drug Ratios
Zhongyuan Zhao
Favorite
Zhao, Zongmin

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Zongmin Zhao
Favorite
Zheng, Fang

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Fang Zheng
Favorite
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Fang Zheng
Favorite
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Fang Zheng
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Fang Zheng
Favorite
Zheng, Jingtian

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Jingtian Zheng
Favorite
Zheng, Wei

Texas A&M University
(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches
Wei Zheng
Favorite
Zhen, Zixuan

University of Connecticut
(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles
Zixuan Zhen
Favorite
Zhong, Ziyue

University of Texas at Austin
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Ziyue Zhong
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Ziyue Zhong
Favorite
Zhou, Andrew

Johnson & Johnson
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Andrew Zhou
Favorite
Zhou, Bangjun

Celerion
(W1030-06-34) Stabilization of a Therapeutic Peptide for a Quantitative ECLIA Assay
Bangjun Zhou
Favorite
Zhou, Dawei

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Dawei Zhou
Favorite
Zhou, Deliang

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Deliang Zhou
Favorite
Zhou, Feng

Chinese Academy of Science
(W0930-04-23) Three Dimensional Industrial DNA Nanorobot as a Functional Drug Delivery System
Feng Zhou
Favorite
Zhou, Guangchun

Medpace
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Guangchun Zhou
Favorite
Zhou, Haiying

Simulations Plus, Inc.
(M1030-02-09) Integration of Gut Microbiome Metabolism in a PBBM-PBPK Model: Its Impact on the Sulfasalazine Absorption
Haiying Zhou
Favorite
(T0930-04-22) Mechanistic In Vitro Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Haiying Zhou
Favorite
(T1430-04-21) Mechanistic Model of In Vitro Intraoral Absorption of Buprenorphine for the Buccal and Gingival Mucosa
Haiying Zhou
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Haiying Zhou
Favorite
Zhou, Hongfei

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Hongfei Zhou
Favorite
Zhou, Kelu

Wake Forest University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Kelu Zhou
Favorite
Zhou, Lang

Auburn University
(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment
Lang Zhou
Favorite
Zhou, Qi (Tony)

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Qi (Tony) Zhou
Favorite
(M1130-05-28) Understanding the Impact of L-leucine on Stability and Inhalation Potential of Dry Powder Protein Formulations
Qi (Tony) Zhou
Favorite
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Qi (Tony) Zhou
Favorite
Zhou, Qun

Huazhong University of Science and Technology
(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity
Qun Zhou
Favorite
Zhou, Xiaomei

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Xiaomei Zhou
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Xiaomei Zhou
Favorite
Zhou, Yiyang

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Yiyang Zhou
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Yiyang Zhou
Favorite
Zhuang, Kai

BASF (China) Company Ltd.
(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets
Kai Zhuang
Favorite
Zhu, Catherine

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Catherine Zhu
Favorite
Zhu, Chunli

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Chunli Zhu
Favorite
Zhu, Fengying

ImmunoGen (now part of AbbVie)
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
Fengying Zhu
Favorite
Zhu, Jiexin

University of Queensland
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Jiexin Zhu
Favorite
Zhu, Julie

GlaxoSmithKline plc
(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes
Julie Zhu
Favorite
Zhu, Koudi

IFF Pharma Solutions
(W1130-10-55) Improving Sensitivity and Accuracy in Nitrite Measurement in Hydroxypropyl Methylcellulose
Koudi Zhu
Favorite
Zhu, Liang

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Liang Zhu
Favorite
(M1330-02-12) Multi-Strain Sars-Cov-2 Neutralization Assay Qualification
Liang Zhu
Favorite
Zhu, Lin

Texas A&M University
(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment
Lin Zhu
Favorite
Zhu, Lingling

Kanwhish Biotech Co.
(W1030-02-12) Comparative Detection of Pre-existing Anti‑AAV8 Antibodies in Normal Human Serum by a Total Antibody Assay Versus a Transduction Inhibition Assay
Lingling Zhu
Favorite
Zhuo, Xuezhi

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Xuezhi Zhuo
Favorite
Zhu, Sherry

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Sherry Zhu
Favorite
Zhu, Yong

University of the Pacific
(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer
Yong Zhu
Favorite
Zidan, Ahmed

US Food and Drug Administration
(M1330-10-55) Evaluation of Critical Microstructural and Performance Attributes of Azelaic Acid Topical Gels
Ahmed Zidan
Favorite
(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations
Ahmed Zidan
Favorite
(W1030-10-56) Validation and Application of an LC-MS/MS Method to Evaluate In Vitro Permeation of Naloxone Nasal Spray Using Artificial Substrate
Ahmed Zidan
Favorite
(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence
Ahmed Zidan
Favorite
(W1130-10-56) Mechanistic Evaluation of Microstructure and Performance Attributes of Medicated Topical Shampoos
Ahmed Zidan
Favorite
Zidar, Stephanie

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Stephanie Zidar
Favorite
Ziegahn, Christina

Altasciences
(W1130-04-23) Implementation of a Semi-Automated Bead Extraction Procedure during Analyte Purification for High Throughput Immunogenicity Assays
Christina Ziegahn
Favorite
Ziehr, Benjamin

PPD Laboratories
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Benjamin Ziehr
Favorite
Zielinski, Chelsea

BioAgilytix
(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System
Chelsea Zielinski
Favorite
Ziemba, Theresa

Bristol-Myers Squibb Company
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Theresa Ziemba
Favorite
Zloh, Mire

University College London
(T1230-04-20) Mechanism of Curcumin Encapsulation by GCPQ Polymers: Unexpected Polymer Mesh (Matrix) Configuration Revealed by Atomistic Molecular Dynamics Simulations
Mire Zloh
Favorite
Zombek, Jessica

GEA Process Engineering, Inc.
(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator
Jessica Zombek
Favorite
Zong, Cathy

BASF (China) Company Ltd.
(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets
Cathy Zong
Favorite
Zou, Junju

Chinese University of Hong Kong, The
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Junju Zou
Favorite
(M1430-04-24) Gut Microbiota-Based Bioassay for the Quality Control of Dendrobium from Different Sources
Junju Zou
Favorite
(M1530-04-24) Isolation and Biological Activity Evaluations of Exosome-Like Nanovesicles Derived from Dendrobium officinale
Junju Zou
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Junju Zou
Favorite
Zou, Linglong

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Linglong Zou
Favorite
(W1030-02-12) Comparative Detection of Pre-existing Anti‑AAV8 Antibodies in Normal Human Serum by a Total Antibody Assay Versus a Transduction Inhibition Assay
Linglong Zou
Favorite
Zou, Peng

Daiichi Sankyo Co., Ltd.
(T1330-02-08) Machine Learning Approaches for Assessing Medication Transfer to Human Breast Milk: Estimating Milk/Plasma Drug Ratios
Peng Zou
Favorite
Zughaier, Susu

Qatar University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Susu Zughaier
Favorite
(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation
Susu Zughaier
Favorite
(M1130-06-36) A Cell-To-Cell Contact Immune System Mimicking In Vitro Overlay Assay: Evaluating Nanoparticle Vaccine Formulations for Adaptive Immunity Responses
Susu Zughaier
Favorite
Zuluaga-Rave, David

Resolian
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
David Zuluaga-Rave
Favorite
Zuo, Jieyu

University of Alberta
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Jieyu Zuo
Favorite
Zuo, Zhong

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Zhong Zuo
Favorite
(M1130-11-62) Network Analysis of Pharmaceutical Products from Hong Kong PIC/S GMP Manufacturers
Zhong Zuo
Favorite
(M1230-01-05) Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants
Zhong Zuo
Favorite
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Zhong Zuo
Favorite
(M1430-04-24) Gut Microbiota-Based Bioassay for the Quality Control of Dendrobium from Different Sources
Zhong Zuo
Favorite
(M1530-02-11) Circumvention of Targeted Anticancer Drug Resistance by Standardized Yunzhi Extract
Zhong Zuo
Favorite
(M1530-04-24) Isolation and Biological Activity Evaluations of Exosome-Like Nanovesicles Derived from Dendrobium officinale
Zhong Zuo
Favorite
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Zhong Zuo
Favorite
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Zhong Zuo
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Zhong Zuo
Favorite
(W0930-04-24) Kidney Metabolomics Demonstrated the Energy Supply Upregulation by Radix Aconiti Lateralis Preparations in Rats
Zhong Zuo
Favorite
Zurek, Nesia

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Nesia Zurek
Favorite
Zybura, Agnes

LabCorp
(M0930-10-59) Validation of a Quantitative PCR (qPCR) Assay for the Detection and Quantification of Replication Competent Lentivirus for Patient Monitoring in Lentiviral Vector-Based Cell Therapy Studies
Agnes Zybura
Favorite